| Period End | Type | Status | Affected | % Workforce | Announced | Expected Completion | Geography | Segment / Function | Charge | Source | Note |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | restructuring | in_progress | 2024-03-27 | 2028-12-31 | Global | All major geographies | USD 1,500 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Board extended program through end of 2028 in Q2 2026. Expected workforce reductions of 4-5% of organization; total pre-tax costs anticipated at approximately $1.5 billion, ~60% cash, primarily workforce reductions and program costs. Cumulative pre-tax charges through June 30, 2026 were $913 million ($706 million after-tax); Q2 2026 charges $54 million pre-tax ($40 million after-tax). | ||
| 2026-06-30 | divestiture_reduction | completed | 2025-06-05 | 2026-07-01 | International | International Family Care and Professional (IFP) | USD 1,300 (millions) | subsequent_events f5-10q / GLM-5.3-flash-fp4-HTML | IFP Transaction with Suzano completed July 1, 2026; Buyer acquired 51% of joint venture for approximately $1.3 billion cash (subject to post-closing adjustments); K-C retained 49% equity interest. IFP Business reported as discontinued operations; no employee headcount figure disclosed. | ||
| 2026-06-30 | acquisition_addition | announced | 2025-11-02 | 2026-12-31 | Global | Kenvue, Inc. | USD 6,700 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Pending acquisition of Kenvue expected to close in second half of 2026; consideration of ~280 million K-C shares plus ~$6.7 billion cash. No employee headcount figure disclosed. | ||
| 2026-06-30 | restructuring | in_progress | 2024-03-27 | 2028-12-31 | Global | USD 105 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program includes workforce reductions expected at 4%-5% of workforce (no absolute count disclosed). Board extended program through end of 2028 during Q2 2026. Charge shown is pre-tax for six months ended 2026-06-30 ($54M in Q2 2026); cumulative pre-tax charges $913M ($706M after-tax) through 2026-06-30. Program also includes expected exit of certain markets. | |||
| 2026-06-30 | divestiture_reduction | completed | 2025-06-05 | 2026-07-01 | International | International Family Care and Professional (IFP) segment | subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML | IFP Transaction with Suzano closed 2026-07-01 (post-quarter); K-C retained 49% of joint venture. No employee counts disclosed. Separation costs of $104M for six months 2026 (advisory, legal, accounting, contractor) reported in discontinued operations. | |||
| 2026-06-30 | acquisition_addition | announced | 2025-11-02 | Global | Kenvue, Inc. (consumer health) | USD 157 (millions) | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Merger expected to close in second half of 2026 (no specific date disclosed); stockholder approvals obtained 2026-01-29, HSR waiting period expired 2026-02-04. No headcount disclosed. Charge shown is acquisition-related costs for six months ended 2026-06-30 ($109M in Q2 2026), reported in Marketing, research and general expenses. | |||
| 2026-06-30 | restructuring | in_progress | 4.5% | 2024-03-27 | 2028-12-31 | Global | All segments | USD 1,500 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Board approved extension through end of 2028. Workforce reductions expected in range of 4% to 5%. Total pre-tax costs anticipated to be approximately $1.5 billion. | |
| 2026-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] | USD 76,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2026-03-31 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | All major geographies | Global operating and management structure; supply chain; corporate and regional overhead | USD 51 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Workforce reductions expected in the range of 4% to 5% of the organization; no absolute employee count disclosed. Q1 2026 pre-tax charges of $51 ($32 after-tax); cumulative pre-tax charges through March 31, 2026 were $859 ($666 after-tax) against an expected total of approximately $1.5 billion pre-tax. Charges split: $42 in cost of products sold, $30 in marketing/research/general, $(21) in other (income) and expense, net. | ||
| 2026-03-31 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | Global | All major geographies; corporate and regional overhead, global supply chain | USD 51 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Q1 2026 pre-tax charges of $51M ($32M after-tax); cumulative pre-tax charges of $859M through 2026-03-31. Program-wide workforce reductions expected in the range of 4% to 5%; no specific employee count disclosed for the quarter. Total program costs approximately $1.5B pre-tax, ~60% cash. | ||
| 2026-03-31 | divestiture_reduction | in_progress | 2025-06-05 | 2026-06-30 | Global | International Family Care and Professional (IFP) segment | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | JV with Suzano; Buyer to acquire 51% for ~$1.7B at closing expected mid-2026. IFP results reported as discontinued operations; no headcount figures disclosed. Separation costs of $32M incurred in Q1 2026. | |||
| 2026-03-31 | acquisition_addition | announced | 2025-11-02 | 2026-12-31 | Global | Kenvue, Inc. — consumer health | USD 48 (millions) | business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Merger approved by both stockholder bases 2026-01-29; HSR waiting period expired 2026-02-04; closing expected 2H 2026. Q1 2026 acquisition-related costs of $48M in MRG expenses. No headcount added yet; no employee count disclosed. | ||
| 2026-03-31 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | All segments | USD 51 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Workforce reductions expected in range of 4% to 5%. Q1 2026 charges of $51M pre-tax include $12M for workforce reductions. Cumulative pre-tax charges through Q1 2026 were $859M. | |
| 2026-03-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] | USD 37,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-12-31 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | Global — all major geographies | Corporate and regional overhead structures; global supply chain | USD 351 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | FY2025 charges of $351 pre-tax ($295 after-tax); cumulative through 2025-12-31 of $808 pre-tax ($634 after-tax). Total program cost expected ~$1.5 billion pre-tax, ~60% cash. Filer states workforce reductions expected in the range of 4% to 5%; no absolute headcount disclosed. Program expected complete by end of 2026. | ||
| 2025-12-31 | divestiture_reduction | in_progress | 2025-06-05 | 2026-06-30 | International | International Family Care and Professional (IFP) segment | discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Joint venture with Suzano; Buyer to acquire 51% for ~$1.7 billion, K-C retains 49%. Closing expected mid-2026 subject to consultation and regulatory approvals. No employee count disclosed; pre-tax separation costs of $77 recognized in FY2025 within discontinued operations. | |||
| 2025-12-31 | acquisition_addition | announced | 2025-11-02 | 2026-12-31 | Global | Consumer health (Kenvue, Inc.) | USD 32 (millions) | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Stockholder approvals obtained 2026-01-29; HSR waiting period expired 2026-02-04. Completion expected in second half of 2026. No Kenvue headcount disclosed; $32 of acquisition-related costs incurred in FY2025. | ||
| 2025-12-31 | voluntary_separation | completed | 2025-08-25 | 2025-10-15 | United States — Chester Facility | Hourly organized employees represented by USW Local 10-448 | other f5-10k / MiMo-V2.6-Flash-fp8-HTML | Election period 2025-09-04 to 2025-09-19; termination date 2025-10-15. Program caps stated as 30 operations employees or 3 maintenance employees if oversubscribed; actual participants not disclosed. Lump sums of $10,000 (0 to <5 years service) or $15,000 (5 to <10 years service). | |||
| 2025-12-31 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | All segments | USD 1,500 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Workforce reductions expected to be in the range of 4% to 5%. Total costs anticipated to be approximately $1.5 billion pre-tax. Cumulative pre-tax charges through Dec 31, 2025 were $808 million. | |
| 2025-12-31 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | All Segments | USD 351 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | 2024 Transformation Initiative. Workforce reductions expected in range of 4% to 5%. Total pre-tax charges for 2025 were $351 million. Cumulative pre-tax charges through Dec 31, 2025 were $808 million. | |
| 2025-12-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] | USD 176,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2025-09-30 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | Global | All major geographies | USD 62 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Workforce reductions expected in the range of 4% to 5% of the organization; total program costs anticipated at approximately $1.5 billion pre-tax, with cash costs about 60%. Quarterly pre-tax charges of $62 ($50 after-tax) for the three months ended September 30, 2025; cumulative pre-tax charges of $718 through September 30, 2025. | ||
| 2025-09-30 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | Global (all major geographies) | Corporate and all segments | USD 718 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions expected in the range of 4% to 5% of employees; no absolute headcount disclosed. Charge shown is cumulative pre-tax through 2025-09-30 ($561 after-tax); total anticipated program cost is approximately $1.5 billion pre-tax, with cash costs about 60% of that amount. Q3 2025 charges were $62 pre-tax; nine-month 2025 charges were $261 pre-tax. | ||
| 2025-09-30 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | All segments | USD 261 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Workforce reductions expected in range of 4% to 5%. Total pre-tax charges incurred YTD were $261 million. Cumulative pre-tax charges through Sept 30, 2025 were $718 million. | |
| 2025-09-30 | restructuring | in_progress | Cost of Sales [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 34,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-09-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 28,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-09-30 | restructuring | in_progress | Other Income [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-09-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 62,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-09-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / After Tax [Member] | USD 50,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-09-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD -3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-09-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] | USD 47,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-09-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / North America (NA) [Member] | USD 32,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-09-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / International Personal Care (IPC) [Member] | USD 36,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-09-30 | restructuring | in_progress | Workforce Reductions and Other Cash Exit Costs [Member] / 2024 Transformation Initiative [Member] | USD 126,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-06-30 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | Global (all major geographies) | Corporate and regional overhead; global supply chain | USD 199 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Workforce reductions expected in the range of 4% to 5% of the organization. Q2 2025 pre-tax charges of $122 ($95 after-tax); YTD 2025 charges $199 pre-tax ($172 after-tax). Cumulative pre-tax charges through June 30, 2025 were $656 ($511 after-tax). Total program costs anticipated at approximately $1.5 billion pre-tax, roughly 60% cash, primarily workforce reductions and other program costs. Restructuring liabilities of $86 as of June 30, 2025. | ||
| 2025-06-30 | divestiture_reduction | announced | 2025-06-05 | 2026-06-30 | International | International Family Care and Professional (IFP) Business | USD 33 (millions) | other f5-10q / GLM-5.3-flash-fp4-HTML | Sale of 51% interest in a joint venture comprising substantially all of the former IFP segment to Suzano for approximately $1.7 billion; K-C retains 49%. Expected to close mid-2026 pending regulatory approvals. Separation costs of $33 million incurred in Q2 2025. No employee headcount figures disclosed. | ||
| 2025-06-30 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | Global | All major geographies; corporate and regional overhead, global supply chain | USD 199 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions expected at 4-5% of workforce per original announcement; no specific employee count disclosed this quarter. Q2 2025 charges were $122M pre-tax ($95M after-tax); YTD charges $199M pre-tax ($172M after-tax). Cumulative pre-tax charges through 2025-06-30 were $656M ($511M after-tax) against total expected program cost of ~$1.5B pre-tax. | ||
| 2025-06-30 | divestiture_reduction | announced | 2025-06-05 | 2026-06-30 | International | International Family Care and Professional (IFP) segment | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale of 51% controlling interest in JV to Suzano for ~$1.7B; K-C retains 49%. IFP results reclassified to discontinued operations effective Q2 2025. No headcount figures disclosed. $33M separation costs incurred in Q2 2025 within discontinued operations. | |||
| 2025-06-30 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | All segments | USD 199 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Workforce reductions expected in range of 4% to 5%. Total pre-tax charges for six months ended June 30, 2025 were $199 million. Cumulative pre-tax charges through June 30, 2025 were $656 million. | |
| 2025-06-30 | restructuring | in_progress | Cost of Sales [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 82,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-06-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 39,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-06-30 | restructuring | in_progress | Other Income [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 122,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / After Tax [Member] | USD 95,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD -4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] | USD 91,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / North America (NA) [Member] | USD 58,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / International Personal Care (IPC) [Member] | USD 71,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-06-30 | restructuring | in_progress | Workforce Reductions and Other Cash Exit Costs [Member] / 2024 Transformation Initiative [Member] | USD 86,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-03-31 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | All major geographies | Global operating and management structure; supply chain; corporate and regional overhead | USD 77 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Workforce reductions expected in the range of 4% to 5% of the organization. Q1 2025 pre-tax charges of $77 ($77 after-tax); cumulative pre-tax charges through March 31, 2025 of $534 ($416 after-tax). Total program costs anticipated at approximately $1.5 billion pre-tax, roughly half cash, primarily workforce reductions. Q1 2025 charges by segment: NA $27, IPC $20, IFP $14, residual Corporate & Other. Transformation liabilities of $108 as of March 31, 2025 recorded in accrued expenses and other current liabilities. | ||
| 2025-03-31 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | All major geographies | All segments (NA, IPC, IFP) and Corporate & Other | USD 77 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions expected in the range of 4% to 5% of workforce; no absolute headcount disclosed. Q1 2025 charges were $77 pre-tax ($77 after-tax); cumulative pre-tax charges through 2025-03-31 were $534 ($416 after-tax). Total program cost estimated at approximately $1.5 billion pre-tax, with cash costs roughly half. Transformation liabilities of $108 million at quarter-end. | ||
| 2025-03-31 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | All segments | USD 77 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Workforce reductions expected in range of 4% to 5%. Total pre-tax costs anticipated ~$1.5 billion. Q1 2025 charges included $16M for workforce reductions. | |
| 2025-03-31 | restructuring | in_progress | Cost of Sales [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 53,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-03-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 22,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-03-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 77,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-03-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / After Tax [Member] | USD 77,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-03-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / North America (NA) [Member] | USD 27,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-03-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / International Personal Care (IPC) [Member] | USD 20,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-03-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / International Family Care & Professional (IFP) [Member] | USD 14,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2025-03-31 | restructuring | in_progress | Workforce Reductions and Other Cash Exit Costs [Member] / 2024 Transformation Initiative [Member] | USD 43,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-12-31 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | All major geographies | Enterprise-wide; corporate and regional overhead, global supply chain | USD 457 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions expected in the range of 4% to 5% of the organization; no absolute headcount disclosed. Total program costs anticipated at approximately $1.5 billion pre-tax through 2026, with cash costs roughly half. The $457 million charge is pre-tax ($339 million after-tax) for FY2024 only; includes $144M in cost of products sold, $228M in marketing/research/general expenses, $84M in other (income) and expense, and $1M nonoperating. Transition to new organizational structure completed 2024-10-01. Segment impact of FY2024 charges: NA $147M, IPC $187M, IFP $82M, remainder in Corporate & Other. Transformation liabilities of $130M accrued at year-end. | ||
| 2024-12-31 | divestiture_reduction | completed | 2024-04-07 | 2024-07-01 | Global | Personal protective equipment business (Kimtech and KleenGuard brands) | other f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sale of PPE business completed 2024-07-01 for total consideration of $635 million; pre-tax gain of $566 million ($453 million after-tax) recognized. No headcount associated with the divested business disclosed. | |||
| 2024-12-31 | other | in_progress | 2024-03-27 | 2026-12-31 | Various exited markets | Exited businesses and markets under the 2024 Transformation Initiative | MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML | Divestitures and business exits contributed (1.2)% to the 2024 net sales change, comprising the Brazil tissue/professional sale, the PPE sale, and other exited businesses and markets in conjunction with the 2024 Transformation Initiative. No separate headcount disclosed; exit losses recorded within the Transformation Initiative charges. | |||
| 2024-12-31 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | All segments | USD 1,500 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | 2024 Transformation Initiative announced March 27, 2024. Workforce reductions expected in range of 4% to 5%. Total costs anticipated approximately $1.5 billion pre-tax. Expected to be completed by end of 2026. | |
| 2024-12-31 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | All segments | USD 1,500 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Workforce reductions expected in range of 4% to 5%. Total costs anticipated to be approximately $1.5 billion pre-tax. 2024 charges were $457 million pre-tax. | |
| 2024-12-31 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 27,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2024-12-31 | restructuring | in_progress | Cost of Sales [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 144,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2024-12-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 228,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2024-12-31 | restructuring | in_progress | Other Income [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 84,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2024-12-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 457,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2024-12-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / After Tax [Member] | USD 339,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2024-12-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / North America (NA) [Member] | USD 147,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2024-12-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / International Personal Care (IPC) [Member] | USD 187,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2024-12-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / International Family Care and Professional (IFP) [Member] | USD 82,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2024-12-31 | restructuring | in_progress | Workforce Reductions and Other Cash Exit Costs [Member] / 2024 Transformation Initiative [Member] | USD 291,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2024-09-30 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | Global | Personal Care | USD 131 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | YTD charges for Personal Care segment; Q3 portion was $59 million. Program includes workforce reductions of 4-5% of workforce globally; transition to new segment structure expected complete by end of 2024. | ||
| 2024-09-30 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | Global | Consumer Tissue | USD 65 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | YTD charges for Consumer Tissue segment; Q3 portion was $37 million. | ||
| 2024-09-30 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | Global | K-C Professional | USD 46 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | YTD charges for K-C Professional segment; Q3 portion was $21 million. | ||
| 2024-09-30 | divestiture_reduction | completed | 2024-04-07 | 2024-07-01 | Global | K-C Professional (PPE business) | USD 566 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Sale of personal protective equipment business for $635 million total consideration; pre-tax gain of $566 million recognized. Headcount transferred not disclosed. | ||
| 2024-09-30 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | Global | All segments (Personal Care, Consumer Tissue, K-C Professional) and corporate/regional overhead | USD 163 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions expected in the range of 4% to 5% of the organization; no absolute headcount given. Charge shown is nine-months-2024 workforce-reduction charges ($46 in cost of products sold plus $117 in marketing, research and general expenses); total transformation charges were $359 pre-tax ($257 after-tax) for the nine months and $124 ($106 after-tax) for the quarter, with total program costs expected to be approximately $1.5 billion pre-tax (about half cash, primarily workforce reductions). Transformation initiative liabilities of $168 were accrued at 2024-09-30. Transition to new organizational structure expected complete by end of 2024; program completion by end of 2026. | ||
| 2024-09-30 | divestiture_reduction | completed | 2024-04-07 | 2024-07-01 | Global | K-C Professional — personal protective equipment (PPE) business (Kimtech, KleenGuard) | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale completed 2024-07-01 for total consideration of $635 with a pre-tax gain of $566 ($453 after-tax). Filing does not disclose any headcount transferred or removed in the transaction. | |||
| 2024-09-30 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | Corporate and Regional Overhead; Supply Chain | USD 124 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Workforce reductions expected in range of 4% to 5%. Total costs anticipated ~$1.5B pre-tax. Q3 charges $124M pre-tax ($106M after-tax). | |
| 2024-09-30 | divestiture_reduction | completed | 2024-04-07 | 2024-07-01 | Global | K-C Professional (PPE Business) | business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0 | Sale of PPE business completed July 1, 2024. Headcount impact not explicitly quantified. | |||
| 2024-09-30 | restructuring | in_progress | Asset write-offs [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 8,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-09-30 | restructuring | in_progress | Cost of Sales [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 31,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-09-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 93,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-09-30 | restructuring | in_progress | Other Income [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-09-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 124,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-09-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Parent [Member] / After Tax [Member] | USD 106,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-09-30 | restructuring | in_progress | Workforce Reductions and Other Cash Exit Costs [Member] / 2024 Transformation Initiative [Member] | USD 244,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-09-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Personal Care [Member] | USD 59,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-09-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Consumer Tissue [Member] | USD 37,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-09-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / K-C Professional [Member] | USD 21,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-06-30 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | All segments; corporate and regional overhead | USD 190 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Workforce reductions expected in range of 4 to 5 percent; Q2 2024 pre-tax charges of $190 million ($117 million after tax). Total program costs anticipated at approximately $1.5 billion pre-tax, roughly half cash, primarily severance. Transition to new organizational structure expected complete by end of 2024. | |
| 2024-06-30 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | All segments; corporate and regional overhead | USD 235 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Year-to-date (six months ended June 30, 2024) pre-tax charges of $235 million ($151 million after tax) under the same program; includes $149 million of charges for workforce reductions and other cash exit costs, with $35 million paid in the period, leaving $114 million of liabilities at June 30, 2024. | |
| 2024-06-30 | divestiture_reduction | completed | 2024-04-07 | 2024-07-01 | Global | K-C Professional (personal protective equipment business) | USD 640 (millions) | subsequent_events f5-10q / GLM-5.3-flash-fp4-HTML | Sale of PPE business (Kimtech and KleenGuard brands) for $640 million completed July 1, 2024; no headcount figures disclosed. Gain to be recognized in Q3 2024. | ||
| 2024-06-30 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | Global — all major geographies | Enterprise-wide: reorganization into three business segments; corporate and regional overhead; global supply chain | USD 1,500 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions expected in the range of 4 to 5 percent; no absolute headcount disclosed. Total program costs anticipated at approximately $1.5 billion pre-tax, roughly half cash, primarily workforce reductions. Charges incurred: $190 pre-tax ($117 after tax) in Q2 2024 and $235 pre-tax ($151 after tax) YTD 2024, including workforce-reduction charges of $80 in Q2 and $103 YTD. Organizational transition expected complete by end of 2024; certain actions still being finalized for implementation. | ||
| 2024-06-30 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | Corporate and Regional Overhead | USD 2 (billions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Workforce reductions expected in range of 4% to 5%. Total costs anticipated to be approximately $1.5 billion pre-tax. | |
| 2024-06-30 | restructuring | in_progress | Asset write-offs [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-06-30 | restructuring | in_progress | Cost of Sales [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 45,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-06-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 70,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-06-30 | restructuring | in_progress | Other Income [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 75,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 190,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Parent [Member] / After Tax [Member] | USD 117,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-06-30 | restructuring | in_progress | Workforce Reductions and Other Cash Exit Costs [Member] / 2024 Transformation Initiative [Member] | USD 149,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Personal Care [Member] | USD 60,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Consumer Tissue [Member] | USD 24,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-06-30 | restructuring | in_progress | 2024 Transformation Initiative [Member] / K-C Professional [Member] | USD 23,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-03-31 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | All major geographies | Corporate and regional overhead; global supply chain | USD 45 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Workforce reductions expected in the range of 4 to 5 percent. Q1 2024 charges: $23M workforce reductions plus $22M other exit costs; $34M liability remaining at March 31, 2024. Total program costs anticipated at approximately $1.5 billion pre-tax, roughly half cash. Organizational transition to new segment structure expected complete by end of 2024. | |
| 2024-03-31 | restructuring | in_progress | 2024-03-27 | 2026-12-31 | All major geographies | Enterprise-wide (reorganizing into three new business segments; corporate and regional overhead; global supply chain) | USD 1,500 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions expected at 4-5% of workforce; exact headcount not disclosed. Total program cost ~$1.5B pre-tax, about half cash, primarily workforce reductions; non-cash mainly incremental depreciation and asset write-offs. Q1 2024 charges were $45M pre-tax ($34M after tax): $23M workforce reductions and $22M other exit costs; segment split of Q1 charges was $12M Personal Care, $4M Consumer Tissue, $2M K-C Professional, remainder in Corporate & Other. Transformation liabilities of $34M at 2024-03-31 after $11M cash payments. Organizational transition expected complete by end of 2024; program by end of 2026. | ||
| 2024-03-31 | divestiture_reduction | announced | 2024-04-07 | 2024-09-30 | Global | K-C Professional — personal protective equipment business (Kimtech and KleenGuard gloves, apparel, masks, respirators, eyewear) | USD 640 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Post-quarter agreement to sell PPE business for $640M subject to customary purchase price adjustment; expected to close Q3 2024 pending conditions and regulatory approval. No headcount associated with the divestiture disclosed. | ||
| 2024-03-31 | restructuring | in_progress | 4.5% | 2024-03-27 | 2026-12-31 | Global | Corporate and Regional Overhead | USD 45 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Announced '2024 Transformation Initiative' to reorganize into three new business segments and optimize supply chain. Workforce reductions expected in range of 4% to 5%. Total costs anticipated ~$1.5 billion pre-tax. Q1 charges of $45 million pre-tax ($23 million workforce reductions, $22 million other exit costs). | |
| 2024-03-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2024 Transformation Initiative [Member] / Before Tax [Member] | USD 45,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-03-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Parent [Member] / After Tax [Member] | USD 34,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-03-31 | restructuring | in_progress | Workforce Reductions and Other Cash Exit Costs [Member] / 2024 Transformation Initiative [Member] | USD 45,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-03-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Personal Care [Member] | USD 12,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-03-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / Consumer Tissue [Member] | USD 4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2024-03-31 | restructuring | in_progress | 2024 Transformation Initiative [Member] / K-C Professional [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2023-12-31 | divestiture_reduction | completed | 2022-10-24 | 2023-06-01 | Brazil | Consumer Tissue and K-C Professional | USD 30 (millions) | discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sale of Neve tissue brand and related Brazil tissue assets for $212; $30 pre-tax divestiture-related costs recorded in cost of products sold and MRG expenses; headcount not disclosed | ||
| 2023-12-31 | acquisition_addition | completed | 2023-12-31 | United States | Personal Care | USD 95 (millions) | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Two redemptions of Thinx minority interest in 2023 ($48 to reach 70 percent in Q2, $47 for remaining 30 percent in Q4); treated as equity transactions with no gain or loss; Thinx already consolidated since Q1 2022, so no incremental headcount addition disclosed | |||
| 2023-12-31 | restructuring | completed | 6,000 | 2018-01-01 | 2021-12-31 | Global | All Segments | USD 2,175 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Program completed in 2021. Total pre-tax costs of $2.2 billion. Workforce reductions approximately 6,000. | |
| 2022-12-31 | acquisition_addition | completed | 2022-02-24 | 2022-02-24 | Personal Care | USD 181 (millions) | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Acquisition of a 58% controlling interest in Thinx Inc. for total consideration of $181; headcount added not disclosed. Consideration includes cash of $53, fair value of previously held equity investment of $127, and share-based award costs of $1. | |||
| 2022-12-31 | divestiture_reduction | announced | 2022-10-24 | Brazil | Consumer Tissue and K-C Professional | USD 175 (millions) | Item_1_Business f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sale price of $175 subject to working capital and other adjustments; includes a licensing agreement for Kleenex, Scott and WypAll in Brazil. Pending customary conditions and regulatory approval, expected to close in the first half of 2023; associated headcount not disclosed. | |||
| 2022-12-31 | acquisition_addition | completed | 2022-02-24 | 2022-02-24 | Global | Personal Care | USD 181 (millions) | Item 1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Acquisition of majority and controlling share of Thinx Inc. for total consideration of $181 million. Employee count not disclosed. | ||
| 2022-12-31 | restructuring | completed | 6,000 | 2018-01-01 | 2021-12-31 | Global | All Segments | USD 2,200 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | 2018 Global Restructuring Program completed in 2021. Workforce reductions approximately 6,000. Total pre-tax costs $2.2 billion. No new activity in 2022. | |
| 2022-12-31 | restructuring | completed | 6,000 | 2018-01-01 | 2021-12-31 | Global | All segments | USD 2,200 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Program completed in 2021. Total pre-tax costs $2.2 billion. Workforce reductions approximately 6,000. Included in 2022 filing as historical context for completed program. | |
| 2022-09-30 | acquisition_addition | completed | 2022-02-24 | 2022-02-24 | Personal Care | USD 181 (millions) | business_combinations_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Acquired majority controlling share (58%) of Thinx Inc.; Thinx operations consolidated into Personal Care segment on a one-month lag. No employee headcount figures disclosed in the filing. | |||
| 2022-09-30 | acquisition_addition | completed | 2022-02-24 | Global | Personal Care | USD 181 (millions) | business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Completed acquisition of 58% controlling interest in Thinx Inc. for $181 total consideration; no headcount added disclosed. Consolidated into Personal Care segment on a one-month lag from Q1 2022. | |||
| 2022-03-31 | acquisition_addition | completed | 2022-02-24 | 2022-02-24 | Personal Care | USD 181 (millions) | business_combinations_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Acquired majority controlling share (58%) of Thinx Inc. for total consideration of $181 million; Thinx operations consolidated into Personal Care segment on a one-month lag. No employee headcount figures disclosed. | |||
| 2021-12-31 | restructuring | completed | 6,000 | 2018 | 2021-12-31 | Global | All business segments and all major geographies | USD 354 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions of approximately 6,000 are cumulative for the program initiated in 2018, not FY2021-only; program actions completed in 2021. Charge shown is FY2021 total pre-tax charges ($354; $281 net charges attributable to Kimberly-Clark). Program-to-date total costs were $2.2 billion pre-tax ($1.6 billion after tax). | |
| 2021-12-31 | plant_closure | completed | 2018 | 2021-12-31 | Global | Manufacturing | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | 11 manufacturing facilities closed or sold, cumulative through program completion in 2021; no facility-level headcount disclosed. Lower-margin businesses representing about 1 percent of net sales were also exited or divested. | |||
| 2021-12-31 | restructuring | completed | 6,000 | 2018-01-01 | 2021-12-31 | Global | All Segments | USD 2,200 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Workforce reductions were approximately 6,000. Restructuring actions completed in 2021. Total pre-tax costs $2.2 billion. | |
| 2021-12-31 | restructuring | completed | 6,000 | 2018 | 2021-12-31 | Global | All segments | USD 2,175 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Workforce reductions were approximately 6,000. Restructuring actions completed in 2021. Total pre-tax charges $2.2 billion. | |
| 2021-12-31 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 17,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 154,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 111,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD -10,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 354,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD 279,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD 281,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 222,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | Corporate and Other [Member] / 2018 Global Restructuring Program [Member] | USD 265,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] | USD 104,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] | USD 118,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] | USD 40,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-12-31 | restructuring | in_progress | 6,000 | 2018 Global Restructuring Program [Member] | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | All major geographies | Manufacturing supply chain and overhead organization | USD 97 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program announced January 2018; workforce reductions expected in range of 6,300 to 6,400; total program costs anticipated at $2.1-$2.2 billion pre-tax; expected to be completed in 2021. Q3 2021 total charges of $97 pre-tax ($81 net of tax attributable to K-C). | ||
| 2021-09-30 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | All major geographies | Manufacturing supply chain and overhead organization | USD 250 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Nine months ended September 30, 2021 total charges of $250 pre-tax ($202 net of tax attributable to K-C); cumulative program charges through September 30, 2021 were $2.1 billion pre-tax ($1.6 billion after tax). Restructuring liabilities of $65 at September 30, 2021. | ||
| 2021-09-30 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global | All segments — manufacturing supply chain and overhead organization | USD 97 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program-level workforce reduction target of 6,300–6,400 positions (total program, not quarterly). Q3 2021 pre-tax charges were $97M; nine-month charges were $250M. Program expected to complete in 2021 with total costs of $2.1–2.2B pre-tax. Restructuring liabilities at Sept 30, 2021 were $65M. | ||
| 2021-09-30 | acquisition_addition | completed | 2020-10-01 | Indonesia | Personal Care | business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Softex Indonesia acquired Oct 1, 2020 for ~$1.2B. No headcount added through the acquisition is disclosed in this filing. Purchase price allocation expected to finalize no later than Q4 2021. | ||||
| 2021-09-30 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global | All segments | USD 97 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program announced Jan 2018. Expected to impact 6,300-6,400 workforce reductions total. Q3 2021 charges were $97M pre-tax. Completion expected in 2021. | ||
| 2021-09-30 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 14,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 48,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 39,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 97,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD 81,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD -2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD 79,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 145,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] / Before Tax [Member] | USD 32,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] / Before Tax [Member] | USD 42,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] / Before Tax [Member] | USD 10,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | 6,300 | 2018-01 | 2021-12-31 | All major geographies | Manufacturing supply chain and overhead organization | USD 2,000 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program announced January 2018; workforce reductions expected in range of 6,300 to 6,400 (lower bound extracted). Total program costs anticipated at $2.0-$2.1 billion pre-tax ($1.5-$1.6 billion after tax); cash costs $1.1-$1.15 billion. Cumulative pre-tax charges through June 30, 2021 were $2.0 billion ($1.5 billion after tax). Restructuring charges in 2021 expected to be $180-$280 pre-tax ($135-$215 after tax). Program includes closing or selling approximately 10 manufacturing facilities and exiting or divesting lower-margin businesses generating approximately 1 percent of net sales. | |
| 2021-06-30 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global | All segments | USD 153 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program-level workforce reductions of 6,300–6,400 expected over full program life; no quarter-specific employee count disclosed. Q2 2021 pre-tax charges were $119M; YTD charges were $153M. Program expected to complete in 2021. | ||
| 2021-06-30 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global | All Segments | USD 119 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program announced Jan 2018 to reduce structural cost base. Expected total workforce reductions of 6,300 to 6,400. Q2 2021 pre-tax charges were $119M. Program expected to complete in 2021. | ||
| 2021-06-30 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 25,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 30,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 8,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 119,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD 94,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD 94,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 77,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] / Before Tax [Member] | USD 24,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] / Before Tax [Member] | USD 26,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] / Before Tax [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | All major geographies | Manufacturing supply chain and overhead organization | USD 34 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program expects workforce reductions of 6,300 to 6,400 and closure or sale of approximately 10 manufacturing facilities; total program costs anticipated at $2.0-$2.1 billion pre-tax. Q1 2021 pre-tax charges were $34 (net charges attributable to Kimberly-Clark $26); cumulative pre-tax charges through March 31, 2021 were $1.9 billion. Q1 2021 pre-tax savings were $40, cumulative $465. Restructuring liabilities of $65 at March 31, 2021. | ||
| 2021-03-31 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global | All segments | USD 26 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program-wide workforce reductions expected at 6,300-6,400; Q1 2021 charges for workforce reductions and other cash exit costs were $26M. Quarterly employee-affected count not separately disclosed. | ||
| 2021-03-31 | acquisition_addition | completed | 2020-10-01 | 2020-10-01 | Indonesia | Personal Care | business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Acquisition closed October 1, 2020; headcount added not disclosed in this filing. | |||
| 2021-03-31 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global | All Segments | USD 34 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program announced Jan 2018 to reduce structural cost base. Expected total workforce reductions of 6,300 to 6,400 employees. Q1 2021 pre-tax charges were $34 million. Program expected to complete in 2021. | ||
| 2021-03-31 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 25,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 9,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 34,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD 27,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD -1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD 26,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 26,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] / Before Tax [Member] | USD 15,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] / Before Tax [Member] | USD 16,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2021-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] / Before Tax [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | 2018-01 | 2021 | Global | All segments and corporate functions | USD 419 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Multi-year program; charge shown is FY2020 pre-tax total ($323 after tax). Program expects cumulative workforce reductions of 6,300-6,400 and closure or sale of approximately 10 manufacturing facilities; FY2020-specific headcount reduction not separately disclosed. Cumulative pre-tax charges through 2020 were $1.8 billion. | ||
| 2020-12-31 | acquisition_addition | completed | 2020-10-01 | 2020-10-01 | Indonesia | Personal Care | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | All-cash acquisition of Softex Indonesia for approximately $1.2 billion; acquired headcount not disclosed. Transaction and integration costs of $32 million recorded in FY2020. | |||
| 2020-12-31 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global | All segments | USD 419 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Pre-tax charges of $419 million incurred in 2020. Program expected to reduce structural cost base by streamlining manufacturing supply chain and overhead organization. Workforce reductions expected to be in the range of 6,300 to 6,400 globally over the life of the program. | ||
| 2020-12-31 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global | All segments | USD 419 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | 2018 Global Restructuring Program. Workforce reductions expected in range of 6,300 to 6,400 total. Pre-tax charges of $419 million incurred in 2020. Program expected to be completed in 2021. | ||
| 2020-12-31 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 63,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 283,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 109,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 9,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 419,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD 325,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD -2,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD 323,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 210,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | Corporate and Other [Member] / 2018 Global Restructuring Program [Member] | USD 392,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] | USD 156,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] | USD 176,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] | USD 53,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | All major geographies | Manufacturing supply chain and overhead organization | USD 157 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program announced January 2018; workforce reductions expected in range of 5,000 to 5,500 employees. Q3 2020 total pre-tax charges of $157 million; nine-month 2020 charges of $337 million. Cumulative pre-tax charges through September 30, 2020 were $1.7 billion ($1.3 billion after tax). Total program costs expected toward high end of $1.7-$1.9 billion pre-tax. Due to COVID-19, some restructuring activity and charges will extend into 2021 rather than completing at end of 2020. Restructuring liabilities of $114 million at September 30, 2020. | ||
| 2020-09-30 | acquisition_addition | completed | 2020-10-01 | 2020-10-01 | Indonesia | Personal Care | USD 9 (millions) | subsequent_events f5-10q / GLM-5.3-flash-fp4-HTML | Acquired Softex Indonesia on October 1, 2020 for approximately $1.2 billion in cash; no employee headcount disclosed. Acquisition-related costs of $9 million recorded in Q3 2020. Softex to be consolidated beginning Q4 2020, reported in Personal Care segment on a one-month lag. | ||
| 2020-09-30 | restructuring | in_progress | 2018-01 | 2021 | Global (all major geographies) | Enterprise-wide; includes closure or sale of approximately 10 manufacturing facilities and exit/divestiture of lower-margin businesses representing about 1% of net sales | USD 337 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program-level workforce reductions are disclosed only as an expected range of 5,000 to 5,500 positions (no quarter-specific count). associated_charge_value is total pre-tax charges for the nine months ended 2020-09-30 ($337 pre-tax, $254 net of tax); Q3 2020 charges were $157 pre-tax ($107 net). Cumulative pre-tax charges through 2020-09-30 were about $1.7 billion; expected program total toward the high end of $1.7-1.9 billion pre-tax ($1.3-1.4 billion after tax). Completion extended into 2021 due to COVID-19; cash costs expected $900 million to $1.0 billion, primarily workforce reductions. Restructuring liability was $114 at 2020-09-30. Cost savings of $95 in the first nine months of 2020 brought cumulative savings to $395. | ||
| 2020-09-30 | acquisition_addition | completed | 2020-10-01 | 2020-10-01 | Indonesia | Personal Care | subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML | All-cash acquisition of Softex Indonesia for approximately $1.2 billion, closed 2020-10-01 (after quarter end); no headcount added disclosed. Softex generated net sales of approximately $420 million in 2019. Financed with short-term commercial paper, cash on hand and a $600 bond issued in September 2020. $9 of acquisition-related costs recorded in Q3 2020 Marketing, research and general expenses. Consolidation begins Q4 2020 on a one-month lag within Personal Care. | |||
| 2020-09-30 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global | All Segments | USD 157 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program announced Jan 2018. Expected to impact 5,000-5,500 employees total. Q3 2020 charges of $157M include workforce reductions, asset write-offs, and other exit costs. Completion extended to 2021 due to COVID-19. | ||
| 2020-09-30 | acquisition_addition | announced | 2020-10-01 | Indonesia | Personal Care | subsequent_events f5-10q / Qwen3.6-27B-Q8_0 | Acquired Softex Indonesia on Oct 1, 2020 for approx $1.2B. Headcount not disclosed. | ||||
| 2020-09-30 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 50,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 107,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 25,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD -1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 157,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD 107,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD 107,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 162,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] / Before Tax [Member] | USD 57,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] / Before Tax [Member] | USD 59,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] / Before Tax [Member] | USD 15,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global (all major geographies) | Manufacturing supply chain and overhead organization | USD 87 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program announced January 2018; expects to close or sell ~10 manufacturing facilities and exit lower-margin businesses (~1% of net sales). Workforce reductions expected in range of 5,000 to 5,500. Total program costs anticipated toward high end of $1.7-$1.9 billion pre-tax ($1.3-$1.4 billion after tax); cash costs $900 million to $1.0 billion. Due to COVID-19, some restructuring activity and charges now expected to extend into 2021 rather than completing at end of 2020. Q2 2020 pre-tax charges of $87 ($72 after tax attributable to KMB); six-month 2020 pre-tax charges of $180 ($146 after tax). Cumulative pre-tax charges through June 30, 2020 were $1.6 billion ($1.2 billion after tax). Restructuring liabilities of $106 at June 30, 2020. Annual pre-tax cost savings target of $500-$550 million; six-month 2020 savings of $80, cumulative $380. | ||
| 2020-06-30 | restructuring | in_progress | 2018-01 | 2021 | Global | All segments | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program announced January 2018. Workforce reductions expected in range of 5,000 to 5,500. Total pre-tax charges expected toward high end of $1.7B–$1.9B range. Completion extended into 2021 due to COVID-19. Cumulative pre-tax charges through June 30, 2020 were $1.6B. Cumulative cost savings of $380M achieved through first six months of 2020. | |||
| 2020-06-30 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global | All Segments | USD 87 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program announced Jan 2018. Expected to impact 5,000-5,500 employees total. Q2 2020 charges of $87M include workforce reductions and other exit costs. Completion extended to 2021 due to COVID-19. | ||
| 2020-06-30 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 60,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 27,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 87,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD 72,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD 72,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 99,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] / Before Tax [Member] | USD 40,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] / Before Tax [Member] | USD 34,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] / Before Tax [Member] | USD 11,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global (all major geographies) | Manufacturing supply chain and overhead organization | USD 93 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q1 2020 pre-tax charges of $93 (net charges attributable to K-C of $74); program targets 5,000-5,500 workforce reductions, closure/sale of ~10 plants, and exit of ~1% of net sales; total program costs expected toward high end of $1.7-$1.9 billion pre-tax; completion extended into 2021 due to COVID-19; cumulative pre-tax charges through March 31, 2020 were $1.5 billion | ||
| 2020-03-31 | restructuring | in_progress | 2018-01 | 2021-12-31 | Global | All segments (Personal Care, Consumer Tissue, K-C Professional); manufacturing supply chain and overhead organization | USD 93 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program-wide plan includes closing or selling about 10 manufacturing facilities, exiting businesses representing roughly 1% of net sales, and total workforce reductions of 5,000 to 5,500 (program-level range, not a quarterly figure). Q1 2020 charges were $93 pre-tax ($70 in cost of products sold, $23 in marketing/research/general); cumulative pre-tax charges through 2020-03-31 were $1.5 billion. Completion extended into 2021 due to COVID-19 delays. No employees-affected count specific to the quarter is disclosed. | ||
| 2020-03-31 | restructuring | in_progress | 2018-01-01 | 2021-12-31 | Global | All segments | USD 93 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program announced Jan 2018. Expected to impact 5,000-5,500 employees total. Q1 2020 charges of $93M pre-tax. Completion extended to 2021 due to COVID-19. | ||
| 2020-03-31 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 70,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 23,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 93,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD 75,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD -1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD 74,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 50,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] / Before Tax [Member] | USD 34,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] / Before Tax [Member] | USD 42,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2020-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] / Before Tax [Member] | USD 15,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | 2018-01 | 2020-12-31 | Global | All business segments and major geographies | USD 366 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Program announced January 2018; expected workforce reductions of 5,000 to 5,500 over the full program life (no separate current-year affected count disclosed). Charge shown is total pre-tax charges incurred in 2019 ($366; $248 after tax), including $31 and $(12) of workforce-reduction charges in cost of products sold and marketing/research/general expenses respectively. Cumulative pre-tax charges through 2019 were $1.4 billion; total program cost expected $1.7-$1.9 billion pre-tax, with 2020 charges expected at $300-$500 pre-tax. Approximately 10 manufacturing facilities expected to be closed or sold and lower-margin businesses representing about 1 percent of net sales exited or divested. | ||
| 2019-12-31 | plant_closure | in_progress | 2018-01 | 2020-12-31 | Global | Manufacturing / supply chain | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Component of the 2018 Global Restructuring Program: closure or sale of approximately 10 manufacturing facilities with capacity expansion at several others; no facility-level or facility-specific headcount figures disclosed. Charges captured under the parent program record to avoid double counting. | |||
| 2019-12-31 | restructuring | in_progress | 2018-01 | 2020-12-31 | Global | All segments | USD 366 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Pre-tax charges of $366 million incurred in 2019 related to the 2018 Global Restructuring Program. Program announced in Jan 2018, expected to complete by end of 2020. Workforce reductions expected to be in range of 5,000 to 5,500 globally (cumulative). | ||
| 2019-12-31 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | Global | All segments | USD 366 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Program announced Jan 2018. Expected to reduce workforce by 5,000-5,500 globally. 2019 pre-tax charges were $366M. Completion expected by end of 2020. | ||
| 2019-12-31 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 54,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 416,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 99,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 194,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 366,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD 248,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD 248,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 221,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | Corporate and Other [Member] / 2018 Global Restructuring Program [Member] | USD 515,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] | USD 252,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] | USD 176,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] | USD 75,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-12-31 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] | USD -194,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | 2018-01 | 2020-12-31 | All major geographies | Personal Care | USD 53 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q3 2019 restructuring charges for Personal Care segment. Program overall expects workforce reductions of 5,000 to 5,500 employees; total program costs anticipated at $1.7-$1.9 billion pre-tax, with 2019 charges expected at $375-$425 pre-tax. | ||
| 2019-09-30 | restructuring | in_progress | 2018-01 | 2020-12-31 | All major geographies | Consumer Tissue | USD 49 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q3 2019 restructuring charges for Consumer Tissue segment. Program overall expects workforce reductions of 5,000 to 5,500 employees; exited businesses concentrated in consumer tissue. | ||
| 2019-09-30 | restructuring | in_progress | 2018-01 | 2020-12-31 | All major geographies | K-C Professional | USD 21 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q3 2019 restructuring charges for K-C Professional segment. Program overall expects workforce reductions of 5,000 to 5,500 employees. | ||
| 2019-09-30 | restructuring | in_progress | 2018-01 | 2020-12-31 | Global — all major geographies | Manufacturing supply chain and overhead organization; business exits concentrated in Consumer Tissue | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Disclosed as a range, not a point estimate: workforce reductions of 5,000 to 5,500 expected; closure or sale of about 10 manufacturing facilities; exit/divestiture of lower-margin businesses representing roughly 1 percent of net sales. Total program costs expected at $1.7 to $1.9 billion pre-tax ($1.35 to $1.5 billion after tax), with cash costs of $900 to $1.0 billion; 2019 charges expected at $375 to $425 million pre-tax. Cumulative pre-tax charges through 2019-09-30 were $1.3 billion ($1.0 billion after tax). Q3 2019 charges for workforce reductions were $1 in cost of products sold and $(4) in marketing/research/general expenses; nine months 2019 were $33 and $(12), respectively. Q3 2019 also included a pre-tax gain of about $182 on the sale of a manufacturing facility and associated real estate under this program (about $200 of proceeds recognized in 2019). Restructuring liabilities were $142 at 2019-09-30. Annual pre-tax savings expected to reach $500 to $550 by 2021; savings of $125 in the first nine months of 2019 brought cumulative savings to $260. Incremental capital spending of about $600 to $700 expected by end of 2020. No per-period employee-count disclosure is provided in this filing. | |||
| 2019-09-30 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | Global | All Segments | USD 215 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program announced Jan 2018. Expected to reduce workforce by 5,000-5,500 globally. YTD 2019 pre-tax charges were $215M. Completion expected by end of 2020. | ||
| 2019-09-30 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 18,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 104,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 21,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD -181,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD -56,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD -33,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD -33,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | Sale of manufacturing facility and associated real estate [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 182,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 159,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] / Before Tax [Member] | USD 53,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] / Before Tax [Member] | USD 49,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-09-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] / Before Tax [Member] | USD 21,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | All major geographies | Primarily consumer tissue; manufacturing supply chain and overhead organization | USD 271 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program announced January 2018; workforce reductions expected in range of 5,000 to 5,500; total program costs anticipated at $1.7-$1.9 billion pre-tax, with cash costs of $900 million to $1.0 billion primarily for workforce reductions. YTD 2019 pre-tax charges of $271 million; segment-level YTD charges: Personal Care $155, Consumer Tissue $82, K-C Professional $31. Cumulative pre-tax charges through June 30, 2019 were $1.3 billion. Expected annual pre-tax savings of $500-$550 million by 2021. | ||
| 2019-06-30 | restructuring | in_progress | 2018-01 | 2020-12-31 | Global | All major geographies; concentrated in Consumer Tissue | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions expected in range of 5,000 to 5,500; total pre-tax costs $1.7B–$1.9B ($900M–$1.0B cash); 2019 charges expected $400M–$500M pre-tax. Cumulative pre-tax charges through June 30, 2019 were $1.3B. Q2 2019 workforce-reduction charges: $2M in COGS and net -$12M in MRG expenses. No single-point employee-affected count disclosed for the quarter. | |||
| 2019-06-30 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | Global | All Segments | USD 119 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program announced Jan 2018. Expected to reduce structural cost base by closing/selling ~10 facilities and exiting lower-margin businesses. Workforce reductions expected in range of 5,000 to 5,500 total over program life. Q2 2019 charges were $119M pre-tax. Cumulative pre-tax charges through June 30, 2019 were $1.3 billion. | ||
| 2019-06-30 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 15,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 102,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 17,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 119,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD 92,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD 92,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 112,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] / Before Tax [Member] | USD 66,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] / Before Tax [Member] | USD 36,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-06-30 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] / Before Tax [Member] | USD 15,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | All major geographies | Primarily consumer tissue; manufacturing supply chain and overhead organization | USD 152 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program announced January 2018; expected workforce reductions of 5,000 to 5,500 positions and closure or sale of approximately 10 manufacturing facilities. Q1 2019 pre-tax charges of $152 million ($121 million after tax attributable to the Corporation); cumulative pre-tax charges of $1.2 billion through March 31, 2019. Restructuring liabilities of $219 million at March 31, 2019. | ||
| 2019-03-31 | restructuring | in_progress | 2018-01 | 2020-12-31 | Global | All segments; workforce reductions concentrated alongside exits in Consumer Tissue | USD 152 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program-level workforce reductions expected in the range of 5,000 to 5,500 (range not representable as a single count). Q1 2019 charges of $152 pre-tax comprise $125 in cost of products sold, $28 in marketing/research/general expenses, and $(1) in other (income) and expense, net; includes $34 of workforce-reduction charges ($30 COGS, $4 MRG). Segment charge split for Q1 2019: Personal Care $89, Consumer Tissue $46, K-C Professional $16. Restructuring liabilities were $219 at 2019-03-31. Cumulative pre-tax charges through 2019-03-31 were $1.2 billion. 2019 full-year charges expected at $600 to $750 pre-tax. | ||
| 2019-03-31 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | Global | All Segments | USD 152 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program announced Jan 2018 expects 5,000-5,500 workforce reductions total. Q1 2019 charges included $30M workforce reductions in COGS and $4M in MRG. Completion expected by end of 2020. | ||
| 2019-03-31 | restructuring | in_progress | Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 12,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | Cost of Sales [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 125,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 28,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD -1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Before Tax [Member] | USD 152,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / After Tax [Member] | USD 121,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] / After Tax [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Parent [Member] / After Tax [Member] | USD 122,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 74,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] / Before Tax [Member] | USD 89,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] / Before Tax [Member] | USD 46,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2019-03-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] / Before Tax [Member] | USD 16,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | 5,000 | 2018-01 | 2020-12-31 | Global | All business segments and all major geographies | USD 1,036 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions expected in the range of 5,000 to 5,500 (lower bound shown); value is total 2018 pre-tax charges of $1,036M, of which workforce-reduction severance was $392M ($149M in cost of products sold, $243M in marketing/research/general); program total cost expected $1.7B-$1.9B pre-tax, cash costs $900M-$1.0B; 2018 savings of $135M | |
| 2018-12-31 | plant_closure | in_progress | 2018-01 | 2020-12-31 | Global | Manufacturing; exited businesses concentrated in Consumer Tissue | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Component of the 2018 Global Restructuring Program: expects to close or sell approximately 10 manufacturing facilities and expand capacity at several others; also exiting or divesting lower-margin businesses representing about 1 percent of net sales; no separate headcount or charge disclosed for this component | |||
| 2018-12-31 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | Global | All segments | USD 1,036 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Announced in January 2018. Expected to reduce workforce by 5,000 to 5,500 employees. Total costs anticipated $1.7B-$1.9B pre-tax. Charges incurred in 2018 were $1,036 million pre-tax. Completion expected by end of 2020. | ||
| 2018-12-31 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | Global | All segments | USD 1,036 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Announced January 2018. Expected workforce reductions in range of 5,000 to 5,500. Total pre-tax costs anticipated $1.7B-$1.9B. Charges incurred in 2018 were $1.036B pre-tax. Employee count not explicitly stated as affected in 2018, only range for total program. | ||
| 2018-12-31 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] | USD 793,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] | USD -10,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] / Parent [Member] | USD 783,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | Before Tax [Member] / Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] | USD 380,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | Before Tax [Member] / Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] | USD 112,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | Before Tax [Member] / Cost of Sales [Member] / 2018 Global Restructuring Program [Member] | USD 541,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | Before Tax [Member] / Other Income [Member] / 2018 Global Restructuring Program [Member] | USD -12,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] | USD 1,036,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | Corporate and Other [Member] / 2018 Global Restructuring Program [Member] | USD 921,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | Other Income [Member] / 2018 Global Restructuring Program [Member] | USD -12,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 559,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] | USD 229,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / K-C Professional [Member] | USD 125,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-12-31 | restructuring | in_progress | 2018 Global Restructuring Program [Member] / Personal Care [Member] | USD 528,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2018-09-30 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | All major geographies | Manufacturing supply chain and overhead organization; lower-margin business exits concentrated in Consumer Tissue | USD 149 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program announced January 2018; expects to close or sell ~10 manufacturing facilities and exit/divest lower-margin businesses (~1% of net sales). Workforce reductions expected in range of 5,000 to 5,500. Total program costs anticipated $1.7-$1.9 billion pre-tax ($1.35-$1.5 billion after tax); cash costs $900 million to $1.0 billion primarily for workforce reductions. Q3 2018 total charges $149 pre-tax ($119 after tax); Q3 cash charges $66 pre-tax, non-cash $83 pre-tax. Restructuring liabilities of $263 at September 30, 2018 ($138 in Accrued expenses, $125 in Other Liabilities). Annual pre-tax savings expected $500-$550 by 2021. | ||
| 2018-09-30 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | Personal Care | USD 476 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Restructuring charges related to the Personal Care segment for the nine months ended September 30, 2018. | |||
| 2018-09-30 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | Consumer Tissue | USD 194 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Restructuring charges related to the Consumer Tissue segment for the nine months ended September 30, 2018. | |||
| 2018-09-30 | restructuring | in_progress | 2018-01-01 | 2020-12-31 | K-C Professional | USD 112 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Restructuring charges related to the K-C Professional segment for the nine months ended September 30, 2018. | |||
| 2018-09-30 | restructuring | in_progress | 2018-01 | 2020-12-31 | All major geographies | Consolidated; exits concentrated in Consumer Tissue | USD 856 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions expected in the range of 5,000 to 5,500 (no single point estimate disclosed). $856 pre-tax charges incurred in the nine months ended 2018-09-30 ($465 in cost of products sold, $341 in marketing/research/general, $50 nonoperating). Full program cost estimated at $1.7B-$1.9B pre-tax ($1.35B-$1.5B after tax); 2018 charges expected at $1.2B-$1.35B pre-tax. Program includes closure or sale of approximately 10 manufacturing facilities and exit/divestiture of lower-margin businesses representing about 1% of net sales. Announcement month only disclosed as January 2018; no specific day given. | ||
| 2018-09-30 | restructuring | in_progress | 5,250 | 2018-01-01 | 2020-12-31 | Global | All segments | USD 2 (billions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program announced Jan 2018 to reduce structural cost base. Workforce reductions expected in range of 5,000 to 5,500. Total costs anticipated $1.7B-$1.9B pre-tax. Midpoint of employee range used for count. | |
| 2018-09-30 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] | USD 119,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-09-30 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-09-30 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] / Parent [Member] | USD 119,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-09-30 | restructuring | in_progress | Before Tax [Member] / Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] | USD 26,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-09-30 | restructuring | in_progress | Before Tax [Member] / Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] | USD 16,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-09-30 | restructuring | in_progress | Before Tax [Member] / Cost of Sales [Member] / 2018 Global Restructuring Program [Member] | USD 103,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-09-30 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] | USD 149,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-09-30 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] | USD 194,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-09-30 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] / K-C Professional [Member] | USD 112,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-09-30 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] / Personal Care [Member] | USD 476,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-09-30 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 512,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-06-30 | restructuring | in_progress | 2018-01-23 | 2020-12-31 | All major geographies | Manufacturing supply chain and overhead organization; lower-margin businesses concentrated in Consumer Tissue | USD 707 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Workforce reductions expected in the range of 5,000 to 5,500 employees; approximately 10 manufacturing facilities to be closed or sold. Total program costs anticipated at $1.7-$1.9 billion pre-tax ($1.35-$1.5 billion after tax), with cash costs of $900 million to $1.0 billion primarily for workforce reductions. Charges incurred in the six months ended June 30, 2018 were $707 million pre-tax ($530 million after tax attributable to Kimberly-Clark); second quarter charges were $130 million pre-tax ($102 million after tax). Restructuring liabilities of $275 million at June 30, 2018. Expected annual pre-tax savings of $500-$550 million by 2021; first-half 2018 savings were $40 million. | ||
| 2018-06-30 | restructuring | in_progress | 2018-01-23 | 2020-12-31 | Personal Care | USD 401 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Restructuring charges related to the Personal Care segment for the six months ended June 30, 2018. | |||
| 2018-06-30 | restructuring | in_progress | 2018-01-23 | 2020-12-31 | Consumer Tissue | USD 159 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Restructuring charges related to the Consumer Tissue segment for the six months ended June 30, 2018. | |||
| 2018-06-30 | restructuring | in_progress | 2018-01-23 | 2020-12-31 | K-C Professional | USD 101 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Restructuring charges related to the K-C Professional segment for the six months ended June 30, 2018. | |||
| 2018-06-30 | restructuring | in_progress | 2018-01-23 | 2020-12-31 | All major geographies | Consolidated; exits/divestitures concentrated in Consumer Tissue (approximately 1 percent of net sales) | USD 707 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program expected to reduce workforce by 5,000 to 5,500 (range disclosed, not a point count) and close or sell approximately 10 manufacturing facilities. Total program costs expected $1.7B-$1.9B pre-tax ($1.35B-$1.5B after tax); cash costs $900M-$1.0B, non-cash $800M-$900M. Charge shown is total pre-tax charges incurred for the six months ended 2018-06-30 ($707M; $130M in Q2). Segment allocation of six-month charges: Personal Care $401M, Consumer Tissue $159M, K-C Professional $101M. Restructuring liabilities of $275M at 2018-06-30. Expected annual pre-tax savings of $500M-$550M by 2021; incremental capital spending of $600M-$700M through 2020. | ||
| 2018-06-30 | restructuring | in_progress | 5,250 | 2018-01-23 | 2020-12-31 | Global | All segments | USD 2 (billions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Workforce reductions expected in range of 5,000 to 5,500. Total pre-tax costs anticipated $1.7B-$1.9B. Charges incurred YTD: $707M pre-tax. | |
| 2018-06-30 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] | USD 106,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-06-30 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] | USD -4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-06-30 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] / Parent [Member] | USD 102,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-06-30 | restructuring | in_progress | Before Tax [Member] / Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] | USD 15,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-06-30 | restructuring | in_progress | Before Tax [Member] / Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] | USD 31,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-06-30 | restructuring | in_progress | Before Tax [Member] / Cost of Sales [Member] / 2018 Global Restructuring Program [Member] | USD 85,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-06-30 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] | USD 130,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-06-30 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] | USD 159,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-06-30 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] / K-C Professional [Member] | USD 101,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-06-30 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] / Personal Care [Member] | USD 401,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-06-30 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 446,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-03-31 | restructuring | in_progress | 2018-01-23 | 2020-12-31 | All major geographies | Manufacturing supply chain and overhead organization | USD 577 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program targets 5,000-5,500 workforce reductions, closure or sale of approximately 10 manufacturing facilities, and exit of lower-margin businesses (~1% of net sales, concentrated in consumer tissue). Total program costs anticipated at $1.7-$1.9 billion pre-tax; Q1 charges of $577 pre-tax ($428 after tax) include $405 of workforce reduction charges and $74 of asset impairments. Annual pre-tax savings of $500-$550 expected by 2021. | ||
| 2018-03-31 | restructuring | in_progress | 2018-01-23 | 2020-12-31 | Personal Care | USD 314 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | First quarter 2018 restructuring charges attributable to the Personal Care segment. | |||
| 2018-03-31 | restructuring | in_progress | 2018-01-23 | 2020-12-31 | Consumer Tissue | USD 141 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | First quarter 2018 restructuring charges attributable to the Consumer Tissue segment. | |||
| 2018-03-31 | restructuring | in_progress | 2018-01-23 | 2020-12-31 | K-C Professional | USD 95 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | First quarter 2018 restructuring charges attributable to the K-C Professional segment. | |||
| 2018-03-31 | restructuring | in_progress | 5,000 | 2018-01-23 | 2020-12-31 | All major geographies (global) | All segments; divestitures concentrated in Consumer Tissue | USD 577 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Filer states expected workforce reductions of 5,000 to 5,500 (value shown is low end of disclosed range). Program includes closing or selling approximately 10 manufacturing facilities, exiting/divesting businesses representing about 1 percent of net sales, and incremental capital spending of $600-700 million. Total program costs expected $1.7-1.9 billion pre-tax ($1.35-1.5 billion after tax); 2018 charges expected $1.2-1.35 billion pre-tax. Q1 2018 charges were $577 million pre-tax ($428 million after tax), including $418 million of workforce reduction and other exit cost charges. First-quarter savings were insignificant; full-year 2018 savings expected $50-70 million, mostly in the second half. | |
| 2018-03-31 | restructuring | in_progress | 5,250 | 2018-01-23 | 2020-12-31 | Global | All segments | USD 2 (billions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Workforce reductions expected in range of 5,000 to 5,500. Total pre-tax costs anticipated $1.7B-$1.9B. Q1 2018 charges were $577M pre-tax. | |
| 2018-03-31 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] | USD 434,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-03-31 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] / Noncontrolling Interest [Member] | USD -6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-03-31 | restructuring | in_progress | After Tax [Member] / 2018 Global Restructuring Program [Member] / Parent [Member] | USD 428,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-03-31 | restructuring | in_progress | Before Tax [Member] / Marketing, Research and General Expenses [Member] / 2018 Global Restructuring Program [Member] | USD 300,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-03-31 | restructuring | in_progress | Before Tax [Member] / Cost of Sales [Member] / Asset write-offs [Member] / 2018 Global Restructuring Program [Member] | USD 55,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-03-31 | restructuring | in_progress | Before Tax [Member] / Cost of Sales [Member] / 2018 Global Restructuring Program [Member] | USD 277,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-03-31 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] | USD 577,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-03-31 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] / Consumer Tissue [Member] | USD 141,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-03-31 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] / K-C Professional [Member] | USD 95,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-03-31 | restructuring | in_progress | Before Tax [Member] / 2018 Global Restructuring Program [Member] / Personal Care [Member] | USD 314,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2018-03-31 | restructuring | in_progress | Workforce reductions and other exit costs [Member] / 2018 Global Restructuring Program [Member] | USD 418,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2017-12-31 | restructuring | announced | 5,000 | 2018-01-23 | 2020-12-31 | Global — all major geographies | All business segments; manufacturing supply chain and overhead organization | USD 1,700 (millions) | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | Filer discloses a range of 5,000 to 5,500 workforce reductions; lower bound shown. Total costs $1.7B-$1.9B pre-tax ($1.35B-$1.5B after tax), cash costs $900M-$1.0B, 2018 charges $1.2B-$1.35B pre-tax; ~10 plants expected to close or sale, exit of businesses representing ~1% of net sales, $500-$550M annual pre-tax savings by 2021, incremental capex $600-$700M. Announced after fiscal year-end but before the February 8, 2018 filing date. | |
| 2017-12-31 | acquisition_addition | completed | India | Personal Care | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | In 2017 the company acquired the remaining 50 percent of its India joint venture, adding $35M of Personal Care goodwill; associated headcount addition not disclosed. | |||||
| 2017-12-31 | restructuring | announced | 2018-01-23 | 2020-12-31 | Global | All segments | USD 2 (billions) | subsequent_events f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | 2018 Global Restructuring Program announced Jan 23, 2018. Workforce reductions expected in range of 5,000 to 5,500. Total costs anticipated $1.7B to $1.9B pre-tax. Completion expected by end of 2020. | ||
| 2017-12-31 | restructuring | announced | 2018-01-23 | 2020-12-31 | Global | All segments | subsequent_events f5-10k / Qwen3.6-27B-Q8_0 | Workforce reductions expected in the range of 5,000 to 5,500. Total costs anticipated $1.7B-$1.9B pre-tax. Announced after fiscal year-end. | |||
| 2016-12-31 | restructuring | completed | 2014 | 2016-12-31 | All major geographies | All business segments | USD 35 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Multi-year program initiated in 2014 to improve organization efficiency and offset stranded overhead from the health care spin-off; actions completed by 2016-12-31. Charge shown is FY2016 pre-tax ($35; $27 after tax). Program cumulative totals through completion were $231 pre-tax / $164 after tax, primarily severance; headcount affected not disclosed. FY2016 cash payments on the program were $60. | ||
| 2016-12-31 | restructuring | completed | 2014 | 2016-12-31 | Global | All segments | USD 35 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Pre-tax charge of $35 million recorded in 2016. Program completed by December 31, 2016. Employee count not disclosed for 2016 activity. | ||
| 2016-12-31 | restructuring | completed | 2014 | 2016-12-31 | Global | All segments and corporate functions | USD 35 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Pre-tax charge of $35 million recorded in 2016. Program completed by Dec 31, 2016. Total program cost $231 million pre-tax. Employee count not disclosed. | ||
| 2016-12-31 | restructuring | in_progress | After Tax [Member] / 2014 Organization Restructuring [Member] | USD 164,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2016-12-31 | restructuring | in_progress | Before Tax [Member] / 2014 Organization Restructuring [Member] | USD 231,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2016-12-31 | restructuring | in_progress | Before Tax [Member] / Corporate and Other [Member] / 2014 Organization Restructuring [Member] | USD 38,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2016-12-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2014 Organization Restructuring [Member] | USD 32,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2016-12-31 | restructuring | in_progress | Cost of Sales [Member] / 2014 Organization Restructuring [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2016-12-31 | restructuring | in_progress | Other Operating Income (Expense) [Member] / 2014 Organization Restructuring [Member] | USD -3,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2016-09-30 | restructuring | in_progress | 2014 | 2016-12-31 | All major geographies | All business segments and organizations | USD 15 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Plan initiated in 2014 to improve organization efficiency and offset stranded overhead costs from the health care business spin-off. Charges primarily severance; total costs expected toward the high end of $130-$160 after tax ($190-$230 pretax), with cash costs approximately 80 percent of total charges. Nine months ended September 30, 2016 charges were $15 pretax ($12 after tax); cumulative pretax charges through September 30, 2016 were $211 ($149 after tax). No employee count disclosed. | ||
| 2016-09-30 | restructuring | in_progress | 2014 | 2016-12-31 | Global — all major geographies | All business segments | USD 15 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Primarily severance; $15 pretax ($12 after tax) charged in nine months 2016. Cumulative pretax charges $211 ($149 after tax) through 2016-09-30; full plan expected toward high end of $190-230 pretax ($130-160 after tax), cash costs ~80% of total. No employee count disclosed. Cash payments $49 in nine months 2016. | ||
| 2016-09-30 | restructuring | in_progress | 2014-01-01 | 2016-12-31 | Global | All segments | USD 15 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Plan initiated in 2014 to improve efficiency post-healthcare spin-off. Nine months ended Sept 30, 2016 charges were $15 million pretax. Expected completion by end of 2016. | ||
| 2016-09-30 | restructuring | in_progress | After Tax [Member] / 2014 Organization Restructuring [Member] | USD 149,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2016-09-30 | restructuring | in_progress | Before Tax [Member] / 2014 Organization Restructuring [Member] | USD 211,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2016-06-30 | restructuring | in_progress | 2014-01-01 | 2016-12-31 | All major geographies | All business segments | USD 1 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Plan initiated in 2014 to improve organization efficiency after health care spin-off; total costs anticipated toward high end of $130-$160 after tax ($190-$230 pretax), primarily severance; cumulative pretax charges $211 through June 30, 2016; no employee count disclosed in this filing. | ||
| 2016-06-30 | restructuring | in_progress | 2014-01-01 | 2016-12-31 | Global | All business segments and major geographies | USD 15 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pretax charge of $15M for six months ended 2016-06-30 ($11M after tax); cumulative pretax charges of $211M ($148M after tax) through 2016-06-30. Plan targets total costs toward the high end of $190–230M pretax ($130–160M after tax), primarily severance, with cash costs ~80% of total. No employee headcount affected is disclosed. Announcement date approximate (plan initiated in 2014; exact date not stated). | ||
| 2016-06-30 | restructuring | in_progress | 2014-01-01 | 2016-12-31 | Global | All segments | USD 1 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Initiated in 2014 to improve efficiency post-health care spin-off. Expected to complete by end of 2016. Total pretax charges of $1 million recorded for Q2 2016. Cumulative pretax savings of $100 million through June 30, 2016. | ||
| 2016-06-30 | restructuring | in_progress | After Tax [Member] / 2014 Organization Restructuring [Member] | USD 148,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2016-06-30 | restructuring | in_progress | Before Tax [Member] / 2014 Organization Restructuring [Member] | USD 211,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2016-03-31 | restructuring | in_progress | 2014-01-01 | 2016-12-31 | All major geographies | All business segments | USD 14 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program initiated in 2014 to improve organization efficiency after health care spin-off; primarily severance. Q1 2016 pretax charge $14 ($10 after tax); cumulative pretax charges $210 through 2016-03-31; total program cost expected toward high end of $190-$230 pretax; cash payments of $24 in Q1 2016. No employee count disclosed. | ||
| 2016-03-31 | restructuring | in_progress | 2014-01-01 | 2016-12-31 | Global | All business segments and major geographies | USD 14 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pretax charge for Q1 2016 ($10 after tax); cumulative pretax charges of $210 ($147 after tax) through 2016-03-31. Program primarily severance, total cost expected toward high end of $190-$230 pretax ($130-$160 after tax), ~80% cash. No employee headcount affected is disclosed. Announced year only (2014); exact announcement date not stated in filing. | ||
| 2016-03-31 | restructuring | in_progress | 2014-01-01 | 2016-12-31 | Global | All segments | USD 14 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Initiated in 2014 to improve efficiency and offset stranded overhead from health care spin-off. Q1 2016 pretax charge of $14 million. Total expected pretax costs $190-$230 million. Completion expected by end of 2016. | ||
| 2016-03-31 | restructuring | in_progress | After Tax [Member] / 2014 Organization Restructuring [Member] | USD 147,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2016-03-31 | restructuring | in_progress | Before Tax [Member] / 2014 Organization Restructuring [Member] | USD 210,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-12-31 | restructuring | in_progress | 2014-10 | 2016-12-31 | Global | All business segments and all major geographies | USD 63 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | FY2015 activity only: $63 pre-tax charges ($42 after tax), primarily workforce reductions; program total expected $190-230 pre-tax ($130-160 after tax) with ~80% cash costs; cumulative pre-tax savings of $70 by end of 2015; no employees-affected count disclosed | ||
| 2015-12-31 | restructuring | in_progress | Turkey | Corporate & Other | USD 23 (millions) | MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML | Nondeductible charges of $23 recorded in 2015 for restructuring of operations in Turkey; no announcement date, employee count, or completion timeline disclosed | ||||
| 2015-12-31 | restructuring | in_progress | 2014-10 | 2016-12-31 | Global | All segments | USD 63 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Pre-tax charges of $63 million recognized in 2015 for the 2014 Organization Restructuring, primarily for workforce reductions. Program expected to be completed by end of 2016. | ||
| 2015-12-31 | restructuring | completed | 2012 | 2014-12-31 | Europe | Consumer and Professional | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Restructuring actions commenced in 2012 and were completed by December 31, 2014. No specific 2015 charges or employee counts disclosed for this completed program. | |||
| 2015-12-31 | restructuring | completed | Turkey | USD 23 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Pre-tax charges of $23 million recorded in 2015 related to restructuring of operations in Turkey. | |||||
| 2015-12-31 | restructuring | in_progress | 2014-10-01 | 2016-12-31 | Global | All segments | USD 63 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Initiated Oct 2014 to improve efficiency and offset stranded overhead from health care spin-off. $63M pre-tax charge in 2015, primarily for workforce reductions. Expected to complete by end of 2016. | ||
| 2015-12-31 | restructuring | completed | 2012-01-01 | 2014-12-31 | Europe | Consumer and Professional | USD 33 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Strategic changes initiated in 2012, completed by Dec 31, 2014. $33M pre-tax charge recorded in 2014 related to this program. No specific 2015 charge listed for this specific program in MD&A, but Note 4 mentions cumulative charges. | ||
| 2015-12-31 | restructuring | completed | 2015-01-01 | 2015-12-31 | Turkey | Operations | USD 23 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Nondeductible charges of $23M related to restructuring of operations in Turkey in 2015. | ||
| 2015-12-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2014 Organization Restructuring [Member] | USD 40,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2015-12-31 | restructuring | in_progress | Cost of Sales [Member] / 2014 Organization Restructuring [Member] | USD 23,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2015-12-31 | restructuring | in_progress | K-C Turkey [Member] / Corporate and Other [Member] | USD 23,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2015-12-31 | restructuring | in_progress | Before Tax [Member] / 2014 Organization Restructuring [Member] | USD 63,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2015-09-30 | restructuring | in_progress | 2014-10-01 | 2016-12-31 | All major geographies | All business segments | USD 11 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Plan initiated October 2014 to improve organization efficiency and offset stranded overhead costs from the health care spin-off; primarily severance. Q3 2015 pre-tax charge of $11 ($7 after tax); YTD pre-tax charge $36 ($20 after tax); cumulative pre-tax charges $169 ($115 after tax) through September 30, 2015. Total program cost anticipated at $190-$230 pre-tax ($130-$160 after tax), with cash costs approximately 80 percent. No employee counts disclosed. | ||
| 2015-09-30 | restructuring | in_progress | 2015-07-01 | Turkey | USD 17 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Charges of $17 for restructuring the business in Turkey recognized in Corporate & Other for both the three and nine months ended September 30, 2015. No employee counts disclosed. | ||||
| 2015-09-30 | restructuring | completed | 2014-01-01 | Europe | USD 13 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Prior-year (2014) charges related to European strategic changes of $1 (three months) and $13 (nine months) ended September 30, 2014; included for context of the restructuring program. No employee counts disclosed. | ||||
| 2015-09-30 | restructuring | in_progress | 2014-10-01 | 2016-12-31 | Global | All business segments and major geographies | USD 210 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Midpoint of disclosed $190-230 million pre-tax total cost range; primarily severance, ~80% cash. Cumulative pre-tax charges of $169 million ($115 million after tax) through 2015-09-30, including $36 million pre-tax in the nine months ended 2015-09-30. No employee headcount affected is disclosed. Aimed at improving organization efficiency and offsetting stranded overhead from the Halyard Health spin-off. | ||
| 2015-09-30 | restructuring | in_progress | Turkey | Corporate & Other | USD 17 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Restructuring charges for the Turkish business of $17 million recognized in both the three and nine months ended 2015-09-30; no employee counts, announcement date, or completion date disclosed. | ||||
| 2015-09-30 | restructuring | in_progress | 2014-10-01 | 2016-12-31 | Global | All segments | USD 11 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Q3 2015 pre-tax charges of $11M ($4M cost of products sold, $7M marketing, research and general expenses). Total plan costs anticipated $190-$230M pre-tax. | ||
| 2015-09-30 | restructuring | in_progress | Turkey | USD 17 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Charges of $17M for restructuring business in Turkey recorded in Q3 2015. | |||||
| 2015-09-30 | restructuring | in_progress | After Tax [Member] / 2014 Organization Restructuring [Member] | USD 115,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-09-30 | restructuring | in_progress | Before Tax [Member] / Cash charges [Member] / 2014 Organization Restructuring [Member] | USD 135,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-09-30 | restructuring | in_progress | Before Tax [Member] / 2014 Organization Restructuring [Member] | USD 169,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-09-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2014 Organization Restructuring [Member] | USD 7,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-09-30 | restructuring | in_progress | Provision for income taxes [Member] / 2014 Organization Restructuring [Member] | USD -4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-09-30 | restructuring | in_progress | Cost of Sales [Member] / 2014 Organization Restructuring [Member] | USD 4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-06-30 | restructuring | in_progress | 2014-10-01 | 2016-12-31 | All major geographies | All business segments and organizations | USD 12 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program initiated October 2014 to improve organization efficiency and offset stranded overhead costs after the health care spin-off; primarily severance. Q2 2015 pre-tax charges of $12 ($8 after tax); YTD pre-tax charges of $25 ($13 after tax). Cumulative pre-tax charges through June 30, 2015 were $158 ($108 after tax), including $125 pre-tax cash charges; cash payments of $49 in the six months ended June 30, 2015. Total program costs anticipated at $190-$230 pre-tax ($130-$160 after tax), with cash costs approximately 80 percent of total charges. No employee headcount affected was disclosed. | ||
| 2015-06-30 | restructuring | in_progress | 2014-10-31 | 2016-12-31 | Global | All business segments and major geographies | USD 25 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pre-tax charge of $25M for six months ended 2015-06-30 ($12M for the quarter, after tax $13M YTD); total program cost estimated at $190-230M pre-tax ($130-160M after tax), primarily severance; no employee count disclosed. Cumulative pre-tax charges through 2015-06-30 were $158M ($108M after tax), including $125M cash charges; $49M cash paid during the six months. | ||
| 2015-06-30 | restructuring | in_progress | 2014-10-01 | 2016-12-31 | Global | All segments | USD 12 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Charges of $12 million pre-tax recognized in Q2 2015 for the 2014 Organization Restructuring. Total expected costs are $190-$230 million pre-tax. Employee count affected is not disclosed. | ||
| 2015-06-30 | restructuring | in_progress | 2014-10-01 | 2016-12-31 | Global | All segments | USD 25 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Charges of $25 million pre-tax recognized in the first six months of 2015 for the 2014 Organization Restructuring. Employee count affected is not disclosed. | ||
| 2015-06-30 | restructuring | in_progress | After Tax [Member] / 2014 Organization Restructuring [Member] | USD 108,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-06-30 | restructuring | in_progress | Before Tax [Member] / Cash charges [Member] / 2014 Organization Restructuring [Member] | USD 125,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-06-30 | restructuring | in_progress | Before Tax [Member] / 2014 Organization Restructuring [Member] | USD 158,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-06-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2014 Organization Restructuring [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-06-30 | restructuring | in_progress | Provision for income taxes [Member] / 2014 Organization Restructuring [Member] | USD -4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-06-30 | restructuring | in_progress | Cost of Sales [Member] / 2014 Organization Restructuring [Member] | USD 7,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-03-31 | restructuring | in_progress | 2014-10-01 | 2016-12-31 | Global (approximately two-thirds of Q1 2015 pre-tax charges outside North America, one-third in North America) | All business segments and organizations in all major geographies | USD 13 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program initiated October 2014 to improve organization efficiency and offset stranded overhead from the health care spin-off. Total costs anticipated at $130-$160 after tax ($190-$230 pre-tax), primarily severance; cash costs approximately 80 percent of total charges. Q1 2015 charges: $8 in cost of products sold and $5 in marketing, research and general expenses, less $8 tax benefit ($5 net). Cumulative pre-tax charges through March 31, 2015 were $146 ($100 after tax), including $116 cumulative pre-tax cash charges; Q1 2015 cash payments were $31. Cumulative pre-tax savings of $15 realized through March 31, 2015, with $120-$140 expected by end of 2017. No employee headcount affected figure disclosed. | ||
| 2015-03-31 | restructuring | in_progress | 2014-10-01 | 2016-12-31 | Global (all major geographies) | All business segments | USD 13 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pre-tax charge of $13 in Q1 2015 ($5 after tax); cumulative pre-tax charges of $146 through 2015-03-31. Total program cost estimated at $190-230 pre-tax ($130-160 after tax), primarily severance; no headcount affected disclosed. | ||
| 2015-03-31 | other | in_progress | 2015-02-01 | 2015-06-30 | United States | Corporate / U.S. defined benefit pension plan | USD 1,300 (millions) | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Group annuity contracts to transfer pension obligations for approximately 21,000 U.S. retirees to two insurers; expected pension settlement charges of $0.8B after tax ($1.3B pre-tax) in 2015, mostly Q2. Involves retirees, not active workforce. | ||
| 2015-03-31 | acquisition_addition | completed | Israel; Turkey | Hogla-Kimberly, Ltd. and Kimberly-Clark Turkey subsidiary | USD 151 (millions) | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Acquired remaining 49.9% interest in Israeli subsidiary (and effectively Turkish subsidiary) for $151; treated as equity transaction reducing noncontrolling interests. No headcount added disclosed. | ||||
| 2015-03-31 | restructuring | in_progress | 2014-10-01 | 2016-12-31 | Global | All segments | USD 13 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Initiated Oct 2014 to improve efficiency post-spin-off. Q1 2015 charges: $8M cost of products sold, $5M marketing/general. Cumulative pre-tax charges $146M. Total expected pre-tax costs $190-$230M. | ||
| 2015-03-31 | other | announced | 21,000 | 2015-02-01 | 2015-06-30 | United States | Retirees | USD 1,300 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Agreement to purchase group annuity contracts transferring pension obligations for approx 21,000 retirees. Expected settlement charges $1.3B pre-tax ($0.8B after-tax) in 2015, mostly Q2. | |
| 2015-03-31 | restructuring | in_progress | After Tax [Member] / 2014 Organization Restructuring [Member] | USD 100,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-03-31 | restructuring | in_progress | Before Tax [Member] / Cash charges [Member] / 2014 Organization Restructuring [Member] | USD 116,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-03-31 | restructuring | in_progress | Before Tax [Member] / 2014 Organization Restructuring [Member] | USD 146,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-03-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2014 Organization Restructuring [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2015-03-31 | restructuring | in_progress | Cost of Sales [Member] / 2014 Organization Restructuring [Member] | USD 8,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | 2014-10 | 2016-12-31 | Global — North America, Europe, and international operations | All business segments; primarily salaried employees | USD 133 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | 2014 pre-tax charge only ($95 after tax); program total expected $190-230 pre-tax ($130-160 after tax), ~80% cash. Expected workforce reductions of 1,100 to 1,300 (range, not a single count). Geographic split of 2014 charges: $47 North America, $28 Europe, $58 other international. Purpose: offset stranded overhead from health care spin-off. | ||
| 2014-12-31 | divestiture_reduction | completed | 2014-10-31 | 2014-10-31 | Global | Health Care business (spun off as Halyard Health, Inc.) | USD 157 (millions) | discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Charge is pre-tax transaction and related costs ($138 after tax), recorded in discontinued operations; headcount transferred with the spin-off not disclosed. Net assets transferred of $1,496 million; health care business had approximately $1.7 billion annual net sales. | ||
| 2014-12-31 | plant_closure | completed | 2012 | 2014-12-31 | Western and Central Europe | Consumer and professional (Personal Care, Consumer Tissue, KCP) — diaper category exit outside Italy | USD 33 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Multi-year program approved 2012; only 2014 activity captured ($33 pre-tax, $30 after tax). Cumulative program charges of $413 pre-tax ($338 after tax) through completion. Five European manufacturing facilities sold or closed; annual net sales reduced by $500 versus 2012. Headcount reductions not quantified. | ||
| 2014-12-31 | restructuring | in_progress | 1,200 | 2014-10-01 | 2016-12-31 | Global | All segments | USD 210 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Workforce reductions expected in range of 1,100 to 1,300, primarily salaried employees. Total costs anticipated $190 to $230 pre-tax. Midpoint used for charge value. | |
| 2014-12-31 | restructuring | in_progress | 2014-10-01 | 2016-12-31 | Global | All segments | USD 133 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Workforce reductions expected in range of 1,100 to 1,300 primarily impacting salaried employees. Total costs anticipated $190-$230 pre-tax. $133 pre-tax charges recognized in 2014. | ||
| 2014-12-31 | restructuring | completed | 2012-01-01 | 2014-12-31 | Europe | Consumer and Professional | USD 33 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Completed by Dec 31, 2014. Exited diaper category in Western/Central Europe (except Italy) and divested lower-margin consumer tissue businesses. $33 pre-tax charges in 2014. | ||
| 2014-12-31 | divestiture_reduction | completed | 2014-10-31 | 2014-10-31 | Global | Health Care | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Spin-off of Halyard Health, Inc. with approx $1.7 billion annual net sales. No specific headcount disclosed for the spun-off entity. | |||
| 2014-12-31 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / 2014 Organization Restructuring [Member] | USD 93,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | Cost of Sales [Member] / 2014 Organization Restructuring [Member] | USD 40,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | Before Tax [Member] / 2014 Organization Restructuring [Member] | USD 133,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | 2014 Organization Restructuring [Member] / International [Member] | USD 58,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | 2014 Organization Restructuring [Member] / Europe [Member] | USD 28,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | 2014 Organization Restructuring [Member] / North America [Member] | USD 47,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | Marketing, research and general and other (income) and expense, net [Member] / European Strategic Changes [Member] | USD 22,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | Cost of Sales [Member] / Asset impairments and other asset-related charges [Member] / European Strategic Changes [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | Cost of Sales [Member] / Benefit from pension curtailment [Member] / European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | Cost of Sales [Member] / Employee Severance [Member] / European Strategic Changes [Member] | USD -5,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | Cost of Sales [Member] / Other Restructuring [Member] / European Strategic Changes [Member] | USD 14,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | Cost of Sales [Member] / European Strategic Changes [Member] | USD 11,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | European Strategic Changes [Member] | USD 33,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | European Strategic Changes [Member] / Consumer Tissue [Member] | USD 12,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | European Strategic Changes [Member] / K-C Professional [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | European Strategic Changes [Member] / Other (Income) And Expense, Net [Member] | USD 0 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | European Strategic Changes [Member] / Personal Care [Member] | USD 20,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2014-12-31 | restructuring | in_progress | 1,300 | Maximum [Member] / 2014 Organization Restructuring [Member] | restructuring_footnote f5-10k / no-ai-xblr | Expected positions to be eliminated | |||||
| 2014-12-31 | restructuring | in_progress | 1,100 | Minimum [Member] / 2014 Organization Restructuring [Member] | restructuring_footnote f5-10k / no-ai-xblr | Expected positions to be eliminated | |||||
| 2014-09-30 | restructuring | announced | 2014-10 | 2016-12-31 | All major geographies | All business segments; primarily salaried employees | USD 190 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Total costs anticipated at $190-$230 pre-tax ($130-$160 after tax); workforce reductions of 1,100 to 1,300 positions expected, primarily salaried; approximately 80% of charges are cash; $125-$150 pre-tax expected in Q4 2014; offsets stranded overhead from health care spin-off | ||
| 2014-09-30 | divestiture_reduction | in_progress | 2013-11 | 2014-10-31 | Global | Health Care | USD 115 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Tax-free spin-off of health care business as Halyard Health, Inc.; one Halyard share per eight KMB shares; expected completion October 31, 2014; $115 pre-tax of spin-off and related charges recognized in the nine months ended September 30, 2014 | ||
| 2014-09-30 | plant_closure | in_progress | 2014-06 | Thailand | Health Care — glove manufacturing | USD 70 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Exit of a health care glove manufacturing facility with production outsourced; expected charges approximately $70 pre-tax ($50 after tax); $54 recognized in cost of products sold in the nine months ended September 30, 2014, including a $42 asset impairment | |||
| 2014-09-30 | restructuring | in_progress | 2012-10 | 2014-12-31 | Western and Central Europe | Consumer Tissue and K-C Professional | USD 393 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Exit of diaper category (except Italy) and divestiture/exit of lower-margin businesses; sale or closure of five European manufacturing facilities and administrative streamlining; cumulative pre-tax charges of $393 through September 30, 2014, including $215 cash charges; $13 pre-tax recognized in the nine months ended September 30, 2014 | ||
| 2014-09-30 | restructuring | announced | 2014-10-01 | 2016-12-31 | Global | All business segments and major geographies | USD 190 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce reductions expected in range of 1,100 to 1,300, primarily salaried employees; pre-tax charges $190-230M ($130-160M after tax), ~80% cash. $125-150M pre-tax expected in Q4 2014. Announced October 2014, after quarter end. | ||
| 2014-09-30 | plant_closure | in_progress | 2014-06-01 | Thailand | Health Care (glove manufacturing) | USD 70 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Exit of one health care glove manufacturing facility with production outsourced; expected charges ~$70 pre-tax ($50 after tax). No employee count disclosed. | |||
| 2014-09-30 | divestiture_reduction | announced | 2013-11-01 | 2014-10-31 | Global | Health Care | subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML | Tax-free spin-off of health care business as Halyard Health, Inc.; distribution expected complete end of day 2014-10-31. No headcount disclosed. | |||
| 2014-09-30 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Western and Central Europe | Consumer and Professional businesses | USD 13 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Includes closure/sale of five European manufacturing facilities; $13M pre-tax charges in nine months ended 2014-09-30. Cumulative pre-tax charges $393M through 2014-09-30. No employee count disclosed. | ||
| 2014-09-30 | restructuring | announced | 2014-10-01 | 2016-12-31 | Global | All segments | subsequent_events f5-10q / Qwen3.6-27B-Q8_0 | Announced October 2014. Workforce reductions expected in range of 1,100 to 1,300, primarily salaried employees. Total costs anticipated $190-$230 pre-tax. | |||
| 2014-09-30 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Europe | Consumer and Professional | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Ongoing strategic changes initiated in 2012. Cumulative pre-tax charges through Sept 30, 2014 were $393 million. Expected completion by Dec 31, 2014. | |||
| 2014-09-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / Spinoff [Member] | USD 56,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-09-30 | restructuring | in_progress | Cost of Sales [Member] / Thailand Mill Closure [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-09-30 | restructuring | in_progress | Asset Impairments [Member] / Thailand Mill Closure [Member] | USD 42,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-09-30 | restructuring | in_progress | Cost of Sales [Member] / Spinoff [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-09-30 | restructuring | in_progress | Expected Charges [Member] / Thailand Mill Closure [Member] | USD 70,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-09-30 | restructuring | in_progress | Spinoff [Member] | USD 40,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-09-30 | restructuring | in_progress | European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-09-30 | restructuring | in_progress | Cash charges [Member] / European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-09-30 | restructuring | in_progress | 1,100 | Minimum [Member] / 2014 Organization Restructuring [Member] | restructuring_footnote f5-10q / no-ai-xblr | Expected positions to be eliminated | |||||
| 2014-09-30 | restructuring | in_progress | 1,300 | Maximum [Member] / 2014 Organization Restructuring [Member] | restructuring_footnote f5-10q / no-ai-xblr | Expected positions to be eliminated | |||||
| 2014-06-30 | plant_closure | announced | 2014-06 | Thailand | Health Care | USD 70 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Exit of a health care glove manufacturing facility with production outsourced; charges of approximately $70 pre-tax ($50 after tax) expected. Q2 2014 charges of $49 recognized in cost of sales, including $42 asset impairment and $7 workforce reductions. No employee count disclosed. | |||
| 2014-06-30 | restructuring | in_progress | 2012-10 | 2014-12-31 | Western and Central Europe | Personal Care, Consumer Tissue, K-C Professional | USD 392 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Exit of diaper category (except Italy), divestiture or exit of lower-margin businesses, sale or closure of five manufacturing facilities, and streamlining of administrative organization. Cumulative pre-tax charges of $392 ($317 after tax) through June 30, 2014, including $215 cash charges; $12 of pre-tax charges recognized in H1 2014. No employee count disclosed. | ||
| 2014-06-30 | divestiture_reduction | announced | 2013-11 | 2014-10-31 | Health Care | USD 75 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Potential tax-free spin-off of health care business (~$1.7 billion annual net sales) as a stand-alone public company; Form 10 filed May 2014, amended June 2014. Transaction and related costs of $19 in Q2 and $26 in H1 2014 recorded in marketing, research and general expenses; total H1 2014 charges for spin-off and related matters $75 pre-tax ($53 after tax). Subject to Board approval and market, regulatory and other conditions. | |||
| 2014-06-30 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Western and Central Europe | Personal Care, Consumer Tissue, K-C Professional | USD 12 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Six months ended 2014-06-30 pre-tax charge; includes workforce reductions and other exit costs. Cumulative pre-tax charges through 2014-06-30 were $392M ($317M after tax), including $215M cash charges. No employee headcount affected is disclosed. Program includes closure/sale of five European manufacturing facilities, administrative streamlining, and exit of the diaper category outside Italy. | ||
| 2014-06-30 | plant_closure | announced | 2014-06-01 | Thailand | Health Care (glove manufacturing) | USD 70 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Decision in June 2014 to exit a health care glove manufacturing facility and outsource production; expected total charges approximately $70M pre-tax ($50M after tax). Q2 2014 charges of $49M in cost of sales comprised a $42M asset impairment and $7M workforce-reduction charge. Number of employees affected not disclosed. Announcement date is month-precision (June 2014). | |||
| 2014-06-30 | divestiture_reduction | announced | 2013-11-01 | 2014-10-31 | Global | Health Care | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Board-authorized potential tax-free spin-off of the health care business (approximately $1.7B annual net sales); Form 10 filed May 2014, amended June 2014, expected completion end of October 2014 subject to conditions. Headcount to be separated not disclosed. Related transaction and other charges were $68M (Q2) and $75M (six months) pre-tax, recorded in Corporate & Other; these are transaction costs, not severance. Announcement date is month-precision (November 2013). | |||
| 2014-06-30 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Europe | Consumer and Professional Businesses | USD 2 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Charges for workforce reductions and other exit costs recognized in Q2 2014. Cumulative pre-tax charges through June 30, 2014 were $392 million. Employee count affected in this quarter is not explicitly disclosed. | ||
| 2014-06-30 | plant_closure | announced | 2014-06-30 | Thailand | Health Care | USD 49 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Decision to exit one health care glove manufacturing facility in Thailand and outsource production. Charges recognized in Q2 2014 included $42 million asset impairment and $7 million related to workforce reductions. Specific employee count not disclosed. | |||
| 2014-06-30 | restructuring | in_progress | Spinoff [Member] | USD 68,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Related to Workforce Reductions [Member] / Thailand Mill Closure [Member] | USD 7,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Asset Impairments [Member] / Thailand Mill Closure [Member] | USD 42,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Expected Charges [Member] / Thailand Mill Closure [Member] | USD 70,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / Spinoff [Member] | USD 26,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Cost of Sales [Member] / Thailand Mill Closure [Member] | USD 49,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Cash charges [Member] / European Strategic Changes [Member] | USD 12,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | European Strategic Changes [Member] | USD 392,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Cost of Sales [Member] / Other Restructuring [Member] / European Strategic Changes [Member] | USD 10,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Cost of Sales [Member] / Benefit from pension curtailment [Member] / European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Cost of Sales [Member] / Asset Write-Offs [Member] / European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Marketing, research and general and other (income) and expense, net [Member] / European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Provision For Income Taxes [Member] / European Strategic Changes [Member] | USD -3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Cost of Sales [Member] / Employee Severance [Member] / European Strategic Changes [Member] | USD -2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Cost of Sales [Member] / European Strategic Changes [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Cost of Sales [Member] / Incremental Depreciation [Member] / European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | European Strategic Changes [Member] / K-C Professional [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | Cost of products sold and marketing, research and general expenses [Member] / European Strategic Changes [Member] | USD 12,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | European Strategic Changes [Member] / Personal Care [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-06-30 | restructuring | in_progress | European Strategic Changes [Member] / Consumer Tissue [Member] | USD 8,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Western and Central Europe | Personal Care, Consumer Tissue, K-C Professional | USD 10 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q1 2014 pre-tax charges of $10 ($6 in cost of products sold, $4 in MR&G); segment split $5 Personal Care, $3 Consumer Tissue, $2 KCP. Cumulative pre-tax charges through March 31, 2014 were $390 ($313 after tax), including $213 cash. Program includes exit of diaper category (except Italy), divestiture of lower-margin businesses, and closure or sale of five European manufacturing facilities. Impacted businesses previously generated about $0.5 billion annual net sales; Q1 2014 net sales reduced by $90 versus prior year. Expected total pre-tax charges slightly above $350-$400 range; after-tax charges expected $300-$350; cash costs 50-55% of total. | ||
| 2014-03-31 | divestiture_reduction | announced | 2013-11-01 | 2014-12-31 | Global | Health Care | USD 7 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Board authorized pursuit of a potential tax-free spin-off of the health care business (about $1.6 billion annual net sales) announced November 2013. Q1 2014 included $7 of transaction and related costs. Form 10 filing expected early May 2014; completion expected end of Q3 or potentially Q4 2014, subject to Board approval and market/regulatory conditions. Headcount affected not disclosed. | ||
| 2014-03-31 | voluntary_separation | completed | 2013-06-17 | 2013-12-27 | Chester, Pennsylvania, United States | Hourly mill employees (USW Local 10-4489) | other f5-10q / GLM-5.3-flash-fp4-HTML | 2013 voluntary program for hourly employees age 57+ with 30+ years of service at the Chester mill; lump-sum severance of $30,000 per participant; elections accepted in seniority order if more than 60 employees elected. Program predates the current reporting period. | |||
| 2014-03-31 | voluntary_separation | completed | 2013-09-19 | 2013-10-15 | Paris, Texas, United States | Operations and maintenance employees | other f5-10q / GLM-5.3-flash-fp4-HTML | Capped at 31 Operations employees plus 4 L5-or-greater Maintenance Technical Resources; elections accepted in seniority order. Program predates the current reporting period. | |||
| 2014-03-31 | voluntary_separation | completed | 2013-06-25 | 2013-10-15 | Ogden, Utah, United States | Operations, maintenance, stores and administration employees | other f5-10q / GLM-5.3-flash-fp4-HTML | Capped at 36 employees (Operations plus up to 4 Maintenance, 2 Stores, 2 Administration); elections accepted in seniority order. Program predates the current reporting period. | |||
| 2014-03-31 | restructuring | in_progress | 2012-10 | 2014-12-31 | Western and Central Europe | Personal Care, Consumer Tissue, K-C Professional | USD 10 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program includes workforce reductions, asset write-offs, incremental depreciation and exit costs; $10 pre-tax charges in Q1 2014 ($6 in cost of products sold, $4 in marketing/research/general), $17 cash payments. Cumulative pre-tax charges through 2014-03-31 were $390 ($313 after tax), including $213 cash. No employee headcount affected is disclosed. Actions commenced 2012, expected complete by 2014-12-31. | ||
| 2014-03-31 | divestiture_reduction | announced | 2013-11 | 2014-09-30 | Global | Health Care | USD 7 (millions) | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Potential tax-free spin-off of the health care business (~$1.6 billion annual net sales) into a standalone public company; Form 10 registration statement expected to be filed in early May 2014, completion targeted for end of Q3 or Q4 2014, subject to Board approval and market/regulatory conditions. $7 of transaction and related costs recorded in Q1 2014. No headcount impact disclosed. | ||
| 2014-03-31 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Europe | Consumer and Professional Businesses | USD 10 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Initiated in 2012 to focus resources on stronger market positions. Includes exit of diaper category (except Italy) and divestiture of lower-margin businesses. Q1 2014 charges: $6M in cost of products sold, $4M in marketing/research/general expenses. Cumulative pre-tax charges through Q1 2014 were $390M. | ||
| 2014-03-31 | restructuring | in_progress | Spinoff [Member] | USD 7,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | Cash charges [Member] / European Strategic Changes [Member] | USD 213,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | European Strategic Changes [Member] | USD 390,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | Cost of Sales [Member] / Benefit from pension curtailment [Member] / European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | Provision For Income Taxes [Member] / European Strategic Changes [Member] | USD -5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | Cost of Sales [Member] / European Strategic Changes [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | Marketing, research and general and other (income) and expense, net [Member] / European Strategic Changes [Member] | USD 4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | Cost of Sales [Member] / Asset Write-Offs [Member] / European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | Cost of Sales [Member] / Incremental Depreciation [Member] / European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | Cost of Sales [Member] / Other Restructuring [Member] / European Strategic Changes [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | Cost of Sales [Member] / Employee Severance [Member] / European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | European Strategic Changes [Member] / K-C Professional [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | European Strategic Changes [Member] / Consumer Tissue [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | European Strategic Changes [Member] / Personal Care [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2014-03-31 | restructuring | in_progress | Cost of products sold and marketing, research and general expenses [Member] / European Strategic Changes [Member] | USD 10,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | 2012 | 2014-12-31 | Western and Central Europe | Personal Care, Consumer Tissue, K-C Professional | USD 81 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Program commenced in Q4 2012; only 2013 activity captured. 2013 pre-tax charges of $81 ($66 after tax), including $10 for workforce reductions; involves sale or closure of five European manufacturing facilities and administrative streamlining. Cumulative program charges expected toward the high end of a $350-$400 pre-tax range; cash payments of $156 made in 2013. Employees affected not disclosed. | ||
| 2013-12-31 | divestiture_reduction | announced | 2013-11 | 2014-09-30 | Global | Health Care | other f5-10k / MiMo-V2.6-Flash-fp8-HTML | Board authorized a potential tax-free spin-off of the health care business (target: end of Q3 2014), creating a standalone company with about $1.6 billion in annual net sales. Approximately 16,000 health care employees and 14 health care facilities would transfer, but the filing does not state affected headcount; no assurance the spin-off will be completed. | |||
| 2013-12-31 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Europe | Consumer Tissue, Personal Care, K-C Professional | USD 81 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Pre-tax charges of $81 million recognized in 2013 for European strategic changes. Program commenced in Q4 2012. Total expected cumulative charges $350-$400 million pre-tax. Employee count not disclosed. | ||
| 2013-12-31 | restructuring | completed | 2011-01-01 | 2012-12-31 | Global | Consumer Tissue, K-C Professional | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Actions substantially complete at December 31, 2012. No specific 2013 charges or employee counts disclosed for this program in 2013 filing. | |||
| 2013-12-31 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Europe | Personal Care, Consumer Tissue, K-C Professional | USD 81 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Pre-tax charges of $81 million recognized in 2013. Program commenced in Q4 2012. Involves sale/closure of five European manufacturing facilities and administrative streamlining. Employee count not explicitly disclosed in footnote. | ||
| 2013-12-31 | restructuring | completed | 2011-01-01 | 2012-12-31 | Global | Consumer Tissue, K-C Professional | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Actions substantially complete at December 31, 2012. Involved streamlining, sale or closure of seven manufacturing facilities. No material charges recorded in 2013. | |||
| 2013-12-31 | restructuring | in_progress | Cost of Sales [Member] / Incremental Depreciation [Member] / European Strategic Changes [Member] | USD 18,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Cost of Sales [Member] / European Strategic Changes [Member] | USD 54,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Cost of Sales [Member] / Asset Write-Offs [Member] / European Strategic Changes [Member] | USD 13,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Marketing, research and general and other (income) and expense, net [Member] / European Strategic Changes [Member] | USD 27,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Cost of Sales [Member] / Asset Impairments [Member] / European Strategic Changes [Member] | USD 22,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Cost of Sales [Member] / Benefit from pension curtailment [Member] / European Strategic Changes [Member] | USD -31,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Cost of Sales [Member] / Employee Severance [Member] / European Strategic Changes [Member] | USD 10,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Cost of Sales [Member] / Other Restructuring [Member] / European Strategic Changes [Member] | USD 22,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Provision For Income Taxes [Member] / European Strategic Changes [Member] | USD -15,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Cash charges [Member] / European Strategic Changes [Member] | USD 69,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | K-C Professional [Member] / European Strategic Changes [Member] | USD 13,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | European Strategic Changes [Member] | USD 81,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Other (Income) And Expense, Net [Member] / European Strategic Changes [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Consumer Tissue [Member] / European Strategic Changes [Member] | USD 27,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-12-31 | restructuring | in_progress | Personal Care [Member] / European Strategic Changes [Member] | USD 36,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Western and Central Europe | Personal Care, Consumer Tissue, K-C Professional | USD 67 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Exit diaper category (except Italy) and divest or exit lower-margin businesses; sale or closure of five European manufacturing facilities plus administrative streamlining. Nine months ended September 30, 2013 pre-tax charges of $67 ($52 net after $15 tax benefit); cumulative pre-tax charges of $366 through September 30, 2013. Impacted businesses generated annual net sales of approximately $0.5 billion. No employee count disclosed. | ||
| 2013-09-30 | restructuring | completed | 2011-01-01 | 2012-12-31 | Global (United States, Australia, other countries) | Consumer Tissue, K-C Professional | USD 85 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Streamlining, sale or closure of seven manufacturing facilities worldwide to exit remaining integrated pulp manufacturing operations; substantially complete at December 31, 2012. Nine months ended September 30, 2012 pre-tax charges of $85 ($80 Consumer Tissue, $5 K-C Professional). No employee count disclosed. | ||
| 2013-09-30 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Western and Central Europe | Personal Care, Consumer Tissue, K-C Professional | USD 67 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Nine-month 2013 pre-tax charges of $67M; Q3 2013 charges of $14M. Involves sale or closure of five European manufacturing facilities, workforce reductions and administrative streamlining. Cumulative pre-tax charges through 2013-09-30 were $366M ($294M after tax), including $187M cash charges. No employee headcount affected is disclosed. Program announced October 2012. | ||
| 2013-09-30 | plant_closure | in_progress | 2012-10-01 | 2014-12-31 | Western and Central Europe | Consumer and professional manufacturing | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Component of the European strategic changes program: sale or closure of five European manufacturing facilities. No facility-level headcount disclosed. | |||
| 2013-09-30 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Western and Central Europe | Consumer and Professional businesses | USD 14 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Pre-tax charges of $14M recognized in Q3 2013. Cumulative pre-tax charges through Sept 30, 2013 were $366M. Employee count not disclosed. | ||
| 2013-09-30 | restructuring | completed | 2011-01-01 | 2012-12-31 | Global | Pulp and Tissue | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Actions substantially complete at Dec 31, 2012. No charges recorded in Q3 2013. Employee count not disclosed. | |||
| 2013-09-30 | restructuring | in_progress | Provision For Income Taxes [Member] / European Strategic Changes [Member] | USD -4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | Cost of Sales [Member] / European Strategic Changes [Member] | USD 44,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | Cost of Sales [Member] / Other Restructuring [Member] / European Strategic Changes [Member] | USD 4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | Cost of Sales [Member] / Benefit from pension curtailment [Member] / European Strategic Changes [Member] | USD -30,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | Marketing, research and general and other (income) and expense, net [Member] / European Strategic Changes [Member] | USD 23,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | Cost of Sales [Member] / Asset Write-Offs [Member] / European Strategic Changes [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | Cost of Sales [Member] / Employee Severance [Member] / European Strategic Changes [Member] | USD 4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | Cost of Sales [Member] / Asset Impairments [Member] / European Strategic Changes [Member] | USD 22,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | Cost of Sales [Member] / Incremental Depreciation [Member] / European Strategic Changes [Member] | USD 18,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Personal Care [Member] | USD 243,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | European Strategic Changes [Member] | USD 366,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | European Strategic Changes [Member] / K-C Professional [Member] | USD 32,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | Cash charges [Member] / European Strategic Changes [Member] | USD 187,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Consumer Tissue [Member] | USD 88,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-09-30 | restructuring | in_progress | Cost of products sold and marketing, research and general expenses [Member] / European Strategic Changes [Member] | USD 11,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Western and Central Europe | Personal Care | USD 29 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Six months ended June 30, 2013 pre-tax charges of $29 for Personal Care; $11 in the three-month period. Program overall will reduce European workforce by approximately 1,300 to 1,500 positions, including sale or closure of five European manufacturing facilities; impacted businesses generated annual net sales of approximately $500. | ||
| 2013-06-30 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Western and Central Europe | Consumer Tissue | USD 15 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Six months ended June 30, 2013 pre-tax charges of $15 for Consumer Tissue; $7 in the three-month period. Part of program exiting diaper category in region (except Italy) and divesting lower-margin consumer tissue businesses. | ||
| 2013-06-30 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Western and Central Europe | K-C Professional | USD 9 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Six months ended June 30, 2013 pre-tax charges of $9 for K-C Professional; $4 in the three-month period. Modest impact on KCP relative to consumer businesses. | ||
| 2013-06-30 | plant_closure | in_progress | 2012-10-01 | 2014-12-31 | Europe | Consumer and professional businesses | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Restructuring involves the sale or closure of five European manufacturing facilities; per-facility headcount impacts not disclosed. | |||
| 2013-06-30 | restructuring | in_progress | 1,300 | 2012-10 | 2014-12-31 | Western and Central Europe | Personal Care, Consumer Tissue, and K-C Professional (primarily consumer businesses) | USD 352 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce reduction of approximately 1,300 to 1,500 positions (value shown is the low end of the disclosed range). Program includes sale or closure of five European manufacturing facilities and administrative streamlining; exiting the diaper category outside Italy and divesting lower-margin businesses. Charge shown is cumulative pre-tax through 2013-06-30 ($284 after tax; cumulative pre-tax cash charges of $189). Impacted businesses generated annual net sales of approximately $500 million with negligible operating profit. Expected cumulative charges of $350 to $400 million pre-tax ($300 to $350 million after tax). | |
| 2013-06-30 | restructuring | in_progress | 1,400 | 2012-10-01 | 2014-12-31 | Europe | Consumer and Professional Businesses | USD 53 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program approved Oct 2012 to exit diaper category in Western/Central Europe (except Italy) and divest lower-margin consumer tissue businesses. Involves sale/closure of 5 manufacturing facilities and administrative streamlining. Total expected reduction of 1,300-1,500 positions. $53M pre-tax charges recognized YTD 2013. | |
| 2013-06-30 | restructuring | in_progress | European Strategic Changes [Member] / K-C Professional [Member] | USD 29,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | European Strategic Changes [Member] | USD 352,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | European Strategic Changes [Member] / Consumer Tissue [Member] | USD 81,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | European Strategic Changes [Member] / Personal Care [Member] | USD 242,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | Cost of Sales [Member] / Employee Severance [Member] / European Strategic Changes [Member] | USD 27,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | Cost of Sales [Member] / Incremental Depreciation [Member] / European Strategic Changes [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | Cost of Sales [Member] / Other Restructuring [Member] / European Strategic Changes [Member] | USD 8,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | Cost of Sales [Member] / European Strategic Changes [Member] | USD 18,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | Cost of Sales [Member] / Asset Write-Offs [Member] / European Strategic Changes [Member] | USD 12,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | Provision For Income Taxes [Member] / European Strategic Changes [Member] | USD -11,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | Cost of Sales [Member] / Benefit from pension curtailment [Member] / European Strategic Changes [Member] | USD -3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | Marketing, Research and General Expenses [Member] / European Strategic Changes [Member] | USD 15,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | European Strategic Changes [Member] / Cash charges [Member] | USD 55,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | 1,500 | Maximum [Member] / European Strategic Changes [Member] | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-06-30 | restructuring | in_progress | 1,300 | Minimum [Member] / European Strategic Changes [Member] | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-03-31 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Western and Central Europe | Personal Care, Consumer Tissue, K-C Professional | USD 31 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program will reduce European workforce by approximately 1,300 to 1,500 positions via sale or closure of five manufacturing facilities and administrative streamlining. Expected cumulative charges of $300-$350 after tax ($350-$400 pre-tax); Q1 2013 pre-tax charges of $31 ($20 in cost of products sold, $11 in marketing/research/general), with $18 Personal Care, $8 Consumer Tissue, $5 KCP. Cash payments of $13 made in the quarter; accrued liability of $154 at March 31, 2013. Impacted businesses generate annual net sales of approximately $500. | ||
| 2013-03-31 | restructuring | completed | 2011-01-01 | 2012-12-31 | North America, Australia | Consumer Tissue, K-C Professional | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Streamlining, sale or closure of six manufacturing facilities to exit remaining integrated pulp manufacturing; substantially complete at December 31, 2012, with one facility sale expected to close in Q2 2013. No current-quarter charges; Q1 2012 comparative charges of $35 pre-tax. Cumulative operating profit benefits of $65 recognized through March 31, 2013. | |||
| 2013-03-31 | restructuring | in_progress | 2012-10-31 | 2014-12-31 | Western and Central Europe | Personal Care, Consumer Tissue, K-C Professional | USD 31 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program announced October 2012; workforce reduction of approximately 1,300 to 1,500 positions (range stated, not a point estimate) plus sale or closure of five European manufacturing facilities. Q1 2013 pre-tax charge $31 ($20 in cost of products sold, $11 in marketing/research/general); cumulative pre-tax charges through 2013-03-31 were $330. Full-program estimate is $350 to $400 pre-tax ($300 to $350 after tax). Exits diaper category outside Italy and divests lower-margin tissue businesses; impacted businesses had annual net sales of about $500 with negligible operating profit. Segment split of Q1 charges: Personal Care $18, Consumer Tissue $8, KCP $5. | ||
| 2013-03-31 | plant_closure | in_progress | 2011-01-01 | 2013-06-30 | Global (North America and Australia) | Consumer Tissue, K-C Professional | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pulp and tissue restructuring involved streamlining, sale or closure of six manufacturing facilities; actions substantially complete at 2012-12-31 with one facility sale pending, expected to close in Q2 2013. No employee-affected count disclosed. No charges recorded in Q1 2013 (prior-year Q1 2012 charges not extracted). Cumulative operating profit benefits of $65 recognized through 2013-03-31 versus 2010 baseline. | |||
| 2013-03-31 | restructuring | in_progress | 2012-10-01 | 2014-12-31 | Europe | Consumer and Professional Businesses | USD 31 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Program approved Oct 2012 to exit diaper category in Western/Central Europe (except Italy) and divest lower-margin tissue businesses. Total program expected to reduce European workforce by 1,300-1,500 positions. Q1 2013 pre-tax charges of $31M recognized ($20M COGS, $11M MRG). Cumulative pre-tax charges through Q1 2013 were $330M. | ||
| 2013-03-31 | restructuring | in_progress | European Strategic Changes [Member] | USD 330,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-03-31 | restructuring | in_progress | European Strategic Changes [Member] / Cash charges [Member] | USD 41,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-03-31 | restructuring | in_progress | Restructuring Cost [Member] / European Strategic Changes [Member] | USD 21,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-03-31 | restructuring | in_progress | K-C Professional [Member] / European Strategic Changes [Member] | USD 25,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-03-31 | restructuring | in_progress | Consumer Tissue [Member] / European Strategic Changes [Member] | USD 74,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-03-31 | restructuring | in_progress | Personal Care [Member] / European Strategic Changes [Member] | USD 231,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-03-31 | restructuring | in_progress | 1,500 | European Strategic Changes [Member] / Maximum [Member] | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2013-03-31 | restructuring | in_progress | 1,300 | European Strategic Changes [Member] / Minimum [Member] | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | 1,300 | 2012-10-23 | 2014-12-31 | Western and Central Europe | Consumer and professional businesses (Personal Care, Consumer Tissue, K-C Professional) | USD 299 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Filer states reduction of approximately 1,300 to 1,500 European positions (count shown is low end of disclosed range); involves sale or closure of five European manufacturing facilities. Charge of $299 is pre-tax charges recognized in 2012; cumulative program charges estimated at $300-$400 pre-tax ($250-$350 after tax) through 2014. | |
| 2012-12-31 | restructuring | in_progress | 2011-01 | 2013-06-30 | Global (North America, Australia, other) | Consumer Tissue and K-C Professional | USD 105 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Pulp and tissue restructuring initiated January 2011 involving streamlining, sale or closure of six manufacturing facilities; charge shown is 2012 activity only ($98 cost of products sold, $6 marketing/research/general, $1 other income/expense). Substantially complete at 2012 year-end, including pending sale of one facility expected to close in first half of 2013. Employees affected not disclosed. | ||
| 2012-12-31 | plant_closure | in_progress | 2012-01 | 2013-06-30 | North America | Consumer Tissue | USD 30 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | January 2012 decision to streamline an additional North American manufacturing facility; 2012 charge of $30 (incremental depreciation $22, other charges $8). Employees affected not disclosed. | ||
| 2012-12-31 | restructuring | in_progress | 1,400 | 2012-10-23 | 2014-12-31 | Western and Central Europe | Consumer and Professional businesses | USD 299 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Range of 1,300 to 1,500 positions reduced; midpoint used. Includes sale/closure of five facilities. | |
| 2012-12-31 | restructuring | completed | 2011-01-01 | 2012-12-31 | Global | Consumer Tissue and K-C Professional | USD 135 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Substantially completed as of Dec 31, 2012. Includes streamlining of additional North American facility. | ||
| 2012-12-31 | restructuring | in_progress | 2012-10-23 | 2014-12-31 | Western and Central Europe | Consumer and Professional businesses | USD 299 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Approved strategic changes to exit diaper category (except Italy) and divest lower-margin businesses. Involves sale/closure of five European facilities and streamlining administrative organization. Expected to reduce European workforce by approximately 1,300 to 1,500 positions. $299 million pre-tax charges recognized in 2012. | ||
| 2012-12-31 | restructuring | completed | 2011-01-01 | 2012-12-31 | Global | Consumer Tissue and K-C Professional | USD 135 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Initiated in 2011 to exit integrated pulp manufacturing and improve profitability. Substantially completed as of December 31, 2012. $135 million pre-tax charges recognized in 2012. | ||
| 2012-12-31 | restructuring | in_progress | Restructuring Cost [Member] / European Strategic Changes [Member] | USD 242,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] | USD 135,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Asset Write-Offs [Member] / Other Geographic Areas [Member] / Pulp And Tissue Restructuring [Member] | restructuring_footnote f5-10k / no-ai-xblr | |||||||
| 2012-12-31 | restructuring | in_progress | Incremental Depreciation [Member] / North America [Member] / Pulp And Tissue Restructuring [Member] | USD 29,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Employee Severance [Member] / North America [Member] / Pulp And Tissue Restructuring [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Asset Write-Offs [Member] / Pulp And Tissue Restructuring [Member] | USD 14,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Incremental Depreciation [Member] / Australia [Member] / Pulp And Tissue Restructuring [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Other Associated Costs [Member] / Pulp And Tissue Restructuring [Member] | USD 85,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Australia [Member] / Pulp And Tissue Restructuring [Member] | USD 35,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Asset Write-Offs [Member] / North America [Member] / Pulp And Tissue Restructuring [Member] | USD 14,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Other Geographic Areas [Member] / Pulp And Tissue Restructuring [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Other Associated Costs [Member] / North America [Member] / Pulp And Tissue Restructuring [Member] | USD 51,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Other Associated Costs [Member] / Other Geographic Areas [Member] / Pulp And Tissue Restructuring [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Employee Severance [Member] / Other Geographic Areas [Member] / Pulp And Tissue Restructuring [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Incremental Depreciation [Member] / Other Geographic Areas [Member] / Pulp And Tissue Restructuring [Member] | USD 0 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Incremental Depreciation [Member] / Pulp And Tissue Restructuring [Member] | USD 30,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | North America [Member] / Pulp And Tissue Restructuring [Member] | USD 97,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Other Associated Costs [Member] / Australia [Member] / Pulp And Tissue Restructuring [Member] | USD 32,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Employee Severance [Member] / Pulp And Tissue Restructuring [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Asset Write-Offs [Member] / Australia [Member] / Pulp And Tissue Restructuring [Member] | USD 0 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Employee Severance [Member] / Australia [Member] / Pulp And Tissue Restructuring [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Additional Streamlining [Member] | USD 18,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Restructuring Cost [Member] | USD 68,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Total Restructuring Cost [Member] | USD 86,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Personal Care [Member] / Pulp And Tissue Restructuring [Member] | USD 0 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | K-C Professional And Other [Member] / Pulp And Tissue Restructuring [Member] | USD 9,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | USD 434,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | |||||||
| 2012-12-31 | restructuring | in_progress | Other (Income) And Expense, Net [Member] / European Strategic Changes [Member] | USD 0 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Consumer Tissue [Member] / European Strategic Changes [Member] | USD 66,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | European Strategic Changes [Member] | USD 299,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | K-C Professional And Other [Member] | USD 29,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Personal Care [Member] / European Strategic Changes [Member] | USD 213,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Other (Income) And Expense, Net [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | K-C Professional And Other [Member] / European Strategic Changes [Member] | USD 20,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Consumer Tissue [Member] | USD 191,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Consumer Tissue [Member] / Pulp And Tissue Restructuring [Member] | USD 125,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Personal Care [Member] | USD 213,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | Other (Income) And Expense, Net [Member] / Pulp And Tissue Restructuring [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | 1,300 | Minimum [Member] | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-12-31 | restructuring | in_progress | 1,500 | Maximum [Member] | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global (North America, Australia, Other) | Consumer Tissue; K-C Professional & Other | USD 500 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Cumulative pre-tax charges of $500 million ($345 million after tax) through September 30, 2012, including $135 million cash charges; program involves streamlining, sale or closure of six manufacturing facilities and exit of non-strategic products. Expected cumulative pre-tax charges of $550-$600 million over 2011-2012. No employee counts disclosed. | ||
| 2012-09-30 | restructuring | in_progress | 2012-01-24 | 2012-12-31 | North America | Consumer Tissue | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Streamlining of an additional North America manufacturing facility to enhance consumer tissue profitability; nine-month 2012 pre-tax charges of $23 million in cost of products sold plus $18 million incremental depreciation and $3 million workforce reductions. No employee counts disclosed. | |||
| 2012-09-30 | restructuring | announced | 2012-10-23 | 2014-12-31 | Western and Central Europe | Personal Care (diaper exit except Italy); Consumer Tissue; modest K-C Professional impact | USD 350 (millions) | subsequent_events f5-10q / GLM-5.3-flash-fp4-HTML | Approximately 1,300 to 1,500 European positions to be eliminated; sale or closure of five manufacturing facilities plus administrative streamlining. Expected cumulative charges of approximately $250-$350 million after tax ($300-$400 million pre-tax): workforce reduction costs $140-$175 million, asset impairments $120-$150 million, incremental depreciation $30-$40 million, other costs $10-$35 million. Exited/divested businesses generate roughly $500 million annual net sales. | ||
| 2012-09-30 | restructuring | announced | 2012-10-23 | 2014-12-31 | Western and Central Europe | Consumer and professional businesses (Personal Care, Consumer Tissue, K-C Professional) | subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML | Post-quarter announcement (2012-10-23) to exit the European diaper category (except Italy) and divest or exit lower-margin businesses. Filer discloses a range of approximately 1,300 to 1,500 positions to be eliminated and cumulative pre-tax charges of $300 to $400 million ($250 to $350 million after tax); involves sale or closure of five European manufacturing facilities. Exited businesses generate about $500 million in annual net sales with negligible operating profit. Actions commence Q4 2012. | |||
| 2012-09-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global (North America, Australia, Other) | Consumer Tissue and K-C Professional | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pulp and tissue restructuring initiated 2011-01-21, involving streamlining, sale or closure of six manufacturing facilities, plus an additional North American facility announced 2012-01-24. No employee headcount affected is disclosed. Cumulative pre-tax charges of $500 million through 2012-09-30; full-program expected charges of $550 to $600 million pre-tax over 2011-2012. Q3 2012 charges were $31 million pre-tax ($16 million after tax). | |||
| 2012-09-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global | Consumer Tissue, K-C Professional | USD 31 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Pre-tax charges of $31 million incurred in Q3 2012. Cumulative pre-tax charges through Sept 30, 2012 were $500 million. Includes incremental depreciation, workforce reductions, asset write-offs, and other exit costs. | ||
| 2012-09-30 | restructuring | announced | 1,400 | 2012-10-23 | 2014-12-31 | Western and Central Europe | Consumer, K-C Professional | USD 350 (millions) | subsequent_events f5-10q / Qwen3.6-27B-Q8_0 | Announced Oct 23, 2012. Workforce reduction of 1,300 to 1,500 positions. Expected cumulative after-tax charges of $250 to $350 million. Includes sale/closure of five manufacturing facilities. | |
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Restructuring Cost [Member] | USD 11,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Additional Streamlining [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Total Restructuring Cost [Member] | USD 16,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Australia [Member] | USD 160,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Other (Income) And Expense, Net [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] | USD 500,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / K-C Professional And Other [Member] | USD 61,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / North America [Member] | USD 262,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Consumer Tissue [Member] | USD 437,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Other Geographic Areas [Member] | USD 78,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Other Associated Costs [Member] / Australia [Member] | USD 22,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Employee Severance [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Other Associated Costs [Member] / North America [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Employee Severance [Member] / Australia [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Other Associated Costs [Member] | USD 24,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Employee Severance [Member] / North America [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Employee Severance [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Incremental Depreciation [Member] / North America [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Other Associated Costs [Member] / Other Geographic Areas [Member] | USD -1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Incremental Depreciation [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Incremental Depreciation [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Incremental Depreciation [Member] / Australia [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Asset Write-Offs [Member] | USD 11,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Asset Write-Offs [Member] / Australia [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Asset Write-Offs [Member] / North America [Member] | USD 11,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] / Asset Write-Offs [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Maximum [Member] / workforce reduction costs [Member] | USD 175,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Maximum [Member] / Incremental Depreciation [Member] | USD 40,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Minimum [Member] / Impairment in Value of Asset [Member] | USD 120,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Maximum [Member] / Impairment in Value of Asset [Member] | USD 150,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Minimum [Member] / Other Associated Costs [Member] | USD 10,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Maximum [Member] / Target Date December 2014 [Member] | USD 400,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Minimum [Member] / Incremental Depreciation [Member] | USD 30,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Maximum [Member] / Other Associated Costs [Member] | USD 35,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Minimum [Member] / workforce reduction costs [Member] | USD 140,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | European Strategic Changes [Member] / Minimum [Member] / Target Date December 2014 [Member] | USD 300,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | K-C Professional And Other [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-09-30 | restructuring | in_progress | USD 31,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | |||||||
| 2012-09-30 | restructuring | in_progress | Consumer Tissue [Member] | USD 80,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | North America, Australia, Other | Consumer Tissue; K-C Professional & Other | USD 469 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Pulp and tissue restructuring plan to exit integrated pulp manufacturing; streamlining, sale or closure of six facilities worldwide. Cumulative pre-tax charges of $469 million through June 30, 2012 ($329 million after tax), including $110 million cash charges; expected total $550-$600 million pre-tax. No employee headcount figures disclosed. | ||
| 2012-06-30 | restructuring | in_progress | 2012-01-24 | 2012-12-31 | North America | Consumer Tissue | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Decision to streamline an additional North America manufacturing facility to enhance consumer tissue profitability; no headcount or standalone charge figures disclosed. | |||
| 2012-06-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | North America; Australia; Other (global) | Consumer Tissue; K-C Professional & Other | USD 39 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pre-tax charge for six months ended 2012-06-30. Program covers streamlining, sale or closure of six facilities; no employee count disclosed. Cumulative pre-tax charges through 2012-06-30 were $469M ($329M after tax), including $110M cash charges; expected program total $550-600M pre-tax. | ||
| 2012-06-30 | restructuring | in_progress | 2012-01-24 | 2012-12-31 | North America | Consumer Tissue | USD 15 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pre-tax charge for six months ended 2012-06-30 for the additional North American facility streamlining announced 2012-01-24; no employee count disclosed. Bundled with The Restructuring under a combined expected program total of $550-600M pre-tax over 2011-2012. | ||
| 2012-06-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global | Consumer Tissue; K-C Professional & Other | USD 19 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Initiated Jan 21, 2011 to exit integrated pulp manufacturing and improve profitability. Includes streamlining, sale, or closure of six facilities. Q2 2012 pre-tax charges were $19 million. Cumulative pre-tax charges through June 30, 2012 were $469 million. Expected cumulative pre-tax charges are $550-$600 million. | ||
| 2012-06-30 | restructuring | in_progress | 2012-01-24 | 2012-12-31 | North America | Consumer Tissue | USD 3 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Announced Jan 24, 2012 to streamline an additional manufacturing facility in North America. Q2 2012 pre-tax charges were $3 million. Part of the broader pulp and tissue restructuring actions. | ||
| 2012-06-30 | restructuring | in_progress | Restructuring Cost [Member] | USD 13,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Additional Streamlining [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Total Restructuring Cost [Member] | USD 16,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Other Geographic Areas [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Incremental Depreciation [Member] / North America [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Incremental Depreciation [Member] / Australia [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Asset Write-Offs [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Other Associated Costs [Member] / North America [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Other Associated Costs [Member] | USD 9,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Asset Write-Offs [Member] / Australia [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | North America [Member] | USD 15,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Asset Write-Offs [Member] / North America [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Asset Write-Offs [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Other Associated Costs [Member] / Australia [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Incremental Depreciation [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Incremental Depreciation [Member] | USD 7,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | USD 19,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | |||||||
| 2012-06-30 | restructuring | in_progress | Other Associated Costs [Member] / Other Geographic Areas [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Australia [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Other (Income) And Expense, Net [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Consumer Tissue [Member] | USD 406,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | K-C Professional And Other [Member] | USD 61,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Employee Severance [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Employee Severance [Member] / Australia [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Employee Severance [Member] | USD 4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-06-30 | restructuring | in_progress | Employee Severance [Member] / North America [Member] | USD 4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | North America, Australia, Other | Consumer Tissue; K-C Professional & Other | USD 35 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program to exit integrated pulp manufacturing via streamlining, sale or closure of six facilities; Q1 2012 pre-tax charges of $35 million ($24 million after tax). Cumulative pre-tax charges through March 31, 2012 were $450 million ($313 million after tax), including $101 million cash charges; total program expected at $550-600 million pre-tax. | ||
| 2012-03-31 | restructuring | announced | 2012-01-24 | 2012-12-31 | North America | Consumer Tissue | USD 40 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Streamlining of an additional North America manufacturing facility to enhance consumer tissue profitability; estimated charges of $30-50 million before tax (midpoint $40 million recorded as estimate). Q1 2012 Additional Streamlining charges were $9 million pre-tax ($6 million after tax). Both restructuring actions anticipated to be substantially completed by end of 2012. | ||
| 2012-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global (North America, Australia, Other) | Consumer Tissue; K-C Professional & Other | USD 26 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pulp and tissue restructuring plan covering streamlining, sale or closure of six facilities; Q1 2012 pre-tax charge of $26M (of $35M total quarter charges). Cumulative pre-tax charges through 2012-03-31 were $450M; full-program estimate $550M-$600M pre-tax. No employee headcount affected is disclosed. | ||
| 2012-03-31 | restructuring | in_progress | 2012-01-24 | 2012-12-31 | North America | Consumer Tissue | USD 9 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Additional streamlining of one North America manufacturing facility announced 2012-01-24; estimated charges $30M-$50M pre-tax for the full action, $9M recognized in Q1 2012. No employee headcount affected is disclosed. | ||
| 2012-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global | Consumer Tissue, K-C Professional & Other | USD 35 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Cumulative pre-tax charges of $450 million through March 31, 2012. Q1 2012 charges included $26 million in cost of products sold and $9 million in other exit costs/workforce reductions. Expected cumulative pre-tax charges of $550-$600 million over 2011 and 2012. | ||
| 2012-03-31 | restructuring | announced | 2012-01-24 | 2012-12-31 | North America | Consumer Tissue | USD 40 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Announced streamlining of an additional manufacturing facility. Estimated charges range from $30 million to $50 million before tax. Included in the cumulative restructuring program. | ||
| 2012-03-31 | restructuring | in_progress | Restructuring Cost [Member] | USD 18,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Additional Streamlining [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Total Restructuring Cost [Member] | USD 24,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Australia [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Employee Severance [Member] | USD 4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Asset Write-Offs [Member] / Australia [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Other Associated Costs [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | North America [Member] | USD 33,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Incremental Depreciation [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | USD 35,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | |||||||
| 2012-03-31 | restructuring | in_progress | Employee Severance [Member] / Australia [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Incremental Depreciation [Member] / Australia [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Other Associated Costs [Member] / Australia [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Asset Write-Offs [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Other Associated Costs [Member] / North America [Member] | USD 9,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Employee Severance [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Asset Write-Offs [Member] | USD 8,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Other Associated Costs [Member] | USD 11,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Employee Severance [Member] / North America [Member] | USD 4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Incremental Depreciation [Member] / North America [Member] | USD 12,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Asset Write-Offs [Member] / North America [Member] | USD 8,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Incremental Depreciation [Member] | USD 12,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | K-C Professional And Other [Member] | USD 59,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Other (Income) And Expense, Net [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2012-03-31 | restructuring | in_progress | Consumer Tissue [Member] | USD 389,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | North America | Consumer Tissue / K-C Professional | USD 27 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Workforce-reduction portion of $204M total 2011 North America restructuring charges; program total $415M in 2011, $550-600M expected cumulatively for 2011-2012. Employee counts not disclosed. | ||
| 2011-12-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Australia | Consumer Tissue / K-C Professional | USD 47 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Workforce-reduction portion of $133M total 2011 Australia restructuring charges; covers two Australian facilities. Employee counts not disclosed. | ||
| 2011-12-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Other (Europe and rest of world) | Consumer Tissue / K-C Professional | USD 3 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Workforce-reduction portion of $78M total 2011 Other-region restructuring charges; includes two Spanish facilities. Employee counts not disclosed. | ||
| 2011-12-31 | plant_closure | announced | 2012-01-24 | 2012-12-31 | North America (Chester, Pennsylvania) | Consumer Tissue | USD 40 (millions) | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | Midpoint of disclosed $30-50M pre-tax estimated charge range; announced after fiscal year-end, before filing date. Streamlining of an additional North American facility. | ||
| 2011-12-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global | Consumer Tissue, K-C Professional & Other | USD 415 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Pulp and tissue restructuring plan to exit integrated pulp manufacturing operations. Charges include incremental depreciation, workforce reductions, asset impairments, and write-offs. Employee count not explicitly disclosed in footnote. | ||
| 2011-12-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | North America | Consumer Tissue | USD 204 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Component of global restructuring. Includes facility in Everett, Washington. | ||
| 2011-12-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Australia | Consumer Tissue | USD 133 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Component of global restructuring. Two facilities impacted. | ||
| 2011-12-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Other | Consumer Tissue | USD 78 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Component of global restructuring. Includes two facilities in Spain. | ||
| 2011-12-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global | Consumer Tissue, K-C Professional & Other | USD 415 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Pulp and tissue restructuring plan to exit integrated pulp manufacturing operations. Charges include incremental depreciation, workforce reductions, asset impairments, and write-offs. Employee count not explicitly disclosed in footnote. | ||
| 2011-12-31 | restructuring | announced | 2012-01-24 | 2012-12-31 | North America | Consumer Tissue | subsequent_events f5-10k / Qwen3.6-27B-Q8_0 | Announced decision to streamline an additional manufacturing facility in North America. Estimated charges $30 million to $50 million before tax. Employee count not disclosed. | |||
| 2011-12-31 | restructuring | in_progress | Restructuring Cost [Member] | USD 289,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Other Associated Costs [Member] / Australia [Member] | USD 4,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Australia [Member] | USD 133,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Asset Write-Offs [Member] / North America [Member] | USD 10,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Other Associated Costs [Member] / North America [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Incremental Depreciation [Member] | USD 252,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Other Associated Costs [Member] | USD 9,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Other Geographic Areas [Member] | USD 78,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Other Associated Costs [Member] / Other Geographic Areas [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Employee Severance [Member] / Other Geographic Areas [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Employee Severance [Member] / Australia [Member] | USD 47,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Impairment in Value of Asset [Member] | USD 58,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | North America [Member] | USD 204,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Incremental Depreciation [Member] / Australia [Member] | USD 73,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Asset Write-Offs [Member] | USD 19,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Asset Write-Offs [Member] / Australia [Member] | USD 9,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Employee Severance [Member] | USD 77,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Impairment in Value of Asset [Member] / Australia [Member] | restructuring_footnote f5-10k / no-ai-xblr | |||||||
| 2011-12-31 | restructuring | in_progress | USD 415,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | |||||||
| 2011-12-31 | restructuring | in_progress | Incremental Depreciation [Member] / Other Geographic Areas [Member] | USD 14,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Impairment in Value of Asset [Member] / North America [Member] | restructuring_footnote f5-10k / no-ai-xblr | |||||||
| 2011-12-31 | restructuring | in_progress | Employee Severance [Member] / North America [Member] | USD 27,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Asset Write-Offs [Member] / Other Geographic Areas [Member] | restructuring_footnote f5-10k / no-ai-xblr | |||||||
| 2011-12-31 | restructuring | in_progress | Impairment in Value of Asset [Member] / Other Geographic Areas [Member] | USD 58,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Incremental Depreciation [Member] / North America [Member] | USD 165,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Other (Income) And Expense, Net [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | K-C Professional And Other [Member] | USD 56,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-12-31 | restructuring | in_progress | Consumer Tissue [Member] | USD 357,000,000 (absolute) | restructuring_footnote f5-10k / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | North America | Consumer Tissue and K-C Professional (pulp and tissue) | USD 142 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Nine months ended September 30, 2011 pretax charges for North America; includes incremental depreciation of $123 million and workforce reduction charges of $10 million. No employee headcount affected was disclosed. | ||
| 2011-09-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Australia | Consumer Tissue and K-C Professional (pulp and tissue) | USD 112 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Nine months ended September 30, 2011 pretax charges for Australia; includes incremental depreciation of $59 million and workforce reduction charges of $46 million. No employee headcount affected was disclosed. | ||
| 2011-09-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Other | Consumer Tissue and K-C Professional (pulp and tissue) | USD 13 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Nine months ended September 30, 2011 pretax charges in other geographies. No employee headcount affected was disclosed. | ||
| 2011-09-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global (North America, Australia, other international) | Consumer Tissue; K-C Professional & Other | USD 267 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pulp and tissue restructuring involves streamlining, sale or closure of 5 to 6 manufacturing facilities. Full-program pretax charges estimated at $400M-$600M ($280M-$420M after tax), including workforce reduction costs of $50M-$100M; no headcount affected disclosed. YTD 2011 charges of $267M ($205M non-cash); Q3 2011 charges of $95M. Cash charges of $62M accrued, $34M paid as of 2011-09-30. Expected by 2013 to reduce annual net sales by $250M-$300M and increase operating profit by at least $75M. | ||
| 2011-09-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global | Consumer Tissue, K-C Professional & Other | USD 95 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Initiated Jan 21, 2011 to exit integrated pulp manufacturing. Q3 2011 charges of $95M pretax ($66M after tax). YTD 2011 charges $267M pretax. Employee count not disclosed. | ||
| 2011-09-30 | restructuring | in_progress | Incremental Depreciation [Member] | USD 76,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Other Associated Costs [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | USD 95,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | |||||||
| 2011-09-30 | restructuring | in_progress | Employee Severance [Member] / Other Geographic Areas [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Australia [Member] | USD 24,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Employee Severance [Member] / Australia [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Asset Write-Offs [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Asset Write-Offs [Member] / North America [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Incremental Depreciation [Member] / Australia [Member] | USD 19,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | North America [Member] | USD 66,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Incremental Depreciation [Member] / North America [Member] | USD 53,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Incremental Depreciation [Member] / Other Geographic Areas [Member] | USD 4,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Other Geographic Areas [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Employee Severance [Member] / North America [Member] | USD 10,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Other Associated Costs [Member] / Australia [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Asset Write-Offs [Member] / Other Geographic Areas [Member] | USD 0 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Other Associated Costs [Member] / North America [Member] | USD 1,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Asset Write-Offs [Member] / Australia [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Other Associated Costs [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Employee Severance [Member] | USD 11,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Minimum [Member] / Expected Completion Date December 2012 [Member] | USD 400,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Maximum [Member] / Expected Completion Date December 2012 [Member] | USD 600,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Maximum [Member] / Employee Severance [Member] / Expected Completion Date December 2012 [Member] | USD 100,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Maximum [Member] / Other Associated Costs [Member] / Expected Completion Date December 2012 [Member] | USD 100,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Minimum [Member] / Incremental Depreciation [Member] / Expected Completion Date December 2012 [Member] | USD 300,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Maximum [Member] / Incremental Depreciation [Member] / Expected Completion Date December 2012 [Member] | USD 400,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Minimum [Member] / Other Associated Costs [Member] / Expected Completion Date December 2012 [Member] | USD 50,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Minimum [Member] / Employee Severance [Member] / Expected Completion Date December 2012 [Member] | USD 50,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Restructuring Cost [Member] | USD 66,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | Consumer Tissue [Member] | USD 233,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-09-30 | restructuring | in_progress | K-C Professional And Other [Member] | USD 34,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | North America | Consumer Tissue and K-C Professional (pulp and tissue operations) | USD 76 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Six months ended June 30, 2011 pretax charges of $76 million in North America, primarily incremental depreciation; includes Everett, Washington facility. No employee counts disclosed. | ||
| 2011-06-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Australia | Consumer Tissue and K-C Professional (pulp and tissue operations) | USD 88 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Six months ended June 30, 2011 pretax charges of $88 million in Australia, including $46 million workforce reduction charges and $40 million incremental depreciation; two Australian pulp and tissue facilities impacted. | ||
| 2011-06-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Other | Consumer Tissue and K-C Professional (pulp and tissue operations) | USD 8 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Six months ended June 30, 2011 pretax charges of $8 million in other geographies. | ||
| 2011-06-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | North America (Everett, Washington) | Consumer Tissue | USD 58 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | North America component of pulp/tissue restructuring; includes $52M incremental depreciation, $6M asset write-offs in Q2 2011; workforce reduction costs not separately quantified for this geography | ||
| 2011-06-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Australia | Consumer Tissue | USD 29 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Australia component; two pulp and tissue facilities impacted; includes $21M incremental depreciation, $6M workforce reduction charges, $2M asset write-offs in Q2 2011 | ||
| 2011-06-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Other | Consumer Tissue | USD 3 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Other geographies component; $3M incremental depreciation in Q2 2011 | ||
| 2011-06-30 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global | Consumer Tissue, K-C Professional | USD 172 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Initiated Jan 21, 2011 to exit integrated pulp manufacturing. Involves streamlining/sale/closure of 5-6 facilities. YTD 2011 charges of $172M include $116M incremental depreciation, $48M workforce reductions, $8M asset write-offs. Expected cumulative charges $400M-$600M pre-tax. | ||
| 2011-06-30 | restructuring | in_progress | USD 172,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | |||||||
| 2011-06-30 | restructuring | in_progress | Asset Write-Offs [Member] | USD 8,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Australia [Member] | USD 88,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Consumer Tissue [Member] | USD 152,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Incremental Depreciation [Member] | USD 116,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | K-C Professional And Other [Member] | USD 20,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | North America [Member] | USD 76,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Other Geographic Areas [Member] | USD 8,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Pulp And Tissue Restructuring [Member] | USD 172,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Restructuring Cost [Member] | USD 116,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Charges For Workforce Reductions [Member] | USD 48,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Asset Write-Offs [Member] / Australia [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Asset Write-Offs [Member] / North America [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Asset Write-Offs [Member] / Other Geographic Areas [Member] | restructuring_footnote f5-10q / no-ai-xblr | |||||||
| 2011-06-30 | restructuring | in_progress | Incremental Depreciation [Member] / Australia [Member] | USD 40,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Incremental Depreciation [Member] / North America [Member] | USD 70,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Incremental Depreciation [Member] / Other Geographic Areas [Member] | USD 6,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Charges For Workforce Reductions [Member] / Australia [Member] | USD 46,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Charges For Workforce Reductions [Member] / North America [Member] | restructuring_footnote f5-10q / no-ai-xblr | |||||||
| 2011-06-30 | restructuring | in_progress | Charges For Workforce Reductions [Member] / Other Geographic Areas [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Maximum [Member] / Expected Completion Date December 2012 [Member] | USD 600,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Minimum [Member] / Expected Completion Date December 2012 [Member] | USD 400,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Maximum [Member] / Incremental Depreciation [Member] / Expected Completion Date December 2012 [Member] | USD 400,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Maximum [Member] / Other Associated Costs [Member] / Expected Completion Date December 2012 [Member] | USD 100,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Maximum [Member] / Charges For Workforce Reductions [Member] / Expected Completion Date December 2012 [Member] | USD 100,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Minimum [Member] / Incremental Depreciation [Member] / Expected Completion Date December 2012 [Member] | USD 300,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Minimum [Member] / Other Associated Costs [Member] / Expected Completion Date December 2012 [Member] | USD 50,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-06-30 | restructuring | in_progress | Minimum [Member] / Charges For Workforce Reductions [Member] / Expected Completion Date December 2012 [Member] | USD 50,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Global | Consumer Tissue and K-C Professional | USD 82 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Plan to exit remaining integrated pulp manufacturing; streamlining, sale or closure of 5 to 6 facilities including Everett, Washington and two Australian facilities. Q1 charges comprised $40 million incremental depreciation and $42 million workforce reductions; no employee count disclosed. Expected cumulative charges of $400-$600 million before tax; by 2013 annual net sales expected to decline $250-$300 million with operating profit up at least $75 million. | ||
| 2011-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | North America | Consumer Tissue and K-C Professional | USD 18 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q1 2011 charges all incremental depreciation; no workforce reduction charges recorded in North America. | ||
| 2011-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Australia | Consumer Tissue and K-C Professional | USD 59 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q1 2011 charges include $19 million incremental depreciation and $40 million workforce reductions. | ||
| 2011-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Other | Consumer Tissue and K-C Professional | USD 5 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q1 2011 charges include $3 million incremental depreciation and $2 million workforce reductions. | ||
| 2011-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | North America | Consumer Tissue; K-C Professional & Other | USD 18 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pulp and tissue restructuring: streamlining, sale or closure of 5-6 facilities; exit of integrated pulp manufacturing. Q1 2011 charges of $18M comprise incremental depreciation and workforce reduction costs; employee counts not disclosed. Program-level charges estimated at $400M-$600M pre-tax. | ||
| 2011-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Australia | Consumer Tissue; K-C Professional & Other | USD 59 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Covers the two Australian pulp and tissue facilities. Q1 2011 charges of $59M include $40M workforce reduction accrual (largely Australia) and incremental depreciation; employee counts not disclosed. | ||
| 2011-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Other (outside North America and Australia) | Consumer Tissue; K-C Professional & Other | USD 5 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Residual geography component of the pulp and tissue restructuring; employee counts not disclosed. | ||
| 2011-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | North America | Consumer Tissue | USD 18 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Incremental depreciation charges of $18 million recorded in Q1 2011. | ||
| 2011-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Australia | Consumer Tissue | USD 59 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Includes $19 million incremental depreciation and $40 million workforce reduction charges. | ||
| 2011-03-31 | restructuring | in_progress | 2011-01-21 | 2012-12-31 | Other | Consumer Tissue | USD 5 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Includes $3 million incremental depreciation and $2 million workforce reduction charges. | ||
| 2011-03-31 | restructuring | in_progress | USD 82,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | |||||||
| 2011-03-31 | restructuring | in_progress | Australia [Member] | USD 59,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Consumer Tissue [Member] | USD 75,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Incremental Depreciation [Member] | USD 40,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | K-C Professional and Other [Member] | USD 7,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | North America [Member] | USD 18,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Other Geographic Areas [Member] | USD 5,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Provision for Income Taxes [Member] | USD -25,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Charges for Workforce Reductions [Member] | USD 42,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Incremental Depreciation [Member] / Australia [Member] | USD 19,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Incremental Depreciation [Member] / North America [Member] | USD 18,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Incremental Depreciation [Member] / Other Geographic Areas [Member] | USD 3,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Maximum [Member] / Expected Completion Date December 2012 [Member] | USD 600,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Minimum [Member] / Expected Completion Date December 2012 [Member] | USD 400,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Charges for Workforce Reductions [Member] / Australia [Member] | USD 40,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Charges for Workforce Reductions [Member] / Other Geographic Areas [Member] | USD 2,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Maximum [Member] / Incremental Depreciation [Member] / Expected Completion Date December 2012 [Member] | USD 400,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Maximum [Member] / Other Associated Costs [Member] / Expected Completion Date December 2012 [Member] | USD 100,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Maximum [Member] / Charges for Workforce Reductions [Member] / Expected Completion Date December 2012 [Member] | USD 100,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Minimum [Member] / Incremental Depreciation [Member] / Expected Completion Date December 2012 [Member] | USD 300,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Minimum [Member] / Other Associated Costs [Member] / Expected Completion Date December 2012 [Member] | USD 50,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2011-03-31 | restructuring | in_progress | Minimum [Member] / Charges for Workforce Reductions [Member] / Expected Completion Date December 2012 [Member] | USD 50,000,000 (absolute) | restructuring_footnote f5-10q / no-ai-xblr | ||||||
| 2010-12-31 | restructuring | announced | 2011-01-21 | 2012-12-31 | Global (including Everett, Washington, USA and two Australia pulp and tissue facilities) | Consumer Tissue; K-C Professional & Other | USD 400 (millions) | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | Cumulative pretax charges estimated at $400M to $600M ($280M to $420M after tax); involves streamlining, sale or closure of 5 to 6 manufacturing facilities. No employee headcount disclosed. Announced after fiscal year-end but before filing date. | ||
| 2010-12-31 | restructuring | announced | 2011-01-21 | 2012-12-31 | Global | Consumer Tissue, K-C Professional & Other | USD 500 (millions) | subsequent_events f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Pulp and tissue restructuring plan initiated Jan 21, 2011. Expected cumulative charges $400M-$600M pretax ($280M-$420M after tax). Includes streamlining, sale or closure of 5-6 facilities. Workforce reduction costs estimated at $50M-$100M. | ||
| 2010-12-31 | restructuring | completed | 1,600 | 2009-06-01 | 2009-12-31 | Global | All Segments | USD 128 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Actions announced June 2009 to reduce worldwide salaried workforce by approx 1,600 positions. Cumulative pretax charges of $128 million recorded in 2009. Related savings of $80 million realized in 2010. | |
| 2010-12-31 | restructuring | completed | 1,600 | 2009-06 | 2009-12-31 | Worldwide | Salaried workforce | USD 128 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Announced June 2009 to reduce worldwide salaried workforce by approx 1,600 positions. Cumulative pretax charges of $128 million recorded in 2009. | |
| 2010-12-31 | restructuring | announced | 2011-01-21 | 2012-12-31 | Worldwide | Consumer Tissue, K-C Professional | USD 500 (millions) | subsequent_events f5-10k / Qwen3.6-27B-Q8_0 | Pulp and tissue restructuring plan initiated Jan 21, 2011. Expected cumulative charges $400M-$600M pretax. Workforce reduction costs estimated $50M-$100M. No specific employee count disclosed. | ||
| 2010-09-30 | restructuring | completed | 1,600 | 2009-06-01 | 2009-12-31 | Worldwide | Salaried workforce across business segments and corporate | USD 128 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Announced June 2009 to reduce worldwide salaried workforce by approximately 1,600 positions by end of 2009; cumulative pretax charges of $128 million in 2009, of which $122 million were recorded in the first nine months of 2009. Accrued expenses related to these actions have been substantially paid. Charges by segment (nine months 2009): Personal Care $44M, Consumer Tissue $47M, K-C Professional & Other $16M, Health Care $6M, Corporate & Other $9M. | |
| 2010-09-30 | restructuring | completed | 1,600 | 2009-06-01 | 2009-12-31 | Worldwide | Salaried workforce | USD 128 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Announced June 2009 to reduce worldwide salaried workforce by approx 1,600 positions by end of 2009. Cumulative pretax charges of $128 million recorded in 2009. Accrued expenses substantially paid. | |
| 2010-06-30 | restructuring | completed | 1,600 | 2009-06 | 2009-12-31 | Worldwide (charges: North America $76M, Europe $34M) | Salaried workforce across Personal Care, Consumer Tissue, K-C Professional & Other, Health Care, and Corporate | USD 110 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Program announced June 2009 to reduce worldwide salaried workforce by approximately 1,600 positions by end of 2009. Cumulative 2009 pretax charges were $128 million, including $110 million pretax ($78 million after-tax) in the quarter ended June 30, 2009. Accrued severance has been substantially paid. Q2 2009 charges by segment: Personal Care $41M, Consumer Tissue $42M, K-C Professional & Other $14M, Health Care $6M, Corporate & Other $7M. MD&A notes current-period comparisons benefited from these 2009 charges. | |
| 2010-06-30 | restructuring | completed | 1,600 | 2009-06-01 | 2009-12-31 | Worldwide | Personal Care, Consumer Tissue, K-C Professional & Other, Health Care, Corporate & Other | USD 128 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Announced June 2009 to reduce worldwide salaried workforce by approx 1,600 positions by end of 2009. Cumulative pretax charges of $128 million in 2009. Accrued expenses substantially paid. | |
| 2010-03-31 | restructuring | completed | Global | Salaried workforce | USD 35 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Benefits realized from 2009 organization optimization initiative that streamlined salaried workforce. | ||||
| 2009-12-31 | restructuring | completed | 1,600 | 2009-06 | 2009-12-31 | Worldwide | Salaried workforce (all segments and corporate) | USD 128 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Program to cut about 1,600 salaried positions by end of 2009; $128M pretax charges in 2009 ($102M paid), about $55M of related savings in 2009. Charges split by segment (Personal Care $47M, Consumer Tissue $50M, K-C Professional & Other $16M, Health Care $6M, Corporate & Other $9M) and by geography (North America $84M, Europe $35M, international operations $9M), but affected-employee counts are disclosed only at the consolidated level. | |
| 2009-12-31 | acquisition_addition | completed | 2009-04 | United States | K-C Professional & Other | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Jackson Products, Inc. acquired for approximately $155M net of cash acquired; acquired headcount not disclosed. Purchase price generated $95M of goodwill. | ||||
| 2009-12-31 | acquisition_addition | completed | 2009-11 | United States | Health Care | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | I-Flow Corporation acquired for $262M net of cash acquired; acquired headcount not disclosed. Purchase price generated $153M of goodwill. | ||||
| 2009-12-31 | acquisition_addition | completed | 2009 | United States | Health Care | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Baylis Medical Company pain management business acquired in Q4 2009; acquired headcount not disclosed. Purchase price generated $19M of goodwill. | ||||
| 2009-12-31 | restructuring | completed | 1,600 | 2009-06 | 2009-12-31 | Worldwide | Salaried workforce | USD 128 (millions) | Item 1. Business / Note 4 f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Reduction of worldwide salaried workforce by approximately 1,600 positions. Cumulative pretax charges of approximately $128 million in 2009. | |
| 2009-12-31 | restructuring | completed | 1,600 | 2009-06 | 2009-12-31 | Worldwide | Salaried workforce | USD 128 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Reduction of worldwide salaried workforce by approximately 1,600 positions. Cumulative pretax charges of approximately $128 million in 2009. | |
| 2009-09-30 | restructuring | in_progress | 1,600 | 2009-06 | 2009-12-31 | Worldwide | Salaried workforce across all segments and corporate | USD 130 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Cumulative pretax charges estimated at $130-$140 million by end of 2009, lowered from prior estimate of $140-$150 million. Q3 2009 charge was $12 million pretax ($9 million after-tax); nine-month charges totaled $122 million pretax ($87 million after-tax). Charges by segment (nine months): Personal Care $44M, Consumer Tissue $47M, K-C Professional & Other $16M, Health Care $6M, Corporate & Other $9M. By geography (nine months): North America $81M, Europe $31M, Other $10M. $82 million of cash payments made through September 30, 2009; $41 million accrued at period end. | |
| 2009-09-30 | restructuring | in_progress | 1,600 | 2009-06 | 2009-12-31 | Worldwide | Salaried workforce (all segments and corporate) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program announced June 2009 targets roughly 1,600 salaried positions worldwide by end of 2009. Estimated cumulative pretax charges lowered to $130-140 million; $12 million recorded in Q3 2009 and $122 million over nine months (North America $81M, Europe $31M, Other $10M; Consumer Tissue $47M, Personal Care $44M, KCP & Other $16M, Corporate $9M, Health Care $6M). $41 million accrued at 2009-09-30 after $82 million cash payments. Employee counts not broken out by geography or segment. | ||
| 2009-09-30 | restructuring | in_progress | 1,600 | 2009-06-01 | 2009-12-31 | Worldwide | Salaried workforce | USD 130 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Announced June 2009 to reduce worldwide salaried workforce by approx 1,600 positions. Cumulative pretax charges estimated $130-$140 million. Q3 charge $12 million; YTD charge $122 million. | |
| 2009-06-30 | reduction_in_force | in_progress | 1,600 | 2009-06 | 2009-12-31 | Worldwide; $76 million of charges in North America and $34 million in Europe | Salaried workforce across Personal Care ($41M), Consumer Tissue ($42M), K-C Professional & Other ($14M), Health Care ($6M), Corporate & Other ($7M) | USD 110 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Pretax charge of $110 million ($78 million after-tax) recorded in Q2 2009; cumulative pretax charges estimated at $140-150 million by end of 2009. Charges recorded $27 million in cost of products sold and $83 million in marketing, research and general expenses. No severance payments made as of June 30, 2009; substantially all benefits to be paid by end of 2009. | |
| 2009-06-30 | restructuring | in_progress | 1,600 | 2009-06 | 2009-12-31 | North America and Europe | Worldwide salaried workforce across all segments | USD 140 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Program announced June 2009 to cut approximately 1,600 salaried positions by end of 2009; cumulative pretax charges estimated at $140-150 million, with $110 million ($78 million after-tax) recorded in Q2 2009. Charge by segment: Personal Care $41M, Consumer Tissue $42M, K-C Professional & Other $14M, Health Care $6M, Corporate & Other $7M. By geography: $76M North America, $34M Europe. No severance payments had been made as of June 30, 2009; substantially all benefits payable by end of 2009. Headcount not disaggregated by segment or geography in the filing. | |
| 2009-06-30 | restructuring | in_progress | 1,600 | 2009-06-30 | 2009-12-31 | Worldwide | Salaried workforce | USD 110 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Announced reduction of worldwide salaried workforce by approx. 1,600 positions. Cumulative pretax charges estimated at $140-$150 million. $110 million pretax charge recorded in Q2 2009. | |
| 2009-03-31 | restructuring | in_progress | 2005-07-01 | North America and Europe | Manufacturing and administrative operations | USD 7 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Multi-year plan completed December 31, 2008; accrual reduced to approximately $7 million at March 31, 2009 after $8 million cash payments and $1 million currency adjustments; about $2 million payable in Q2 2009 | |||
| 2009-03-31 | acquisition_addition | completed | 2009-01-31 | Andean region (Colombia) | Colombiana Kimberly Colpapel S.A. | USD 289 (millions) | business_combinations_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Acquired remaining ~31 percent interest in Andean subsidiary for $289 million, bringing ownership to 100 percent; recorded as equity transaction under SFAS 160; no employee headcount figures disclosed | |||
| 2008-12-31 | restructuring | completed | 5,800 | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Manufacturing and administrative operations | USD 60 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Headcount figure is cumulative net workforce reduction since plan inception in July 2005 through completion on 2008-12-31, not current-year-only. Charge shown is 2008 pretax charges; cumulative program charges were $880 million pretax ($610 million after tax). Program covered 23 facilities, including 3 facilities closed and being marketed for sale. | |
| 2008-12-31 | plant_closure | completed | 2008-12-31 | Primarily North America and Europe | Manufacturing | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Three facilities had been closed and were being marketed for sale as of 2008-12-31 under the strategic cost reduction plan; facility-level headcount not disclosed. Part of the same program as the restructuring record above. | ||||
| 2008-12-31 | acquisition_addition | completed | Trinidad and Tobago; South Africa; Chile | Personal Care and consolidated subsidiaries | USD 98 (millions) | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | 2008 acquisitions: a personal care business in Trinidad and Tobago (Q1), remaining 50% of Kimberly-Clark of South Africa (Q2), and remaining 40% of Kimberly-Clark Chile (Q3), totaling approximately $98 million. Headcount added not disclosed; charge value is total acquisition cost, not a severance charge. | ||||
| 2008-12-31 | restructuring | completed | 5,800 | 2005-07 | 2008-12-31 | North America and Europe | Manufacturing and administrative operations | USD 880 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Multi-year plan authorized in July 2005. Cumulative net workforce reduction of 5,800. Cumulative pretax charges of $880 million. Completed by December 31, 2008. | |
| 2008-12-31 | restructuring | completed | 5,800 | 2005-07 | 2008-12-31 | North America and Europe | Manufacturing and administrative operations | USD 880 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Multi-year plan authorized in July 2005, completed by Dec 31, 2008. Cumulative net workforce reduction of 5,800. Cumulative pretax charges of $880 million. | |
| 2008-09-30 | restructuring | in_progress | 6,000 | 10% | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Corporate-wide (manufacturing and administrative operations) | USD 875 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Multi-year plan announced July 2005; cumulative pretax charges of $875 million (~$610 million after tax) incurred to date; expected cumulative charges of $880-$900 million pretax ($610-$620 million after tax). Net workforce reduction expected to be about 10 percent, or approximately 6,000 employees, by end of 2008; approximately 5,300 reductions have occurred since inception. To date 14 facilities disposed of, three closed and being marketed for sale, two more to close before December 31, 2008, and streamlining completed at four facilities. Q3 2008 pretax charges of $16.1 million; nine-month 2008 charges of $54.4 million. Accrued severance-related expenses of $29.4 million at September 30, 2008. |
| 2008-09-30 | restructuring | in_progress | 2005-07 | 2008-12-31 | North America and Europe (primarily) | Corporate-wide (manufacturing and administrative operations) | USD 16 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Multi-year plan authorized July 2005; no employee count disclosed for the quarter. Cumulative net workforce reduction of approximately 5,300 since inception, targeting about 6,000 (roughly 10% of workforce) by end of 2008. Q3 2008 pretax charges $16.1M (YTD $54.4M); cumulative charges to date about $875M pretax, with expected program total of $880-900M pretax ($610-620M after tax). Employees notified of actions at all 23 facilities slated for sale, closure or streamlining; 14 facilities disposed of to date, three closed and being marketed for sale, two more closures planned before year-end. Charges are corporate decisions and excluded from segment operating profit. | ||
| 2008-09-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Global | Corporate / All Segments | USD 16 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Multi-year plan authorized in July 2005. Cumulative net workforce reduction of approx. 5,300 to date; total expected reduction of approx. 6,000. Q3 2008 pretax charges of $16.1M. Program expected to complete by Dec 31, 2008. | ||
| 2008-06-30 | restructuring | in_progress | 10% | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Manufacturing and administrative operations | USD 880 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Multi-year plan authorized July 2005; cumulative charges now expected at $880-$900 million pretax ($610-$620 million after tax), lowered by up to $10 million. Net workforce reduction of about 10 percent, or approximately 6,000 employees, anticipated by end of 2008; approximately 5,200 reductions have occurred since inception. Pretax charges of $859 million (about $599 million after tax) incurred to date. | |
| 2008-06-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | North America | All affected facilities | USD 8 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Second quarter 2008 pretax charges for North America, comprising incremental depreciation, workforce reductions, and asset disposal losses. | ||
| 2008-06-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Europe | All affected facilities | USD 6 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Second quarter 2008 pretax charges for Europe, comprising incremental depreciation, workforce reductions, and asset disposal losses. | ||
| 2008-06-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Other | All affected facilities | USD 0 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Second quarter 2008 pretax charges for other geographies. | ||
| 2008-06-30 | plant_closure | in_progress | 2005-07-01 | 2008-12-31 | North America and Europe | Manufacturing and administrative facilities | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | To date, 14 facilities disposed of, three closed and being marketed for sale, two more to close before December 31, 2008, and streamlining completed at four facilities. Employees notified at all 23 facilities slated for sale, closure or streamlining. | |||
| 2008-06-30 | restructuring | in_progress | 5,200 | 2005-07 | 2008-12-31 | North America and Europe (primarily) | Manufacturing and administrative operations (corporate-level program) | USD 859 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Cumulative net workforce reduction of approximately 5,200 since the program began in Q3 2005; a net reduction of about 10 percent, or roughly 6,000 employees, is anticipated by the end of 2008. Charge shown is cumulative pretax incurred to date ($859M pretax / ~$599M after tax); total expected program cost is $880-900M pretax ($610-620M after tax). Counts are program-to-date, not quarterly. Employees notified at all 23 facilities slated for sale, closure or streamlining. | |
| 2008-06-30 | plant_closure | in_progress | 2005-07 | 2008-12-31 | North America and Europe (primarily) | Manufacturing and administrative facilities | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Facility actions within the same strategic cost reduction program: 14 facilities disposed of to date, three additional facilities closed and being marketed for sale, two more facilities to close before 2008-12-31, and streamlining completed at four facilities. No separate headcount or charge disclosed for the facility actions; charges are captured on the parent restructuring record to avoid double counting. | |||
| 2008-06-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Global | Corporate / All Segments | USD 15 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Ongoing plan authorized in July 2005. Q2 2008 pretax charges of $14.5M recorded. Cumulative net workforce reduction of ~5,200 to date; total expected reduction of ~6,000. Total expected cumulative charges $880-$900M. | ||
| 2008-03-31 | restructuring | in_progress | 6,000 | 10% | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Corporate decision; charges not recorded at business segment level | USD 24 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Multi-year plan authorized July 2005; expected net workforce reduction of about 10 percent (~6,000 employees) by end of 2008, with ~5,200 reductions already realized. Q1 2008 pretax charges of $23.8 million ($16.1 million after tax) include $9.4 million for workforce reductions, $6.3 million noncash charges, $4.8 million other cash charges and $3.3 million special pension/benefits. Cumulative pretax charges of $844 million incurred to date against expected total of $880-$910 million pretax ($610-$630 million after tax). To date 14 facilities disposed, 3 closed and being marketed, 2 more to close before year-end 2008, and 4 facilities streamlined. Q1 savings approximately $28 million against full-year target of $75-$100 million. |
| 2008-03-31 | restructuring | in_progress | 5,200 | 2005-07 | 2008-12-31 | North America; Europe; Other | Corporate-wide (Personal Care, Consumer Tissue, K-C Professional & Other, Health Care) | USD 844 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Net workforce reduction of approximately 5,200 employees since inception as of 2008-03-31; plan targets a net reduction of about 10 percent, or roughly 6,000 employees, by end of 2008. Cumulative pretax charges of $844 million (about $590 million after tax), roughly 95 percent of the plan's expected cost, incurred to date; expected cumulative charges of $880 to $910 million pretax ($610 to $630 million after tax), of which about 35 percent is expected to be paid in cash. Q1 2008 pretax charges were $23.8 million ($16.1 million after tax). First-quarter savings of about $28 million against a full-year target of $75 to $100 million. Employees notified at all 23 facilities slated for sale, closure or streamlining. Facilities: 14 disposed of, three closed and being marketed for sale, two more to close before 2008-12-31, streamlining completed at four facilities. Charges are corporate decisions and excluded from segment operating profit. | |
| 2008-03-31 | plant_closure | in_progress | 2005-07 | 2008-12-31 | North America; Europe | Manufacturing and administrative operations | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Facility dispositions under the strategic cost reduction plan: 14 facilities disposed of, three additional facilities closed and being marketed for sale, and two other facilities to be closed prior to 2008-12-31. No separate employee count disclosed for the facility closures; charges for these activities are included in the consolidated program record above. | |||
| 2008-03-31 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Global | Corporate / All Segments | USD 24 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Ongoing plan authorized in July 2005. Q1 2008 pretax charges of $23.8M recorded. Cumulative net workforce reduction of approx. 5,200 employees to date, with total expected reduction of approx. 6,000 by end of 2008. Charges include workforce reductions, asset write-offs, and incremental depreciation. | ||
| 2007-12-31 | restructuring | in_progress | 4,700 | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Manufacturing and administrative operations | USD 107 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Cumulative net workforce reduction of approximately 4,700 through 2007-12-31 since program inception in Q3 2005; program targets ~6,000 (about 10% of workforce) by end of 2008. Charge shown is 2007 pretax charges only; cumulative program charges expected at $880-910M pretax by end of 2008. Approximately 24 facilities (17% of worldwide total) expected to be sold, closed or streamlined; charges recorded for 23 facilities to date. | |
| 2007-12-31 | plant_closure | in_progress | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Manufacturing | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Approximately 24 manufacturing facilities expected to be sold, closed or streamlined under the Strategic Cost Reduction Plan; 14 facilities disposed of and 3 additional closed and marketed for sale as of 2007-12-31. Facility-level headcount not separately disclosed. | |||
| 2007-12-31 | acquisition_addition | completed | 2007-03-31 | Indonesia | Personal Care / Consumer Tissue | USD 16 (millions) | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Acquisition of remaining 50% interest in P.T. Kimberly-Lever Indonesia completed in Q1 2007 for $15.7M; headcount added not disclosed. | |||
| 2007-12-31 | restructuring | in_progress | 4,700 | 2005-07 | 2008-12-31 | North America and Europe | Manufacturing and Administrative | USD 107 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Cumulative net workforce reduction of approximately 4,700 as of December 31, 2007. Part of a multi-year plan authorized in July 2005. Total expected cumulative charges of $880-$910 million by end of 2008. | |
| 2007-12-31 | restructuring | in_progress | 4,700 | 8.87% | 2005-07 | 2008-12-31 | Global | Manufacturing and Administrative | USD 107 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Cumulative net workforce reduction of approximately 4,700 as of Dec 31, 2007. Part of multi-year plan announced July 2005. 2007 pretax charges were $107.2 million. |
| 2007-09-30 | restructuring | in_progress | 6,000 | 10% | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Manufacturing and administrative operations | USD 875 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Multi-year plan announced July 2005; expected cumulative pretax charges of $875-$925 million ($615-$650 million after tax); net workforce reduction of about 10 percent, or approximately 6,000 employees, anticipated by end of 2008. More than 4,500 positions already eliminated since inception. Approximately 24 facilities to be sold, closed or streamlined; charges recorded for 23 facilities as of September 30, 2007, with 13 disposed of and one closed and being marketed for sale. Cumulative pretax charges of $794.2 million (about $558 million after tax) recorded to date. Expected to yield annual pretax savings of at least $350 million in 2009. |
| 2007-09-30 | restructuring | in_progress | 4,500 | 2005-07 | 2008-12-31 | North America and Europe (primarily) | Corporate-wide; manufacturing and administrative operations | USD 794 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Cumulative net workforce reduction of more than 4,500 since program inception in Q3 2005; expected to reach approximately 6,000 (about 10% of workforce) by end of 2008. Cumulative pretax charges of $794.2M recorded through 2007-09-30 against a total program estimate of $875–925M. Charges cover 23 of approximately 24 facilities slated for sale, closure or streamlining; 13 facilities disposed of to date. Q3 2007-specific pretax charges were $22.8M. No quarterly-specific employee reduction count is disclosed. | |
| 2007-09-30 | plant_closure | in_progress | 2005-07 | 2008-12-31 | North America and Europe (primarily) | Manufacturing facilities | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Approximately 24 manufacturing facilities expected to be sold, closed or streamlined under the strategic cost reduction plan. As of 2007-09-30, charges recorded for 23 facilities; 13 disposed of; one additional facility closed and being marketed for sale. Facility-specific headcount reductions are not separately disclosed. | |||
| 2007-09-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Global | Corporate / All Segments | USD 23 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Ongoing plan authorized July 2005. Q3 2007 pretax charges of $22.8M. Cumulative net workforce reduction of >4,500 to date; total expected reduction of ~6,000 (10%). 23 facilities affected; 13 disposed, 1 closed. | ||
| 2007-06-30 | restructuring | in_progress | 6,000 | 10% | 2005-07 | 2008-12-31 | Primarily North America and Europe | Manufacturing and administrative operations | USD 771 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Multi-year plan announced July 2005; cumulative pretax charges of $771.4 million (about $537 million after tax) recorded to date; expected cumulative charges lowered to $875-$925 million pretax. Net workforce reduction of more than 3,700 has occurred since inception; ~6,000 employees (about 10%) expected by end of 2008. Approximately 20 manufacturing facilities (17% of worldwide total) expected to be sold or closed; as of June 30, 2007 charges recorded for 23 facilities, 11 disposed of, 3 closed and being marketed for sale. Q2 2007 pretax charges of $17.8 million ($9.9 million after tax); six-month 2007 pretax charges of $58.4 million. Expected annual pretax savings of at least $350 million in 2009. |
| 2007-06-30 | restructuring | in_progress | 6,000 | 10% | 2005-07 | 2008-12-31 | Primarily North America and Europe | Corporate-wide (manufacturing and administrative operations) | USD 875 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Multi-year plan authorized July 2005; expected cumulative pretax charges of $875M to $925M ($615M-$650M after tax) through 2008, revised down from prior $950M-$1.0B estimate. Target is a net workforce reduction of about 10% (~6,000 employees) by end of 2008; more than 3,700 net reductions have occurred since inception. Charges of $17.8M pretax in Q2 2007 and $58.4M pretax for six months ended 2007-06-30 per Note 3's primary charges table (Note 3 geographic tables and Note 9 segment tables show $67.7M for the six-month period). Employees notified at 22 of ~24 facilities slated for sale, closure or streamlining; charges recorded for 23 facilities, 11 disposed of, 3 closed and being marketed. ~20 facilities (17% of worldwide total) expected sold or closed and 4 streamlined. Expected annual pretax savings of at least $350M in 2009; 2007 full-year pretax charges expected ~$120M. Counts are program targets/cumulative, not quarter-specific. |
| 2007-06-30 | restructuring | in_progress | Not specified | Corporate & Other — administrative processes | USD 11 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Incremental implementation costs of $11.0M in Q2 2007 ($23.2M for six months ended 2007-06-30) for transferring certain administrative processes to third-party providers. No employee count, announcement date, or completion date disclosed; no explicit headcount reduction stated. | ||||
| 2007-06-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Global | Corporate / All Segments | USD 18 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Multi-year plan authorized July 2005. Q2 2007 pretax charges of $17.8M. Cumulative net workforce reduction of >3,700 since inception; total expected reduction ~6,000 (10%). Charges include incremental depreciation, asset write-offs, and workforce reductions. | ||
| 2007-06-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | North America | Corporate / All Segments | USD 25 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Geographic breakdown of Q2 2007 charges for the Strategic Cost Reduction Plan. | ||
| 2007-06-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Europe | Corporate / All Segments | USD -11 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Geographic breakdown of Q2 2007 charges for the Strategic Cost Reduction Plan. Negative charge reflects reversal of previously accrued severance for a facility contracted for sale. | ||
| 2007-06-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Other | Corporate / All Segments | USD 4 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Geographic breakdown of Q2 2007 charges for the Strategic Cost Reduction Plan. | ||
| 2007-03-31 | restructuring | in_progress | 10% | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Manufacturing and administrative operations | USD 41 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Multi-year plan announced July 2005; expected net workforce reduction of about 10 percent, or approximately 6,000 employees, by end of 2008; more than 3,300 positions eliminated to date. Q1 2007 pretax charges of $40.6 million ($15.0 million after tax); cumulative pretax charges of $753.6 million recorded to date; total program expected at $950 million to $1.0 billion pretax. Charges by segment in Q1 2007: Personal Care $20.4M, Consumer Tissue $15.9M, K-C Professional & Other $2.6M, Health Care $1.7M; by geography: North America $27.2M, Europe $12.7M, Other $0.7M. | |
| 2007-03-31 | plant_closure | in_progress | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Manufacturing facilities | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Approximately 20 manufacturing facilities (17 percent of worldwide total) expected to be sold or closed and 4 additional facilities streamlined. As of March 31, 2007, charges recorded for 23 facilities; 11 facilities disposed of to date and 2 additional facilities closed and being marketed for sale. | |||
| 2007-03-31 | other | in_progress | Corporate & Other / administrative functions | USD 12 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Incremental implementation costs related to the transfer of certain administrative processes to third-party providers, recorded in Corporate & Other in Q1 2007. | |||||
| 2007-03-31 | restructuring | in_progress | 3,300 | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Corporate-wide (manufacturing and administrative operations); charges allocated across Personal Care, Consumer Tissue, K-C Professional & Other, Health Care | USD 41 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Net workforce reduction of more than 3,300 since program inception (cumulative, not quarterly); program targets about 6,000 positions, roughly 10% of workforce, by end of 2008. Charge shown is Q1 2007 pretax ($15.0M after tax); cumulative pretax charges to date $753.6M against a $950M-$1.0B program estimate. Approximately 20 facilities expected sold or closed and 4 streamlined; 11 facilities disposed of to date, 2 more closed and being marketed. Q1 2007 charges split by geography: North America $27.2M, Europe $12.7M, Other $0.7M. Employees notified at 22 of ~24 facilities slated for action. | |
| 2007-03-31 | plant_closure | in_progress | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Manufacturing operations | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Facility component of the strategic cost reduction plan: about 20 manufacturing facilities (17% of worldwide total) expected to be sold or closed, plus 4 streamlined. Charges recorded for 23 facilities as of 2007-03-31; 11 disposed of, 2 closed and marketed for sale. No facility-level employee counts disclosed; part of the same program as the restructuring record above. | |||
| 2007-03-31 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Global | Corporate / All Segments | USD 41 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Pretax charges of $40.6M recorded in Q1 2007. Cumulative net workforce reduction of >3,300 since inception. Total expected cumulative charges $950M-$1.0B by end of 2008. | ||
| 2006-12-31 | restructuring | in_progress | 3,000 | 2005-07-31 | 2008-12-31 | Primarily North America and Europe | Manufacturing and administrative operations (corporate-level program) | USD 484 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Cumulative through fiscal year-end: net workforce reduction of more than 3,000 since inception (announced July 2005); program targets about 6,000 positions (roughly 10% of workforce) by end of 2008. Charge shown is 2006 pretax charges only ($484.4M; $345.0M after tax); cumulative program charges expected at $950M-$1.0B pretax. About 20 facilities expected to be sold or closed and 4 streamlined; charges recorded for 23 facilities to date. | |
| 2006-12-31 | acquisition_addition | completed | 2006-10-01 | 2006-12-31 | Brazil | Personal Care | USD 100 (millions) | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Acquisition of the remaining 30% interest in Kimberly-Clark Kenko Industria e Comercio Ltda. for $99.6 million in Q4 2006 (purchase price, not a charge); headcount added not disclosed. Announcement date approximated to the disclosed quarter. | ||
| 2006-12-31 | restructuring | in_progress | 3,000 | 2005-07-01 | 2008-12-31 | Global | Manufacturing and Administrative | USD 484 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Cumulative charges of $484.4 million recorded in 2006. Net workforce reduction of more than 3,000 occurred as of Dec 31, 2006. Plan authorized July 2005. | |
| 2006-12-31 | restructuring | in_progress | 3,000 | 2005-07 | 2008-12-31 | Global | Manufacturing and Administrative | USD 484 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Cumulative net workforce reduction of more than 3,000 occurred as of Dec 31, 2006. Total pretax charges of $484.4 million recorded in 2006. Program expected to result in cumulative charges of $950 million to $1.0 billion by end of 2008. | |
| 2006-09-30 | restructuring | in_progress | 6,000 | 10% | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Manufacturing and administrative operations | USD 422 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Multi-year plan announced July 2005; net workforce reduction of about 10% (approximately 6,000 employees) anticipated by end of 2008; more than 2,600 positions eliminated since inception. Cumulative pretax charges expected of $1.0-$1.1 billion ($700-$775 million after tax); year-to-date 2006 pretax charges of $421.6 million ($306.5 million after tax). Approximately 20 manufacturing facilities expected to be sold or closed and 4 streamlined; charges recorded for 23 facilities to date. Annual pretax savings of at least $350 million targeted in 2009. |
| 2006-09-30 | restructuring | in_progress | 2005-07 | 2008-12-31 | Primarily North America and Europe | Corporate-wide; charges related to Personal Care, Consumer Tissue, K-C Professional & Other, and Health Care activities | USD 124 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Multi-year plan authorized July 2005. Cumulative net workforce reduction of more than 2,600 since inception; plan targets a net reduction of about 6,000 employees (roughly 10 percent of workforce) by end of 2008. Q3 2006 pretax charges $123.6M ($91.0M after tax); nine-month 2006 charges $421.6M ($304.9M after tax); cumulative expected pretax charges $1.0-1.1B ($700-775M after tax) through 2008, expected to yield at least $350M annual pretax savings in 2009. About 20 facilities (17 percent of worldwide total) expected to be sold or closed plus 4 streamlined; employees notified at 19 of approximately 24 facilities to date. Q3 2006 charges comprise $80.2M in cost of products sold, $46.7M in marketing/research/general expenses, and a $3.3M net gain in other income. Charges are corporate decisions and excluded from segment operating profit; geographic split of Q3 charges: North America $42.4M, Europe $71.8M, Other $9.4M. Savings of about $35M realized in Q3 2006 (nearly $75M YTD). | ||
| 2006-09-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | North America | Corporate & Other | USD 42 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Pretax charges for Q3 2006. Part of multi-year plan authorized July 2005. Total expected cumulative charges $1.0-$1.1 billion. Net workforce reduction target ~6,000 employees by end of 2008. | ||
| 2006-09-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Europe | Corporate & Other | USD 72 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Pretax charges for Q3 2006. Includes consolidation of consumer tissue operations. | ||
| 2006-09-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Other | Corporate & Other | USD 9 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Pretax charges for Q3 2006. | ||
| 2006-06-30 | restructuring | in_progress | 6,000 | 10% | 2005-07 | 2008-12-31 | Primarily North America and Europe | Manufacturing and administrative operations | USD 298 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Multi-year program announced July 2005; cumulative pretax charges expected of $1.0-$1.1 billion through 2008 targeting annual savings of at least $350 million in 2009. Net workforce reduction of more than 1,600 achieved to date; approximately 20 of ~55 facilities expected to be sold or closed. YTD charges by geography: North America $144.5M, Europe $129.0M, Other $24.5M. Q2 2006 charges of $89.4M pretax ($60.1M after tax); YTD charges $298.0M pretax ($215.3M after tax). |
| 2006-06-30 | restructuring | in_progress | 2005-07 | 2008-12-31 | North America | Multiple segments | USD 68 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q2 2006 pretax charges: incremental D&A $39.1M, asset write-offs $0.9M, workforce reductions $17.5M, asset disposals and other $10.1M. | ||
| 2006-06-30 | restructuring | in_progress | 2005-07 | 2008-12-31 | Europe | Multiple segments | USD 15 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q2 2006 pretax charges: incremental D&A $10.8M, asset write-offs $1.6M, workforce reductions $1.3M, asset disposals and other $1.1M. | ||
| 2006-06-30 | restructuring | in_progress | 2005-07 | 2008-12-31 | Other | Multiple segments | USD 7 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q2 2006 pretax charges: incremental D&A $6.3M, workforce reductions $0.4M, asset disposals and other $0.3M. | ||
| 2006-06-30 | restructuring | in_progress | 6,000 | 10% | 2005-07 | 2008-12-31 | Primarily North America and Europe | Corporate-wide; manufacturing and administrative operations (all four reportable segments) | USD 527 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Multi-year strategic cost reduction program authorized July 2005. employees_affected_count is the anticipated net workforce reduction of about 6,000 (about 10% of workforce) by end-2008, not an actual figure; a net reduction of more than 1,600 had occurred since inception as of the filing. associated_charge_value is cumulative pretax charges recorded to date ($527M pretax / ~$382M after tax); expected program total is $1.0–1.1B pretax ($700–775M after tax) through 2008, yielding at least $350M annual pretax savings in 2009. Charges by period: Q2 2006 $89.4M pretax ($60.1M after tax); YTD 2006 $298.0M pretax ($215.3M after tax), of which workforce-reduction charges were $95.0M YTD. Q2 charges by geography: North America $67.6M, Europe $14.8M, Other $7.0M; YTD: North America $144.5M, Europe $129.0M, Other $24.5M. Q2 charges by segment: Personal Care $56.3M, Consumer Tissue $16.8M, K-C Professional & Other $4.0M, Health Care $12.3M. Approximately 20 manufacturing facilities (17% of worldwide total) expected to be sold or closed plus 4 streamlined; charges recorded for 21 facilities as of 2006-06-30 and employees notified at 19 of ~24 slated facilities. Full-year 2006 pretax charges expected to total approximately $500M. Employee counts are disclosed only at program level, so no geographic/segment sub-records were emitted despite the charge disaggregation. |
| 2006-06-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | North America | Corporate & Other / Manufacturing | USD 68 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Part of multi-year program authorized July 2005. Q2 2006 charges include incremental depreciation, asset write-offs, and workforce reductions. Total program expected to reduce workforce by ~6,000 employees by 2008. | ||
| 2006-06-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Europe | Corporate & Other / Manufacturing | USD 15 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Part of multi-year program authorized July 2005. Q2 2006 charges include incremental depreciation, asset write-offs, and workforce reductions. | ||
| 2006-06-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Other | Corporate & Other / Manufacturing | USD 7 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Part of multi-year program authorized July 2005. Q2 2006 charges include incremental depreciation, asset write-offs, and workforce reductions. | ||
| 2006-03-31 | restructuring | in_progress | 6,000 | 10% | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Corporate-wide (manufacturing and administrative operations) | USD 1,050 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Cumulative pretax charges of approximately $1.0 to $1.1 billion expected through 2008; midpoint used for charge value. Net workforce reduction of about 10 percent, or approximately 6,000 employees, anticipated by end of 2008. Annual pretax savings of at least $350 million expected in 2009. |
| 2006-03-31 | restructuring | in_progress | 950 | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Corporate-wide | USD 437 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Since inception, net workforce reduction of more than 950 has occurred; cumulative pretax charges of $437 million (about $323 million after tax) recorded through March 31, 2006. | |
| 2006-03-31 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | North America and Europe | Personal Care | USD 116 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q1 2006 strategic cost reduction charges attributable to Personal Care activities. | ||
| 2006-03-31 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | North America and Europe | Consumer Tissue | USD 63 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q1 2006 strategic cost reduction charges attributable to Consumer Tissue activities. | ||
| 2006-03-31 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | North America and Europe | K-C Professional & Other | USD 7 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q1 2006 strategic cost reduction charges attributable to K-C Professional & Other activities. | ||
| 2006-03-31 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | North America and Europe | Health Care | USD 12 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q1 2006 strategic cost reduction charges attributable to Health Care activities. | ||
| 2006-03-31 | plant_closure | in_progress | 2005-07-01 | 2008-12-31 | Worldwide | Manufacturing | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Approximately 20 manufacturing facilities (17 percent of worldwide total) expected to be sold or closed, plus 4 additional facilities to be streamlined. Charges recorded for 20 facilities as of March 31, 2006; employees notified at 18 of approximately 24 facilities slated for sale, closure or streamlining. | |||
| 2006-03-31 | restructuring | in_progress | 950 | 2005-07-01 | 2008-12-31 | North America and Europe (primarily) | Corporate-wide (Competitive Improvement Initiatives); charges by segment: Personal Care, Consumer Tissue, K-C Professional & Other, Health Care | USD 209 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Net workforce reduction of more than 950 since inception (not quarter-specific); program targets about 6,000 positions (roughly 10% of workforce) and cumulative pretax charges of $1.0–$1.1 billion through 2008. Q1 2006 pretax charge of $208.6 million ($155.2 million after tax), of which $124.1 million noncash. Charges recorded for 20 facilities; employees notified at 18 of about 24 facilities slated for sale, closure or streamlining; cumulative pretax charges of $437 million since inception. | |
| 2006-03-31 | plant_closure | in_progress | 2005-07-01 | 2008-12-31 | North America and Europe (primarily) | Manufacturing operations | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | About 20 manufacturing facilities (17% of worldwide total) expected to be sold or closed, plus 4 additional facilities streamlined; charges recorded for 20 facilities as of 2006-03-31. Facility-level employee counts not disclosed; part of the consolidated restructuring program record above. | |||
| 2006-03-31 | restructuring | in_progress | 950 | 2005-07-01 | 2008-12-31 | North America and Europe | Corporate & Other | USD 209 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Net workforce reduction of more than 950 has occurred since inception. Total charges incurred in Q1 2006 were $208.6 million. Program expected to result in cumulative charges of $1.0-$1.1 billion and net reduction of ~6,000 employees by end of 2008. | |
| 2005-12-31 | restructuring | in_progress | 400 | 2005-07 | 2008-12-31 | Primarily North America and Europe | Manufacturing and administrative operations (all segments) | USD 229 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Net workforce reduction of more than 400 as of 2005-12-31; program targets about 6,000 positions (roughly 10% of workforce) by end of 2008. 2005 pretax charge of $228.6M ($167.6M after tax), of which $179.7M noncash; recorded in Cost of Products Sold ($201.6M) and Marketing, Research and General Expenses ($27.0M). Charge by segment: Personal Care $146.0M, Consumer Tissue $31.3M, Business-to-Business $51.3M; by geography: North America $84.9M, Europe $113.5M, Asia/Latin America/Other $30.2M. Approximately 20 facilities (17% of worldwide total) expected to be sold or closed plus 4 streamlined; charges recorded for 14 facilities to date. Employee counts not disaggregated by geography or segment. Also includes $2.3M of pension curtailments and special pension benefits. Cumulative program charges of $900M-$1.1B pretax expected over the full program. | |
| 2005-12-31 | restructuring | announced | 2006-01-18 | Europe | Administrative operations | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | Subsequent-phase project under the Competitive Improvement Initiatives to reduce the European workforce and streamline administrative operations; headcount and charge not disclosed | ||||
| 2005-12-31 | plant_closure | announced | 2006-01-18 | Not specified | Manufacturing | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | Subsequent-phase project under the Competitive Improvement Initiatives authorizing closure of two manufacturing facilities; locations, headcount and charge not disclosed | ||||
| 2005-12-31 | acquisition_addition | completed | 2005 | Germany | Health Care | USD 16 (millions) | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Acquisition of Microcuff GmbH, a medical device and technology company, during the fourth quarter of 2005 for approximately $16 million; acquired headcount not disclosed | |||
| 2005-12-31 | restructuring | in_progress | 400 | 2005-07-01 | 2008-12-31 | North America and Europe | Manufacturing and Administrative | USD 229 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Initial phase authorized in July 2005. Net workforce reduction of more than 400 occurred by year-end. Total program expected to reduce workforce by approx 6,000 by 2008. | |
| 2005-12-31 | restructuring | in_progress | 400 | 2005-07-01 | 2008-12-31 | North America and Europe | Corporate & Other | USD 229 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | Initial phase authorized in July 2005. As of Dec 31, 2005, net workforce reduction of more than 400 had occurred. Total charges incurred in 2005 were $228.6 million. Program expected to be substantially completed by Dec 31, 2008. | |
| 2005-09-30 | restructuring | in_progress | 6,000 | 10% | 2005-07-01 | 2008-12-31 | Primarily North America and Europe | Manufacturing and administrative operations | USD 1,000 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Multi-year program announced July 2005; cumulative pretax charges estimated at $900 million to $1.1 billion ($625-$775 million after tax). Expected net workforce reduction of about 10 percent, or approximately 6,000 employees, by end of 2008. Approximately 20 manufacturing facilities (17 percent of worldwide total) expected to be sold or closed and 4 additional facilities streamlined. Annual pretax savings expected to reach $300-$350 million by 2009. |
| 2005-09-30 | reduction_in_force | in_progress | 235 | 2005-07-01 | 2008-12-31 | USD 28 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Workforce reductions completed to date under the Competitive Improvement Initiatives as of September 30, 2005. Charges for workforce reductions of $27.6 million recorded in Q3 2005; $21.7 million remained accrued at quarter-end after cash payments of $2.3 million and pension curtailments/special benefits of $3.6 million. | |||
| 2005-09-30 | restructuring | in_progress | 2005-07-01 | 2007-06-30 | USD 390 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Initial phase (2005 to mid-2007) includes sale, closure or streamlining of 15 facilities and expansion of 3 others; after-tax charges expected at approximately $355-$390 million. Pretax charge categories: workforce reduction costs ~$150 million; incremental depreciation and amortization ~$225 million; asset impairments ~$100 million; other costs ~$55 million. | ||||
| 2005-09-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Personal Care | USD 117 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | 2005 Competitive Improvement Initiatives costs related to Personal Care activities; costs not recorded at segment level in segment operating profit. | |||
| 2005-09-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Consumer Tissue | USD 18 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | 2005 Competitive Improvement Initiatives costs related to Consumer Tissue activities. | |||
| 2005-09-30 | restructuring | in_progress | 2005-07-01 | 2008-12-31 | Business-to-Business | USD 33 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | 2005 Competitive Improvement Initiatives costs related to Business-to-Business activities. | |||
| 2005-09-30 | divestiture_reduction | completed | 2004-11-30 | 2004-11-30 | Fine paper and technical paper businesses | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Spin-off of Neenah Paper, Inc. completed November 30, 2004, including divestiture of pulp operations; prior periods recast as discontinued operations. No headcount figures disclosed in this filing. | ||||
| 2005-09-30 | restructuring | in_progress | 235 | 2005-07 | 2008-12-31 | North America and Europe | Corporate-wide (manufacturing and administrative operations) | USD 168 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Multi-year program authorized July 2005; 235 positions reduced as of 2005-09-30. Full program expected to cut about 6,000 employees (~10% of workforce) and close/sell ~20 facilities by end-2008, with cumulative pretax charges of $900M-$1.1B. Q3 2005 charge of $168.0M ($126.4M after tax), of which $140.4M noncash; includes workforce reduction charges of $27.6M. Segment-related costs: Personal Care $117.0M, Consumer Tissue $17.8M, Business-to-Business $33.2M. | |
| 2005-09-30 | restructuring | in_progress | 235 | 2005-07-01 | 2008-12-31 | North America and Europe | Corporate / Manufacturing / Administrative | USD 168 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Initial phase of multi-year program. 235 employees reduced as of Sept 30, 2005. Total expected reduction ~6,000 by 2008. Charges include $27.6M workforce reductions, $140.4M noncash charges. | |
| 2005-06-30 | restructuring | announced | 6,000 | 10% | 2005-07-20 | 2008-12-31 | Worldwide, with particular focus on Europe | Manufacturing and administrative operations | USD 1,000 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Multi-year program; cumulative pretax charges estimated at $900 million to $1.1 billion ($625-$775 million after tax). Net workforce reduction of about 10 percent (~6,000 employees) by end of 2008; approximately 20 manufacturing facilities (~17% of worldwide total) to be sold or closed, 4 streamlined, and 7 expanded. Cash costs expected to be roughly 45 percent of charges; noncash primarily accelerated depreciation and asset write-downs. Charges to begin in Q3 2005. |
| 2005-06-30 | restructuring | announced | 2005-07-20 | 2007-06-30 | North America and Europe | Manufacturing and administrative operations | USD 525 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Initial phase (July 2005 to mid-2007): sale, closure or streamlining of 15 facilities and expansion of 3 others. Pretax charges of $500-$550 million ($355-$390 million after tax), comprising workforce reduction costs (~$150 million), accelerated depreciation (~$190 million), asset impairments (~$100 million), and other associated costs (~$90 million). No employee count disclosed for the initial phase alone. | ||
| 2005-06-30 | restructuring | announced | 6,000 | 10% | 2005-07-20 | 2008-12-31 | Primarily North America and Europe | Worldwide manufacturing and administrative operations | USD 900 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Authorized 2005-07-20, after quarter end. Multi-year program; charges of $900M-$1.1B pretax ($625M-$775M after tax) over three and a half years, with annual pretax savings rising to $300M-$350M by 2009. About 20 manufacturing facilities (17% of worldwide total) to be sold or closed, 4 streamlined, 7 expanded; cash costs roughly 45% of charges. Initial phase (July 2005 to mid-2007) covers 15 facility actions and 3 expansions at $500M-$550M pretax ($355M-$390M after tax), comprising workforce reduction costs ~$150M, accelerated depreciation ~$190M, asset impairments ~$100M, other ~$90M. Employee count disclosed only as program-wide total; not split by phase or geography. |
| 2005-06-30 | restructuring | announced | 6,000 | 10% | 2005-06-30 | 2008-12-31 | Worldwide | Manufacturing | USD 900 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Announced cost reduction initiatives expected to result in net workforce reduction of about 10%, or approx. 6,000 employees, by end of 2008. Includes sale/closure of 20 facilities and streamlining of 4 others. Cumulative charges estimated at $900M-$1.1B before tax. |
| 2004-12-31 | restructuring | in_progress | 2005-12-31 | United States and United Kingdom | Personal Care — infant care (diaper) manufacturing and distribution | USD 40 (millions) | MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML | Plan to end diaper production and reduce distribution operations at New Milford, Conn. (facility converted to tissue only) and redeploy diaper capacity from Barton-upon-Humber, U.K. Total pre-tax cost about $40M, of which about $37M recorded in 2004 (incl. ~$10M severance, ~$3M other cash costs, ~$24M asset write-offs); balance to be recorded in 2005. Employees affected not disclosed. No restructuring footnote exists in this filing; MD&A is the most detailed source. | |||
| 2004-12-31 | divestiture_reduction | completed | 2004-04-30 | 2004-11-30 | United States and Canada | Business-to-Business — U.S. fine paper and technical paper businesses (Canadian pulp mills retained) | discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | All Neenah Paper common stock distributed to stockholders on 2004-11-30; Neenah Paper entity formed April 2004. Assets of $617.7M and related liabilities spun off; headcount transferred not disclosed. Canadian pulp business results remain in continuing operations under a long-term pulp supply agreement. | |||
| 2004-12-31 | restructuring | in_progress | 2004-01-01 | 2005-12-31 | North America and Europe | Personal Care | USD 37 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Plan to cease diaper manufacturing and scale-back distribution at New Milford, Conn. and Barton-upon-Humber, U.K. Total costs approx $40 million; $37 million recorded in 2004. Balance to be recorded in 2005. | ||
| 2004-12-31 | restructuring | in_progress | 2004 | 2005 | North America and Europe | Personal Care (Diaper manufacturing) | USD 40 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Plan to cease diaper manufacturing at New Milford, Conn. and redeploy capacity from Barton-upon-Humber, U.K. Total costs approx $40 million before tax, including $37 million recorded in 2004. Balance to be recorded in 2005. Includes $10 million employee severance. | ||
| 2004-09-30 | restructuring | in_progress | North America | Personal Care (diaper operations) | USD 20 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Costs in Q3 2004 for ceasing diaper manufacturing and scaling back distribution at New Milford, Conn. facility: ~$8M accelerated depreciation, ~$10M severance recorded when employees notified, ~$2M asset removal and other exit costs; recorded in cost of products sold. Part of previously announced plans to improve efficiency of global diaper operations; full-year pretax costs expected at ~$40 million (~6 cents per share). No employee count disclosed. | ||||
| 2004-09-30 | divestiture_reduction | announced | 2004-11-04 | 2004-11-30 | Neenah Paper (noncore pulp and paper) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Spin-off of Neenah Paper expected November 30, 2004; 1 Neenah share per 33 K-C shares held as of record date November 19, 2004; IRS ruling confirms tax-free distribution. Neenah to incur $225M new debt and provide K-C ~$215M cash proceeds. Estimated 2-3 cents per share dilution and other costs in Q4. No headcount figures disclosed. | ||||
| 2004-09-30 | plant_closure | announced | 2004-12-31 | Asia | Paper-related operations | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Anticipated costs of about 2 cents per share in Q4 2004 to exit certain paper-related operations in Asia; part of exiting noncore pulp and paper operations (combined 4-5 cents per share impact with Neenah spin-off). No headcount disclosed. | ||||
| 2004-09-30 | plant_closure | in_progress | United States — New Milford, Connecticut | Personal Care — diaper manufacturing and distribution | USD 20 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Part of previously announced plan to improve diaper operations efficiency. Q3 2004 charge of $20M comprised about $8M accelerated depreciation, nearly $10M severance recorded upon employee notification, and about $2M asset removal/exit costs; recorded in cost of products sold. Number of employees affected not disclosed. Nine-month 2004 costs related to diaper operations changes totaled approximately $36M. | ||||
| 2004-09-30 | divestiture_reduction | announced | 2004-11-04 | 2004-11-30 | United States | Business-to-Business — noncore pulp and paper operations (Neenah Paper) | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Spin-off of Neenah Paper announced with record date 2004-11-19 and distribution expected 2004-11-30; one Neenah share per 33 Kimberly-Clark shares. Guidance reflects 2 to 3 cents per share of dilution and other spin-off costs. Headcount removed not disclosed. | |||
| 2004-09-30 | other | announced | Asia | Business-to-Business — paper-related operations | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Anticipated costs of about 2 cents per share to exit certain paper-related operations in Asia; no employee counts or dates disclosed. | |||||
| 2004-06-30 | restructuring | in_progress | 2004-06-30 | 2004-09-30 | United States and United Kingdom | Personal Care (diaper manufacturing) | USD 40 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Cease diaper manufacturing at New Milford, Conn. facility (to focus on tissue) and redeploy capacity from Barton-upon-Humber, U.K.; diaper machines moved to other markets. Total pre-tax costs ~$40 million: ~$11 million employee severance, ~$4 million other cash costs (equipment removal), $25 million asset write-offs. $16 million charged in Q2 2004; ~$25 million expected in Q3 2004, minimal costs thereafter. No employee count disclosed. | ||
| 2004-06-30 | divestiture_reduction | announced | 2004-06-08 | United States and Canada | Paper and Canadian pulp operations | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Board approved previously disclosed plan to spin off paper and Canadian pulp operations; preliminary Form 10 filed with SEC on July 7, 2004. No headcount impact disclosed. | ||||
| 2004-06-30 | restructuring | in_progress | 2004-09-30 | North America (New Milford, Connecticut, USA) and Europe (Barton-upon-Humber, United Kingdom) | Personal Care — diaper manufacturing and distribution operations | USD 40 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Plan to cease diaper manufacturing at New Milford, Conn. (facility refocused to tissue) and scale back diaper production at Barton-upon-Humber, U.K., redeploying diaper machines to other markets. Total pre-tax implementation cost estimated at ~$40M: $16M incurred in Q2 2004 and ~$25M expected in Q3 2004, with minimal costs thereafter. Cost breakdown disclosed as ~$11M employee severance, ~$4M other cash costs (mainly equipment removal), and $25M asset write-offs. No employee headcount affected is disclosed. Exact announcement date not stated; decision made during Q2 2004. | |||
| 2003-12-31 | acquisition_addition | completed | 2003 | Poland | Consumer Tissue | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Klucze tissue business purchased during the first quarter of 2003; purchase price allocation recognized approximately $20 million of goodwill and other intangible assets. No headcount disclosed. | ||||
| 2003-12-31 | acquisition_addition | completed | 2003-08 | Brazil; Peru | Consumer Tissue | USD 200 (millions) | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Acquired an additional 49 percent interest in Kimberly-Clark Peru S.A. and the remaining 50 percent interest in tissue joint venture Klabin Kimberly S.A. (consolidated August 2003) for approximately $200 million; approximately $150 million of goodwill recorded. Acquisition cost, not a severance charge. No headcount disclosed. | |||
| 2003-12-31 | plant_closure | in_progress | 2003 | Outside North America | MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML | Charges of nearly $20 million in 2003 combined a write-off of an investment in a historic restoration project with the cost of exiting a nonstrategic facility outside North America; the facility-exit portion is not separately quantified and no employee count is disclosed. | |||||
| 2003-12-31 | restructuring | announced | 2004-01 | Global | Personal Care; Consumer Tissue; Business-to-Business | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | January 2004 announcement reorganizing personal care and consumer tissue into separate North Atlantic groups, consolidating developing and emerging market operations into one group, moving North American pulp operations to Business-to-Business, and transferring wet wipes to Personal Care. No headcount impact or charge disclosed. | ||||
| 2003-12-31 | divestiture_reduction | announced | 2004-02-25 | 2004-12-31 | United States; Canada | Neenah Paper; Technical Paper; pulp and timber assets (Pictou, Nova Scotia; Terrace Bay, Ontario) | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | Announced evaluation of a potential tax-free spin-off of the Neenah Paper and Technical Paper businesses plus Canadian pulp and timber assets; subject to Board approval and expected in the second half of 2004. Stand-alone Pulp and Paper operations net sales were approximately $650 million in 2003. No headcount disclosed. | |||
| 2003-12-31 | restructuring | completed | 2002 | Latin America and Europe | Manufacturing and Administrative | USD 33 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Charges related to plans to streamline manufacturing and administrative operations in Latin America ($14.3 million) and Europe ($19.1 million) recorded in 2002. Consisted principally of employee severance ($16.8 million) and asset write-off/disposal costs ($8.4 million). Substantially completed prior to end of 2002. | |||
| 2003-12-31 | restructuring | completed | 2001 | North America and China | Personal Care Operations | USD 40 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Charges totaling approximately $40 million recorded in 2001 to streamline personal care operations in North America and China, consisting of workforce severance costs of about $6 million and asset write-off/disposal costs of approximately $34 million. Programs completed during 2001. | |||
| 2003-12-31 | restructuring | completed | 2001-11 | Latin America and North America | Manufacturing | USD 85 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Plans announced in November 2001 for streamlining manufacturing operations in Latin America (shutdown of four small, older plants) and closure of a technical paper mill in North America. Total cash charges were $18.4 million. Noncash costs recorded in Q4 2001 totaled $66.7 million, including write-off of assets associated with the closed mill and excess manufacturing equipment. Plans substantially completed prior to end of 2002. | |||
| 2003-12-31 | restructuring | completed | 2002 | Latin America and Europe | Manufacturing and Administrative | USD 33 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Charges recorded in 2002 for plans to streamline manufacturing and administrative operations. Consisted principally of employee severance of $16.8 million and asset write-off/disposal costs of $8.4 million. Programs substantially completed prior to end of 2002. | |||
| 2003-12-31 | restructuring | completed | 2001-11 | Latin America and North America | Manufacturing | USD 18 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Cash charges for streamlining manufacturing operations in Latin America (shutdown of four plants) and closure of technical paper mill in North America. Programs substantially completed prior to end of 2002. | |||
| 2003-12-31 | restructuring | completed | 2001 | North America and China | Personal Care | USD 40 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Workforce severance costs of about $6 million and asset write-off/disposal costs of approximately $34 million to streamline personal care operations. Programs completed during 2001. | |||
| 2003-09-30 | acquisition_addition | completed | Peru | business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Acquired remaining 49% interest in Kimberly-Clark Peru S.A. during Q3 2003; no headcount disclosed. | ||||||
| 2003-09-30 | acquisition_addition | completed | Brazil | Consumer Tissue | business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Acquired remaining 50% interest in Klabin Kimberly S.A. (joint tissue venture), consolidated in August 2003; no headcount disclosed. | |||||
| 2003-06-30 | restructuring | completed | Latin America, Europe | Manufacturing, Administrative | USD 15 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Charges for business improvement programs in Q2 2002 included severance costs of approx $9.7 million and additional depreciation of $2.3 million. Related to streamlining manufacturing in Latin America and consolidating admin functions in Europe. Employee count not disclosed. | ||||
| 2003-06-30 | acquisition_addition | completed | Peru | Consumer Tissue | subsequent_events f5-10q / Qwen3.6-27B-Q8_0 | Acquisition of 49% ownership in Kimberly-Clark Peru S.A. closed in July 2003. Employee count not disclosed. | |||||
| 2003-06-30 | acquisition_addition | announced | 2003-06-30 | 2003-08-31 | Brazil | Consumer Tissue | subsequent_events f5-10q / Qwen3.6-27B-Q8_0 | Partner in joint tissue venture in Brazil exercised option to sell 50% ownership. Acquisition expected to close in August 2003. Employee count not disclosed. | |||
| 2002-12-31 | restructuring | in_progress | 2001-11-01 | Latin America | Manufacturing and administrative operations | USD 14 (millions) | MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML | Previously announced plan; 2002 charge of $14.3M included employee severance and asset write-off costs. No employee count disclosed. | |||
| 2002-12-31 | restructuring | in_progress | 2001-11-01 | Europe | Manufacturing and administrative operations | USD 19 (millions) | MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML | Previously announced plan; 2002 charge of $19.1M included employee severance and asset write-off costs. No employee count disclosed. | |||
| 2002-12-31 | restructuring | completed | 2001-01-01 | 2002-12-31 | North America | Personal care operations | USD 4 (millions) | MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML | Approximately $4 million severance charge in 2002 to complete workforce actions originally initiated in 2001. No employee count disclosed. | ||
| 2002-12-31 | acquisition_addition | completed | 2002-06-30 | 2002-06-30 | Australia | All segments | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Acquired remaining 45% interest from Amcor for A$697.5M (~$390M); KCA became wholly-owned subsidiary. No headcount added disclosed. | |||
| 2002-12-31 | restructuring | completed | 1998-Q4 | 2000-12-31 | Global | Various | USD 18 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Costs of $18.2 million recorded in 2000 for the 1998 facilities consolidation plan. Plan completed as of Dec 31, 2000. Included reduction of 814 employees in 1998. | ||
| 2002-12-31 | restructuring | completed | 2001-11 | 2002-12-31 | Latin America, North America | Manufacturing, Technical Paper | USD 14 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Charges of $14.3 million recorded in 2002 for streamlining manufacturing in Latin America and Europe. Plans substantially completed prior to end of 2002. | ||
| 2002-12-31 | restructuring | completed | 2001 | 2002-12-31 | North America, China | Personal Care | USD 4 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Approximately $4 million for employee severance to complete actions initiated in 2001. | ||
| 2002-12-31 | restructuring | completed | 1998-Q4 | 2000-12-31 | Global | Global | USD 18 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | 1998 Plan completed Dec 31, 2000. $18.2M charged in 2002. Original plan reduced workforce by 814 employees. | ||
| 2002-12-31 | restructuring | completed | 2001-11 | 2002-12-31 | Latin America; Europe | Manufacturing; Administrative | USD 33 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Streamlining manufacturing and administrative operations. $14.3M Latin America, $19.1M Europe. Principally employee severance ($16.8M) and asset write-offs ($8.4M). | ||
| 2002-12-31 | restructuring | completed | 2001 | 2002 | Global | Global | USD 4 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Employee severance to complete actions initiated in 2001. | ||
| 2002-09-30 | restructuring | in_progress | Latin America and Europe | Manufacturing and administrative operations | USD 12 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Q3 2002 charge of $11.6M; nine-month 2002 charge of $35.6M. No employee counts, announcement date, or completion date disclosed. Related Q3 charge also includes a Colombian special tax, which is not a workforce cost. | ||||
| 2002-09-30 | restructuring | in_progress | Latin America and Europe | Manufacturing and administrative operations | USD 12 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Charges associated with plans to streamline manufacturing and administrative operations. Employee count not disclosed. | ||||
| 2002-06-30 | restructuring | in_progress | Latin America and Europe | Manufacturing and administrative operations | USD 15 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Second quarter 2002 pretax charge of $15.1 million primarily for previously announced plans to streamline manufacturing and administrative operations in Latin America and Europe; no employee counts disclosed. | ||||
| 2002-06-30 | acquisition_addition | completed | 2002-06-30 | Australia | Kimberly-Clark Australia Pty. Ltd. | USD 390 (millions) | business_combinations_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Purchased remaining 45 percent ownership of Kimberly-Clark Australia from Amcor Limited for A$697.6 million (approximately US$390 million); KCA operating results consolidated from July 1, 2001. No headcount figures disclosed. | |||
| 2002-06-30 | acquisition_addition | completed | 2002-06-30 | 2002-06-30 | Australia | Consolidated (Kimberly-Clark Australia Pty. Ltd.) | USD 390 (millions) | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Purchase of remaining 45% of KCA from Amcor for A$697.6M (~US$390M); no headcount added disclosed. Purchase price allocation expected in Q3 2002. | ||
| 2002-06-30 | restructuring | in_progress | Latin America and Europe | Manufacturing and administrative operations | USD 24 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Six-month 2002 charge of $24.0M ($15.1M in Q2) for previously announced plans to streamline manufacturing and administrative operations; no employee counts or completion dates disclosed. | ||||
| 2002-06-30 | divestiture_reduction | completed | North America | Business-to-Business | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | B2B divestitures during 2001 reduced segment sales; no headcount removed disclosed in this filing. | |||||
| 2002-06-30 | restructuring | in_progress | Latin America and Europe | Manufacturing and administrative operations | USD 15 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Pretax charges of $15.1 million recorded in Q2 2002 for costs associated with plans to streamline manufacturing and administrative operations in Latin America and Europe. Employee count not disclosed. | ||||
| 2002-03-31 | restructuring | in_progress | Latin America | Manufacturing | USD 9 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Q1 2002 business improvement program charges of $8.9 million related to previously announced plans to streamline manufacturing operations in Latin America; no employee count, announcement date, or completion date disclosed. | ||||
| 2002-03-31 | restructuring | in_progress | Latin America | Manufacturing operations | USD 9 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Charges associated with previously announced plans to streamline manufacturing operations in Latin America. Employee count not disclosed. | ||||
| 2001-12-31 | restructuring | in_progress | 243 | 2001-11-30 | 2002-03-31 | North America and Latin America | Manufacturing operations | USD 53 (millions) | MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML | 243 employees notified of severance; 141 separated by year-end, 102 to separate in Q1 2002. Includes closure of four small Latin American plants, a technical paper mill, and excess equipment write-offs. Total charge $52.6M operating profit impact. | |
| 2001-12-31 | restructuring | in_progress | 2001-11-30 | 2003-12-31 | North America and Latin America | Manufacturing operations | USD 33 (millions) | MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML | Streamlining of Latin American manufacturing including shutdown of four small older plants; $32.5M charge in 2001. Approximately $32M additional expected through end of 2003, including $14M severance for ~1,100 employees to be notified. | ||
| 2001-12-31 | restructuring | in_progress | North America and China | Personal Care | USD 56 (millions) | MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML | 2001 charges primarily for workforce severance and asset consolidation to streamline personal care operations in North America and China. | ||||
| 2001-12-31 | acquisition_addition | completed | 2001-01-31 | 2001-01-31 | Italy | Personal Care | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Acquisition of Linostar S.p.A., Italian diaper manufacturer; headcount not disclosed. | |||
| 2001-12-31 | acquisition_addition | completed | 2001-07-01 | 2001-07-01 | Australia | All segments | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Purchased additional 5% of Kimberly-Clark Australia, increasing ownership to 55% and beginning consolidation of KCA results; headcount not disclosed. | |||
| 2001-12-31 | other | completed | United States | Corporate / Legal | USD 43 (millions) | MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML | Arbitration rulings on MESC disputes related to Mobile pulp mill closure; $43.2M charge recorded in Q4 2001. Not a workforce action per se but included as a material 2001 charge; no employees affected disclosed. | ||||
| 2001-12-31 | restructuring | completed | 243 | 2001-11-30 | 2003-12-31 | Latin America and North America | Manufacturing and Technical Paper | USD 132 (millions) | MD&A f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Announced Nov 30, 2001. Includes shutdown of four small older plants in Latin America, closure of technical paper mill in North America, and write-off of excess equipment. $2.3M severance for 243 employees notified in Q4 2001. Total estimated cost to complete plans by end of 2003 is $32M (including $14M severance for approx 1,100 employees to be notified later). Charges recorded in 2001 include $52.6M North American mill closing/write-offs and $32.5M Latin American asset plan. | |
| 2001-12-31 | restructuring | completed | 1997-11-21 | 2000-12-31 | Worldwide | Manufacturing | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | 1997 Plan completed as of Dec 31, 2000. Originally involved workforce reduction of approx 3,740 employees. No new charges in 2001. | |||
| 2001-12-31 | restructuring | completed | 1998-Q4 | 2000-12-31 | Europe, Canada, Thailand, North America | Manufacturing | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | 1998 Plan completed as of Dec 31, 2000. Originally involved workforce reduction of 814 employees. No new charges in 2001. | |||
| 2001-12-31 | restructuring | completed | 243 | 2001-11-30 | 2003-12-31 | North America | Personal Care; Business-to-Business | USD 2 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Part of Latin American asset plan and North American mill closing. 243 employees notified of severance in Q4 2001. 141 no longer employed by Dec 31, 2001; 102 to cease employment principally in Q1 2002. Total plan expected to affect approx 1,100 employees by end of 2003. | |
| 2001-12-31 | restructuring | completed | 3,740 | 1997-11-21 | 2000-12-31 | Worldwide | Various | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | 1997 Plan completed as of Dec 31, 2000. Resulted in workforce reduction of approx 3,740 employees. | ||
| 2001-12-31 | restructuring | completed | 814 | 1998-Q4 | 2000-12-31 | Worldwide | Various | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | 1998 Plan completed as of Dec 31, 2000. Resulted in workforce reduction of 814 employees. | ||
| 2001-09-30 | restructuring | in_progress | North America and China | Personal Care | USD 49 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Nine-month 2001 business improvement charges primarily relate to workforce severance and asset consolidation programs to streamline personal care operations in North America and China; no employee counts disclosed. Third-quarter portion of the charge was $6.5 million. | ||||
| 2001-09-30 | restructuring | in_progress | North America; China | Personal Care | USD 49 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Nine-month 2001 business improvement charges of $48.8M primarily for workforce severance and asset consolidation programs in personal care operations in North America and China; no employee count or completion date disclosed. | ||||
| 2001-09-30 | restructuring | in_progress | North America and China | Personal Care | USD 7 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Business improvement charges primarily relate to workforce severance and asset consolidation programs to streamline personal care operations. | ||||
| 2001-09-30 | restructuring | in_progress | North America and China | Personal Care | USD 49 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Year-to-date business improvement charges primarily relate to workforce severance and asset consolidation programs to streamline personal care operations. | ||||
| 2001-06-30 | restructuring | in_progress | North America and China | Personal Care | USD 21 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Second-quarter 2001 charge primarily for workforce severance and asset consolidation to streamline personal care operations in North America and China; no employee count disclosed. | ||||
| 2001-06-30 | restructuring | in_progress | North America and China | Personal Care | USD 42 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Year-to-date 2001 business improvement charge primarily for workforce severance and asset consolidation programs; no employee count disclosed. | ||||
| 2001-06-30 | restructuring | in_progress | North America; China | Personal Care | USD 21 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce severance and asset consolidation programs streamlining personal care operations; Q2 charge $21.1M, six-month charge $42.3M. No employee counts or completion dates disclosed. | ||||
| 2001-06-30 | restructuring | in_progress | not specified | Corporate / acquired businesses | USD 7 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Costs to integrate acquired businesses into existing operations; Q2 charge $7.4M, six-month charge $14.3M. Workforce impact not quantified. | ||||
| 2001-06-30 | restructuring | in_progress | North America and China | Personal Care | USD 21 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Charges relate to workforce severance and asset consolidation programs to streamline personal care operations. | ||||
| 2001-06-30 | restructuring | in_progress | Global | Various | USD 7 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Costs to integrate acquired businesses into existing operations. | ||||
| 2001-03-31 | restructuring | in_progress | North America | Personal Care (feminine and adult care operations) | USD 21 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Workforce severance and asset consolidation program to streamline feminine and adult care operations in North America; employee count not disclosed. | ||||
| 2001-03-31 | restructuring | in_progress | North America | Personal Care (feminine and adult care operations) | USD 21 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Workforce severance and asset consolidation program to streamline feminine and adult care operations in North America; no employee count disclosed. | ||||
| 2001-03-31 | restructuring | in_progress | Not specified | Corporate / acquired businesses | USD 7 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Costs to integrate acquired businesses into existing operations; no employee count disclosed. | ||||
| 2001-03-31 | restructuring | in_progress | North America | Feminine and adult care operations | USD 21 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Workforce severance and asset consolidation program to streamline operations. | ||||
| 2000-12-31 | restructuring | completed | 814 | 1998-10-01 | 2000-12-31 | Worldwide | Tissue, Personal Care | USD 18 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Cumulative through fiscal year-end; 814 employees notified through Dec 31, 2000. 2000 charge of $18.2M primarily severance and accelerated depreciation for Larkfield, U.K. facility shut down October 2000. Plan completed as of Dec 31, 2000. | |
| 2000-12-31 | restructuring | completed | 3,740 | 1997-11-21 | 2000-12-31 | Worldwide | Multiple | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Cumulative through fiscal year-end; sale, closure or downsizing of 16 manufacturing facilities. Plan completed as of Dec 31, 2000. No incremental charge in 2000. | ||
| 2000-12-31 | plant_closure | completed | 1998-10-01 | 2000-10-31 | United Kingdom | Tissue | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Larkfield, U.K. tissue manufacturing facility shut down October 2000; 2000 charges included accelerated depreciation and severance. | |||
| 2000-12-31 | acquisition_addition | completed | 2000-02-08 | 2000-02-08 | United States | Health Care | USD 750 (millions) | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Acquisition valued at approximately $750 million in stock; headcount added not disclosed. | ||
| 2000-12-31 | acquisition_addition | completed | 2000-07-05 | 2000-06-30 | Taiwan | Tissue, Personal Care | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Majority shares of privately held S-K Corporation acquired; holds trademark and distribution rights in Taiwan. Headcount added not disclosed. | |||
| 2000-12-31 | acquisition_addition | completed | 2000-12-20 | 2000-12-20 | Taiwan | Tissue | Item_1_Business f5-10k / MiMo-V2.6-Flash-fp8-HTML | Purchased additional 33.3 percent interest, increasing ownership to 100 percent. Headcount added not disclosed. | |||
| 2000-12-31 | acquisition_addition | announced | 2001-01-31 | 2001-01-31 | Italy | Personal Care | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | Subsequent event after fiscal year-end; Italian diaper manufacturer producing Lines brand. Headcount added not disclosed. | |||
| 2000-12-31 | restructuring | completed | 814 | 1998-Q4 | 2000-12-31 | Worldwide | Tissue, Personal Care, Health Care | USD 18 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Facilities consolidation plan announced in Q4 1998. Included workforce reduction of approx 830 employees. 814 employees notified/terminated through Dec 31, 2000. Plan completed as of Dec 31, 2000. Costs recorded in 2000 were $18.2 million. | |
| 2000-12-31 | restructuring | completed | 3,740 | 1997-11-21 | 2000-12-31 | Worldwide | Multiple | USD 0 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Restructuring plan announced Nov 1997. Resulted in workforce reduction of approx 3,740 employees. Plan completed as of Dec 31, 2000. No incremental charges recorded in 2000 (net credit recorded in 1999). | |
| 2000-12-31 | plant_closure | completed | 450 | 1998-05-05 | 1999-08-31 | United States | Tissue | USD 18 (millions) | Note_11 f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Closure of Mobile, Alabama pulp mill. Elimination of approx 450 jobs. Severance costs of $18.0 million charged in 1998. | |
| 2000-12-31 | restructuring | completed | 814 | 1998-Q4 | 2000-12-31 | Worldwide | Tissue, Personal Care | USD 18 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Facilities consolidation plan announced in Q4 1998. Costs of $18.2 million recorded in 2000. Plan completed as of Dec 31, 2000. | |
| 2000-12-31 | restructuring | completed | 1997-11-21 | 2000-12-31 | Worldwide | Various | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Restructuring plan announced Nov 1997 involving sale/closure of 16 facilities and reduction of approx 3,740 employees. Plan completed as of Dec 31, 2000. No specific employee count or charge attributed to 2000 activity in the text, only prior year costs and 1999 credits mentioned. | |||
| 2000-12-31 | plant_closure | completed | 450 | 1998-05-05 | 1999-08 | Mobile, Alabama | Pulp/Tissue | USD 18 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Closure of Mobile pulp mill. Severance costs of $18.0 million charged in Q3 1998. Mill shut down in Aug 1999. | |
| 2000-09-30 | plant_closure | completed | 1998-10-01 | 2000-10-31 | United Kingdom | Tissue | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Tissue manufacturing facility in the United Kingdom remained in use until its shutdown in October 2000; subject to accelerated depreciation recorded in Q3 and nine months ended September 30, 2000 and 1999. Part of the facilities consolidation plan announced in Q4 1998 to align tissue capacity with demand in Europe. | |||
| 2000-09-30 | plant_closure | completed | 1998-10-01 | Canada | Personal Care | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Diaper manufacturing facility closure announced as part of the Q4 1998 facilities consolidation plan. | ||||
| 2000-09-30 | restructuring | completed | 1998-10-01 | North America | Personal Care | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Write-down of certain excess feminine care production equipment in North America under the Q4 1998 facilities consolidation plan. | ||||
| 2000-09-30 | divestiture_reduction | completed | 1999-01-01 | United States (southeastern United States) | Pulp and timberlands operation (SET) | USD 9 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Severance costs related to the 1999 sale of the pulp and timberlands operation in the southeastern United States (SET); recorded in 1999. | |||
| 2000-09-30 | plant_closure | announced | 1998-10 | 2000-10 | United Kingdom | Tissue | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Facilities consolidation plan announced Q4 1998; UK tissue facility shut down October 2000 (after quarter end). Accelerated depreciation of $5.5M charged in Q3 2000; no employee count disclosed. | |||
| 2000-09-30 | acquisition_addition | completed | 2000-02-08 | North America | Health Care and Other | business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Safeskin Corporation acquisition completed 2000-02-08 at approximately $750 million; integration costs expensed as incurred. No headcount added disclosed. | ||||
| 2000-09-30 | acquisition_addition | completed | 2000-07 | Asia | Personal Care | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | S-K Corporation acquired at the beginning of Q3 2000; no headcount added disclosed. | ||||
| 2000-09-30 | restructuring | in_progress | 1998-10-01 | Global | Tissue, Personal Care | USD 6 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Charges relate to facilities consolidation plan announced in Q4 1998, including UK tissue facility shutdown (Oct 2000), Canadian diaper facility closure, and NA feminine care equipment write-down. Employee count not disclosed. | |||
| 2000-09-30 | restructuring | in_progress | 1998-10-01 | Global | Tissue, Personal Care | USD 21 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | YTD charges for the same facilities consolidation plan. Employee count not disclosed. | |||
| 2000-09-30 | other | completed | 2000-03-31 | United States | Pulp | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Write-down of non-productive assets related to 1999 shutdown of Mobile, Alabama pulp mill due to lower salvage value. Charged to cost of products sold in Q1 2000. Employee count not disclosed. | ||||
| 2000-06-30 | plant_closure | in_progress | 1998-10-01 | 2000-10-31 | United Kingdom | Tissue | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Facilities consolidation plan announced Q4 1998; UK tissue facility remains in use until expected shutdown in October 2000; assets subject to accelerated depreciation. No employee count disclosed. | |||
| 2000-06-30 | plant_closure | in_progress | 1998-10-01 | Canada | Personal Care | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Diaper manufacturing facility closure announced as part of Q4 1998 facilities consolidation plan. No employee count disclosed. | ||||
| 2000-06-30 | restructuring | in_progress | 1998-10-01 | North America | Personal Care | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Write-down of certain excess feminine care production equipment in North America under the 1998 facilities consolidation plan. | ||||
| 2000-06-30 | restructuring | announced | 165 | 2000-07-01 | 2003-10-31 | Europe | Administrative offices | USD 26 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Plan announced July 2000 to consolidate 14 European administrative offices into one centralized office; expected net reduction of approximately 165 employees and annual net cost savings of about $5 million when fully implemented in Q4 2003; costs recorded as they become accruable. | |
| 2000-06-30 | acquisition_addition | completed | 2000-02-08 | Health Care and Other | other f5-10q / GLM-5.3-flash-fp4-HTML | Acquisition of Safeskin Corporation completed February 8, 2000, accounted for as a purchase; no headcount disclosed. | |||||
| 2000-06-30 | acquisition_addition | completed | 2000-06-30 | Taiwan | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Acquisition of majority shares of S-K Corporation of Taiwan completed June 30, 2000; Corporation now owns more than 99 percent; no headcount disclosed. | |||||
| 2000-06-30 | restructuring | announced | 165 | 2000-07 | 2003-12-31 | Europe | Corporate / Administrative | USD 26 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Plan to consolidate 14 European administrative offices into one centralized office; net reduction of approximately 165 employees; annual net cost savings of approximately $5 million when fully implemented in Q4 2003. | |
| 2000-06-30 | plant_closure | in_progress | 1998-10 | 2000-10-31 | United Kingdom | Tissue | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Facilities consolidation plan announced Q4 1998 includes shutdown of a UK tissue manufacturing facility expected October 2000; accelerated depreciation recorded. No employee count disclosed. | |||
| 2000-06-30 | plant_closure | completed | 1998-10 | Canada | Personal Care | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Facilities consolidation plan includes closure of a diaper manufacturing facility in Canada; no employee count or completion date disclosed. | ||||
| 2000-06-30 | acquisition_addition | completed | 2000-02-08 | North America | Health Care and Other | business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Acquisition of Safeskin Corporation completed February 8, 2000, accounted for as a purchase; no headcount added disclosed. | ||||
| 2000-06-30 | acquisition_addition | completed | North America | Health Care and Other | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Integration of acquired businesses including Ballard Medical Products and Attisholz tissue brands; additional $10 million of integration costs expected in 2000. No headcount added disclosed. | |||||
| 2000-06-30 | restructuring | in_progress | 165 | 2000-07 | 2003-12-31 | Europe | Administrative | USD 26 (millions) | subsequent_events f5-10q / Qwen3.6-27B-Q8_0 | Plan to consolidate 14 European administrative offices into one centralized office. Expected net reduction of approximately 165 employees and annual net cost savings of approximately $5 million when fully implemented in Q4 2003. Implementation costs expected to aggregate approximately $26 million. | |
| 2000-03-31 | acquisition_addition | completed | 2000-02-08 | 2000-02-08 | North America | Health Care and Other | business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Safeskin Corporation acquired for approximately $750 million; no headcount disclosed. | |||
| 2000-03-31 | restructuring | in_progress | 1998-10-01 | 2000-10-31 | Europe; Canada; North America | Tissue; Personal Care | USD 10 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Facilities consolidation plan announced Q4 1998; includes UK tissue plant shutdown expected October 2000, Canadian diaper facility closure, and feminine care equipment write-down. No employee counts disclosed. | ||
| 2000-03-31 | restructuring | in_progress | 1997-10-01 | 2000-12-31 | Worldwide | All segments | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Worldwide restructuring plan announced Q4 1997; accelerated depreciation on assets held for disposal. No employee counts disclosed. | |||
| 2000-03-31 | acquisition_addition | completed | 1999-01-01 | 1999-12-31 | United States | Health Care and Other | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Ballard Medical Products and Attisholz Holding AG acquisitions integrated during the period; integration costs of $12.2 million expensed in Q1 2000. No headcount disclosed. | |||
| 2000-03-31 | restructuring | in_progress | 1998-Q4 | 2000-10-31 | Europe, Canada, North America | Tissue, Personal Care | USD 10 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Facilities consolidation plan announced in Q4 1998. Includes aligning tissue capacity in Europe, closing diaper facility in Canada, and writing down feminine care equipment in North America. UK tissue facility remains in use until expected shutdown in Oct 2000. Charges include accelerated depreciation. | ||
| 2000-03-31 | restructuring | in_progress | 1997-Q4 | Worldwide | Worldwide Operations | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Plan to restructure worldwide operations announced in Q4 1997. Certain assets subject to accelerated depreciation as they remain in use until disposed of in 1999 and 2000. Specific employee counts not disclosed in this filing. | ||||
| 2000-03-31 | acquisition_addition | completed | 2000-02-08 | 2000-02-08 | Health Care and Other | USD 750 (millions) | business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0 | Acquisition of Safeskin Corporation completed on Feb 8, 2000 for approx $750 million. Headcount added not explicitly disclosed. | |||
| 2000-03-31 | acquisition_addition | completed | 2000-03-31 | 2000-03-31 | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Acquired additional 0.2% of Hogla-Kimberly Limited, increasing ownership to 50.1%. Consolidation of income statement begins April 2000. Headcount impact not disclosed. | |||||
| 1999-12-31 | restructuring | in_progress | 3,740 | 1997-11-21 | 1999-12-31 | Worldwide | Multiple — Tissue, Personal Care, Health Care | USD -17 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Cumulative through fiscal year-end. Plan targeted ~4,800 employees and 17 facility closures; 3,740 employees reduced and 16 of 17 facilities closed by Dec 31, 1999. 1999 charge was a net credit of $16.7M due to estimate changes. Substantially completed. | |
| 1999-12-31 | restructuring | in_progress | 830 | 1998-10-01 | 2000-12-31 | Worldwide | Tissue and Personal Care | USD 43 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Cumulative through fiscal year-end. Targeted ~830 employees; 800 notified and 530 terminated by Dec 31, 1999. 270 more to be terminated in 2000 and ~50 additional to be notified in 2000. Announcement date approximate (Q4 1998). Substantially completed. | |
| 1999-12-31 | plant_closure | completed | 450 | 1998-05-05 | 1999-08-31 | United States — Mobile, Alabama | Tissue — pulp operations | USD 18 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Pulp mill shut down August 1999. Severance of $18.0M charged to cost of products sold in Q3 1998 when employees were notified. Closure driven by EPA Cluster Rule compliance costs exceeding $250M. | |
| 1999-12-31 | acquisition_addition | completed | 1999-06-10 | 1999-06-10 | Europe — Germany, Switzerland, Austria | Tissue | USD 365 (millions) | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Acquisition of European consumer and away-from-home tissue businesses of Attisholz Holding AG for $365M in cash. No headcount disclosed. | ||
| 1999-12-31 | acquisition_addition | completed | 1999-09-23 | 1999-09-23 | United States | Health Care | USD 788 (millions) | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Acquisition of Ballard Medical Products via exchange of ~13.8M shares; value including costs ~$788M. No headcount disclosed. | ||
| 1999-12-31 | acquisition_addition | announced | 1999-11-17 | 2000-02-08 | United States | Health Care | USD 800 (millions) | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | Definitive agreement signed November 17, 1999; merger completed February 8, 2000 (after fiscal year-end). Exchange ratio .1956 KMB shares per Safeskin share; valued ~$800M. No headcount disclosed. | ||
| 1999-12-31 | restructuring | completed | 830 | 1998-Q4 | 2000-10-31 | Worldwide | Tissue, Personal Care | USD 43 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Facilities consolidation plan announced in Q4 1998. 800 employees notified by Dec 31, 1999; 530 terminated, 270 to be terminated in 2000. Costs of $42.6M recorded in 1999. | |
| 1999-12-31 | restructuring | completed | 4,800 | 1997-11-21 | 1999-12-31 | Worldwide | Tissue, Personal Care, Health Care | USD -17 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Restructuring plan announced Nov 1997. Workforce reduction of approx 4,800 employees. Total reduction of 3,740 realized by Dec 31, 1999. Net credit of $16.7M recorded in 1999 due to changes in estimates. | |
| 1999-12-31 | plant_closure | completed | 450 | 1998-05-05 | 1999-08-31 | Mobile, Alabama | Pulp | USD 18 (millions) | Notes to Consolidated Financial Statements f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Closure of Mobile pulp mill in Aug 1999. Severance costs of $18.0M charged in Q3 1998. | |
| 1999-12-31 | restructuring | in_progress | 830 | 1998-Q4 | 2000-10-31 | Worldwide | Tissue, Personal Care | USD 43 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Announced Q4 1998. 800 employees notified through 1999-12-31; 530 terminated, 270 to be terminated in 2000. ~50 additional to be notified in 2000. $42.6M charged in 1999. | |
| 1999-12-31 | restructuring | completed | 4,800 | 1997-11-21 | 1999-12-31 | Worldwide | Tissue, Personal Care, Health Care | USD -17 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Announced 1997. Workforce reduction of approx 4,800. 3,740 realized through 1999-12-31. Net credit of $16.7M recorded in 1999 due to changes in estimates. | |
| 1999-12-31 | plant_closure | completed | 450 | 1998-05-05 | 1999-08-31 | Mobile, Alabama | Pulp/Tissue | USD 18 (millions) | Note_12_Acquisitions_and_Dispositions f5-10k / Qwen3.6-27B-Q8_0 | Closure of Mobile pulp mill. 450 jobs eliminated. Severance costs of $18.0M charged in 1998. | |
| 1999-09-30 | plant_closure | completed | 1998-04-01 | 1999-08-31 | Mobile, Alabama, United States | Pulp manufacturing | USD 24 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Energy contract termination penalty recorded in Q2 1998 when pulp mill closure was announced; mill shut down in August 1999. Employee counts not disclosed. | ||
| 1999-09-30 | layoff | completed | 1999-04-01 | 1999-06-30 | Southeastern United States (woodlands operations) | Mobile pulp mill associated woodlands operations | USD 9 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Employee severance costs recorded in Q2 1999 for terminations in woodlands operations when severance arrangements were communicated to affected employees; headcount not disclosed. | ||
| 1999-09-30 | layoff | completed | 1998-07-01 | 1999-08-31 | Mobile, Alabama, United States | Pulp manufacturing | USD 18 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Employee severance costs recorded in Q3 1998 in connection with planned closure of the pulp mill; headcount not disclosed. | ||
| 1999-09-30 | restructuring | in_progress | 1997-10-01 | Worldwide | Worldwide operations | USD -17 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Nine-month 1999 restructuring credit of $16.9 million from changes in estimates returned to earnings; accrual balance reduced to $25.3 million at September 30, 1999, estimated adequate to complete the plan. Headcount not disclosed. | |||
| 1999-09-30 | restructuring | in_progress | 1998-10-01 | 2000-10-31 | Europe, Canada, Thailand, North America | Tissue and personal care manufacturing | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Plan includes aligning European tissue capacity, closing a Canadian diaper plant, shutting down a Thailand tissue machine, and writing down excess feminine care equipment; UK tissue facility subject to accelerated depreciation until expected October 2000 shutdown. Headcount not disclosed. | |||
| 1999-09-30 | acquisition_addition | completed | 1999-09-23 | 1999-09-23 | United States | Health Care and Other | USD 788 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Acquisition of Ballard Medical Products completed September 23, 1999 for approximately $788 million, accounted for as a purchase; headcount added not disclosed. | ||
| 1999-09-30 | plant_closure | completed | 1998-04-01 | 1999-09-30 | Mobile, Alabama, USA | Pulp mill operations | USD 18 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pulp mill shutdown August 1999; $18.0M employee severance recorded Q3 1998; $24.3M energy contract termination penalty recorded Q2 1998; timberlands sale completed September 1999. No employee count disclosed. | ||
| 1999-09-30 | restructuring | in_progress | 1997-10-01 | 2000-12-31 | Worldwide | All segments | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | 1997 worldwide restructuring plan; accrued balance $25.3M at 1999-09-30 after charges of $(22.3)M and payments of $(63.4)M during first nine months 1999. No employee count disclosed. | |||
| 1999-09-30 | restructuring | in_progress | 1998-10-01 | 2000-10-31 | Europe, Canada, Thailand, North America | Tissue, Personal Care | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Q4 1998 facilities consolidation plan: align tissue capacity in Europe, close Canadian diaper facility, dispose Thailand tissue machine, write down North American feminine care equipment. UK tissue facility subject to accelerated depreciation until expected shutdown October 2000. No employee count disclosed. | |||
| 1999-09-30 | acquisition_addition | completed | 1999-09-23 | 1999-09-23 | United States | Health Care and Other | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Ballard Medical Products acquisition completed 1999-09-23 at approximately $788 million, accounted for as a purchase. No headcount added disclosed. | |||
| 1999-09-30 | restructuring | in_progress | 1997-Q4 | Worldwide | Operations | USD -17 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Credit to restructuring for changes in estimates for previously accrued costs related to the 1997 worldwide restructuring plan. | |||
| 1999-09-30 | plant_closure | completed | 1998-Q2 | 1999-08-31 | Mobile, Alabama | Pulp Mill | USD 9 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Employee severance costs for terminations in associated woodlands operations recorded in Q2 1999. Pulp mill shutdown in August 1999. | ||
| 1999-09-30 | acquisition_addition | completed | Health Care and Other | USD 788 (millions) | business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0 | Acquisition of Ballard Medical Products completed September 23, 1999. Headcount not disclosed. | |||||
| 1999-06-30 | restructuring | in_progress | 1997-10-01 | Worldwide | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | 1997 worldwide restructuring plan; accrual balance of $53.8 million at June 30, 1999, deemed adequate to complete plan actions; $54.2 million paid and $3.0 million credited during first six months of 1999. | |||||
| 1999-06-30 | restructuring | in_progress | 1998-10-01 | 2000-10-31 | Europe; Canada; Thailand; North America | Tissue; Personal Care | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Facilities consolidation plan announced Q4 1998: align European tissue capacity with demand, close a Canadian diaper plant, shut down a Thai tissue machine, write down excess North America feminine care equipment; UK tissue facility subject to accelerated depreciation until expected October 2000 shutdown. | |||
| 1999-06-30 | plant_closure | in_progress | 1999-09-30 | Mobile, Alabama, United States | Pulp mill / integrated pulp operation | USD 9 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Employee severance costs of $9.0 million recorded in Q2 1999 for terminations in associated woodlands operations; an energy contract termination penalty of $24.3 million was recorded in Q2 1998 for the planned pulp mill closure; net gain still expected on overall disposal. | |||
| 1999-06-30 | acquisition_addition | completed | 1999-06-10 | 1999-06-10 | Germany, Switzerland, Austria | Consumer and away-from-home tissue | USD 365 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Purchased European consumer and away-from-home tissue businesses of Attisholz Holding AG for approximately $365 million; no headcount disclosed. | ||
| 1999-06-30 | plant_closure | in_progress | 1999-09-30 | Mobile, Alabama, United States | Pulp mill operations / woodlands operations | USD 9 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Employee severance costs of $9.0M recorded in Q2 1999 for woodlands operations terminations; no employee count disclosed. Planned disposal of entire integrated pulp operation expected in Q3 1999. | |||
| 1999-06-30 | restructuring | in_progress | Worldwide | Corporate / operations | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | 1997 worldwide restructuring plan; accrued balance of $53.8M at June 30, 1999 after charges of $(3.0)M and payments of $54.2M in H1 1999. No employee count disclosed. | |||||
| 1999-06-30 | restructuring | in_progress | 2000-10-31 | Europe, Canada, Thailand, North America | Tissue, Personal Care (diapers, feminine care) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Q4 1998 facilities consolidation plan: align tissue capacity in Europe, close Canadian diaper facility, dispose of Thailand tissue machine, write down excess feminine care equipment. Accelerated depreciation recorded in Q2 1999. No employee count disclosed. | ||||
| 1999-06-30 | acquisition_addition | completed | 1999-06-10 | Germany, Switzerland, Austria | Tissue | USD 365 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Acquisition of Attisholz Holding AG European consumer and away-from-home tissue businesses for approximately $365 million. No headcount added disclosed. | |||
| 1999-06-30 | restructuring | in_progress | 1997-Q4 | Worldwide | Operations | USD -3 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | 1997 Plan accrued expenses; $3.0 million credit recorded in first six months of 1999. | |||
| 1999-06-30 | restructuring | in_progress | 1998-Q4 | 2000-10 | Europe | Tissue | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Facilities consolidation plan; UK tissue facility to remain in use until expected shutdown in October 2000. | |||
| 1999-06-30 | plant_closure | in_progress | 1998-Q4 | Canada | Personal Care | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Closure of a diaper manufacturing facility. | ||||
| 1999-06-30 | plant_closure | in_progress | 1998-Q4 | Thailand | Tissue | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Shut down and dispose of a tissue machine. | ||||
| 1999-06-30 | restructuring | in_progress | 1998-Q4 | North America | Personal Care | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Write down certain excess feminine care production equipment. | ||||
| 1999-06-30 | restructuring | in_progress | 1999-Q3 | Mobile, Alabama | Pulp/Woodlands | USD 9 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Employee severance costs for terminations related to associated woodlands operations. | |||
| 1999-03-31 | restructuring | in_progress | 1997-10-01 | Worldwide | USD 810 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | 1997 Announced Plan to restructure worldwide operations; estimated total pretax cost $810.0 million. Unutilized balance of $166.0 million at 1999-03-31 after $11.1 million utilized in the quarter; balance estimated adequate to complete plan. No employee counts disclosed. Q1 1999 included a $22.3 million pretax credit from changes in estimates; all programs related to the 1995 Scott Paper merger charge are complete. | ||||
| 1999-03-31 | restructuring | in_progress | 1997-10-01 | Worldwide | Tissue | USD -22 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Q1 1999 pretax credit of $22.3M from estimate changes on prior restructuring costs; programs from the 1995 Scott Paper merger charge now complete. No employee counts disclosed. | |||
| 1999-03-31 | restructuring | in_progress | 1997-10-01 | Worldwide | All segments | USD 166 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | 1997 Announced Plan: $177.1M balance at 1998-12-31, $11.1M utilized in Q1 1999, $166.0M remaining at 1999-03-31; total plan cost originally estimated at $810.0M. No employee counts disclosed. | |||
| 1999-03-31 | acquisition_addition | announced | 1999-04-29 | 1999-06-30 | Germany, Switzerland, Austria | Tissue | USD 380 (millions) | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Board approved purchase of consumer and away-from-home tissue businesses of Attisholtz Holding AG for approximately $380 million; to be accounted for as a purchase. No headcount disclosed. | ||
| 1999-03-31 | restructuring | completed | 1997-Q4 | 1999-03-31 | Worldwide | All segments | USD -22 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Credit of $22.3 million recorded due to changes in estimates for previously recorded restructuring costs related to the 1997 Announced Plan. Programs completed. | ||
| 1999-03-31 | acquisition_addition | announced | 1999-04-29 | 1999-Q2 | Germany, Switzerland, Austria | Tissue | USD 380 (millions) | subsequent_events f5-10q / Qwen3.6-27B-Q8_0 | Agreement to purchase consumer and away-from-home tissue businesses of Attisholtz Holding AG for approx. $380 million. | ||
| 1998-12-31 | restructuring | in_progress | 1,800 | 1997-11-21 | Worldwide | Primarily Tissue (76%) and Personal Care (22%) | USD 109 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | 1998 portion of multi-year Announced Plan announced 1997-11-21; cumulative workforce reduction through 1998 was 3,700 of 5,000 projected; ~1,100 more planned for 1999 | ||
| 1998-12-31 | restructuring | in_progress | 450 | 1998-12-31 | Worldwide (Europe, Canada, Thailand, North America) | Tissue (57%) and Personal Care (43%) | USD 123 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Q4 1998 charge for facility consolidations; exact announcement date not specified; includes European tissue asset write-downs, Canadian diaper facility closure, Thailand tissue machine shutdown | ||
| 1998-12-31 | plant_closure | announced | 450 | 1998-05-05 | 1999-09-01 | United States (Mobile, Alabama) | Pulp mill operations | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Closure driven by new US environmental emission rules requiring >$250M in compliance spending; associated Southeast Timberlands sale expected to generate net gain | ||
| 1998-12-31 | divestiture_reduction | completed | 1998-08-19 | 1998-08-19 | United States | Aviation services (K-C Aviation Inc.) | other f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sold to Gulfstream Aerospace for $250M cash; pretax gain of $140.0M; headcount not disclosed | |||
| 1998-12-31 | restructuring | in_progress | 1,800 | 1997-11-21 | Worldwide | USD 109 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | 1998 Charge related to Announced Plan. Costs primarily composed of severance payments for 1,800 employees notified by Dec 31, 1998. | |||
| 1998-12-31 | restructuring | completed | 450 | 1998-10-01 | Europe, Canada, Thailand, North America | Tissue, Personal Care | USD 123 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Fourth quarter 1998 facility consolidations charge. Employee severance costs of $12.3 million recorded for approximately 450 employees notified by Dec 31, 1998. | ||
| 1998-12-31 | divestiture_reduction | completed | 1998-08-19 | United States | Aviation | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Sale of K-C Aviation Inc. to Gulfstream Aerospace Corporation for $250 million. | ||||
| 1998-12-31 | plant_closure | announced | 450 | 1998-05-05 | 1999-09-01 | Alabama, United States | Pulp | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Intention to shut down Mobile pulp mill and sell Southeast Timberlands. Closure results in elimination of approximately 450 jobs. | ||
| 1998-12-31 | restructuring | in_progress | 1,800 | 1997-11-21 | Worldwide | USD 109 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | 1998 Charge related to the Announced Plan. Workforce reduction primarily composed of severance payments for 1,800 employees at facilities sold, closed, or downsized. Total plan projected 5,000 reductions; 3,700 realized through Dec 31, 1998. | |||
| 1998-12-31 | plant_closure | announced | 450 | 1998-05-05 | 1999-09-01 | Mobile, Alabama | Tissue / Pulp | Item 1_Business f5-10k / Qwen3.6-27B-Q8_0 | Announced intention to shut down pulp mill in Mobile, Alabama on September 1, 1999. Closure expected to eliminate approximately 450 jobs. | ||
| 1998-12-31 | restructuring | completed | 450 | 1998-10-01 | Worldwide | USD 12 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Fourth quarter 1998 facility consolidations charge included employee severance costs of $12.3 million for approximately 450 employees notified by Dec 31, 1998. | |||
| 1998-12-31 | restructuring | in_progress | 1997-11-21 | 2000-12-31 | Worldwide | Multiple segments | USD 251 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Multi-year program announced Nov 1997; FY1998 charge of $250.8M recorded as costs became accruable. Total program cost estimated at $679.5M. Through 1998-12-31, cumulative workforce reduction of 3,700 realized out of ~4,800 target; ~1,100 more expected in 1999-2000. 12 of 17 facilities closed or downsized through 1998-12-31. | ||
| 1998-12-31 | plant_closure | in_progress | 450 | 1998-10-01 | 2000-10-31 | Canada, Europe, Thailand, North America | Personal Care and Tissue | USD 49 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Q4 1998 facilities consolidation plan; $124.0M aggregate cost, $49.1M recorded in 1998. Includes Canadian diaper facility closure (~450 employees notified before year-end, $11.1M severance), European tissue capacity alignment, Thai tissue machine shutdown, and North American feminine care equipment write-down. Remaining $74.9M to be recorded in 1999-2000. | |
| 1998-12-31 | plant_closure | in_progress | 450 | 1998-05-05 | 1999-09-01 | United States (Mobile, Alabama) | Tissue — pulp operations | USD 42 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Mobile pulp mill closure announced 1998-05-05; ~450 jobs eliminated. $18.0M severance charged in Q3 1998; $24.3M energy contract termination penalty charged in Q2 1998. Total $42.3M in Mobile pulp mill fees and severances. | |
| 1998-12-31 | divestiture_reduction | completed | 1998-08-19 | 1998-08-19 | United States | Aviation services (K-C Aviation Inc.) | discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | KCA sold to Gulfstream Aerospace for $250M cash; pretax gain of $140.0M. Headcount not disclosed. | |||
| 1998-12-31 | acquisition_addition | completed | 1998-05-28 | 1998-05-28 | Brazil | Tissue | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Purchased 50% equity interest in Klabin Tissue S.A. (now Klabin Kimberly S.A.); headcount not disclosed | |||
| 1998-12-31 | acquisition_addition | completed | 1998-07-21 | 1998-07-21 | South Korea | Multiple | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Purchased additional 10% ownership in YuHan-Kimberly, Limited, increasing ownership to 70%; headcount not disclosed | |||
| 1998-12-31 | acquisition_addition | completed | 1998-07-29 | 1998-07-29 | Bolivia | Multiple | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Purchased 51% ownership interest in Kimberly Bolivia, S.A., a new joint venture; headcount not disclosed | |||
| 1998-12-31 | acquisition_addition | announced | 1998-12-23 | 1999-09-30 | United States | Health Care | USD 764 (millions) | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | Definitive agreement to acquire Ballard Medical Products valued at ~$764M, payable in KMB shares; subject to regulatory clearances and shareholder approval; expected completion by 1999-09-30; headcount not disclosed | ||
| 1998-09-30 | restructuring | in_progress | 1997-10-01 | Worldwide | USD 58 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | 1997 Announced Plan had total estimated pretax cost of $810.0 million; $701.2 million charged in 1997, remaining $108.8 million recorded when accruable. Nine months 1998 charge of $58.2 million reduced operating profit, net income and EPS by $58.2 million, $38.8 million and $.07 respectively; Q3 1998 portion was $4.4 million. Approximately $360 million of total 1997 and 1998 charges remained to be utilized at September 30, 1998. | ||||
| 1998-09-30 | restructuring | announced | 500 | 1998-09-30 | Europe | Tissue-Based Products; feminine care; administrative organization | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Plan to reduce up to 60,000 tons of tissue capacity across Europe (in addition to 30,000 tons eliminated with the May 1998 sale of the Orleans, France mill), close the Sealand, UK feminine care facility transferring production to Germany and the Czech Republic, and streamline European administration with expected $20 million annual savings; workforce reduction of approximately 500 employees expected. | |||
| 1998-09-30 | plant_closure | announced | 1998-05-05 | 1999-09-30 | Mobile, Alabama, United States | Pulp mill and associated woodlands operations | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Shutdown expected to result in a net gain and avoids approximately $260 million of environmental compliance investment; associated woodlands to be sold. Closure will reduce virgin fiber share from nearly 70 percent to about 45 percent. The Mobile tissue mill will continue operating with planned ~$100 million investment in recycled fiber systems. | |||
| 1998-09-30 | acquisition_addition | completed | 1998-05-28 | Brazil | Tissue (Klabin Tissue, S.A.) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Purchased 50 percent equity interest in Klabin Tissue, S.A., the leading tissue manufacturer in Brazil; no headcount figures disclosed. | ||||
| 1998-09-30 | acquisition_addition | completed | 1998-07-01 | Bolivia | Joint venture (Kimberly Bolivia, S.A.) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Purchased 51 percent ownership in new joint venture company Kimberly Bolivia, S.A.; no headcount figures disclosed. | ||||
| 1998-09-30 | acquisition_addition | completed | 1998-07-01 | South Korea | Affiliate Yuhan-Kimberly, Limited | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Purchased additional 10 percent interest in Korean affiliate Yuhan-Kimberly, Limited, raising ownership to 70 percent; no headcount figures disclosed. | ||||
| 1998-09-30 | restructuring | announced | 500 | 1998-11-09 | Europe | Multiple — tissue, feminine care, administration | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Consolidated European restructuring actions under the 1997 Announced Plan: tissue capacity reduction of up to 60,000 tons, closure of Sealand (UK) feminine care facility with production transferred to Germany and Czech Republic, and administrative streamlining yielding $20M annual savings. Filer presents one combined workforce-reduction figure of approximately 500 employees across all sub-actions. | |||
| 1998-09-30 | plant_closure | announced | 1998-05-05 | 1999-09-30 | United States — Mobile, Alabama | Tissue-Based Products — pulp manufacturing | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pulp mill shutdown announced May 5, 1998 with associated woodlands divestiture; avoids ~$260M environmental compliance investment. No employee count disclosed. | |||
| 1998-09-30 | plant_closure | announced | 1998-11-09 | United Kingdom — Sealand | Personal Care Products — feminine care manufacturing | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Facility closure with production transferred to Germany and Czech Republic; part of broader European restructuring. Employee count not separately disclosed — included in the ~500 consolidated European reduction. | ||||
| 1998-09-30 | divestiture_reduction | completed | 1998-08-19 | 1998-08-19 | United States | K-C Aviation Inc. | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale of K-C Aviation subsidiary completed August 19, 1998 for $250M cash; pretax gain $140M. No employee count disclosed. | |||
| 1998-09-30 | acquisition_addition | completed | 1997-12-31 | 1997-12-31 | United States | Personal Care Products — professional health care | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Acquisition of Tecnol Medical Products, Inc. in December 1997 contributed to professional health care volume growth. No headcount added disclosed. Included for context as a prior-period acquisition referenced in current-quarter MD&A. | |||
| 1998-09-30 | restructuring | in_progress | 500 | 1998-09-30 | Europe | Administrative | USD 20 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Management announced actions to reduce workforce by approximately 500 employees in Europe, including closing a facility in Sealand, UK and streamlining administrative organization, expected to result in $20 million in annual savings. | ||
| 1998-06-30 | restructuring | in_progress | 1997-10-01 | North America | USD 16 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Second-quarter portion of the 1998 Charge attributable to North America under the worldwide restructuring plan announced in Q4 1997; no employee count disclosed. | ||||
| 1998-06-30 | restructuring | in_progress | 1997-10-01 | Outside North America | USD 24 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Second-quarter portion of the 1998 Charge attributable to operations outside North America; no employee count disclosed. | ||||
| 1998-06-30 | restructuring | in_progress | 1997-10-01 | North America | USD 24 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | First-half 1998 Charge attributable to North America under the Announced Plan; no employee count disclosed. | ||||
| 1998-06-30 | restructuring | in_progress | 1997-10-01 | Outside North America | USD 29 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | First-half 1998 Charge attributable to operations outside North America; no employee count disclosed. | ||||
| 1998-06-30 | plant_closure | announced | 1998-05-05 | 1999-09-30 | Mobile, Alabama, United States | Pulp mill | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Pulp mill shutdown planned for September 1999 with sale of associated woodlands; expected to result in a net gain and avoids roughly $260 million in environmental compliance investment. No headcount disclosed. | |||
| 1998-06-30 | restructuring | in_progress | 1997-10-01 | Worldwide | Worldwide operations | USD 810 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Announced Plan total pretax cost estimated at $810.0M; $701.2M recorded in 1997, remaining $108.8M to be recorded when accrual conditions met. 1998 Charge of $53.8M pretax recorded in first six months of 1998. No employee counts disclosed. | |||
| 1998-06-30 | plant_closure | announced | 1998-05-05 | 1999-09-30 | United States — Mobile, Alabama | Tissue-Based Products — pulp mill | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pulp mill shutdown announced May 5, 1998, with associated woodlands sale. Avoids ~$260M environmental compliance investment. No employee count disclosed. | |||
| 1998-06-30 | divestiture_reduction | announced | 1998-07-24 | 1998-09-30 | United States | K-C Aviation Inc. | subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML | Agreement to sell K-C Aviation to Gulfstream Aerospace for $250M cash; expected to close Q3 1998. No employee count disclosed. | |||
| 1998-06-30 | acquisition_addition | completed | 1998-05-28 | Brazil | Tissue-Based Products | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Purchased 50% equity interest in Klabin Tissue, S.A., leading tissue manufacturer in Brazil. No employee count disclosed. | ||||
| 1998-06-30 | restructuring | in_progress | 1997-Q4 | Worldwide | Personal Care Products; Tissue-Based Products | USD 40 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | 1998 Charge related to Announced Plan from Q4 1997. Q2 1998 charge was $39.6 million pretax ($26.1 million net). YTD 1998 charge was $53.8 million pretax ($35.5 million net). Employee count not disclosed. | |||
| 1998-06-30 | plant_closure | announced | 1998-05-05 | 1999-09-01 | Mobile, Alabama | Tissue-Based Products | subsequent_events f5-10q / Qwen3.6-27B-Q8_0 | Announced shutdown of pulp mill in Mobile, AL in Sept 1999 and sale of associated woodlands. Expected to result in a net gain. Employee count not disclosed. | |||
| 1998-06-30 | divestiture_reduction | announced | 1998-07-24 | 1998-Q3 | United States | Other | USD 250 (millions) | subsequent_events f5-10q / Qwen3.6-27B-Q8_0 | Agreement to sell subsidiary K-C Aviation Inc. to Gulfstream Aerospace for $250 million cash. Transaction expected to close in Q3 1998. Employee count not disclosed. | ||
| 1998-03-31 | restructuring | in_progress | 1997-11-01 | North America | USD 9 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Q1 1998 portion of the November 1997 worldwide restructuring plan attributable to North America; part of $14.2 million total quarterly charge. No employee counts disclosed. | ||||
| 1998-03-31 | restructuring | in_progress | 1997-11-01 | Outside North America | USD 6 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Remainder of the $14.2 million Q1 1998 restructuring charge incurred outside North America, derived as total minus the $8.5 million North America portion. No employee counts disclosed. | ||||
| 1998-03-31 | restructuring | in_progress | 1997-11-01 | Personal Care Products | USD 5 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q1 1998 charge related to the Announced Plan included in Personal Care Products operating profit. | ||||
| 1998-03-31 | restructuring | in_progress | 1997-11-01 | Tissue-Based Products | USD 9 (millions) | restructuring_footnote f5-10q / GLM-5.3-flash-fp4-HTML | Q1 1998 charge related to the Announced Plan included in Tissue-Based Products operating profit. | ||||
| 1998-03-31 | plant_closure | announced | 1998-05-05 | 1999-09-30 | Mobile, Alabama, United States | Pulp mill | subsequent_events f5-10q / GLM-5.3-flash-fp4-HTML | Pulp mill shutdown announced May 5, 1998, effective September 1999; expected to result in a net gain and avoid approximately $260 million in environmental compliance investment. Associated woodlands operations to be sold. No headcount figures disclosed. | |||
| 1998-03-31 | restructuring | in_progress | 1997-11 | Worldwide | Consolidated (Personal Care Products and Tissue-Based Products sub-charges disclosed) | USD 14 (millions) | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Announced Plan announced November 1997 with total estimated pretax cost of $810.0 million; $701.2 million charged in 1997 and $14.2 million charged in Q1 1998, reducing quarterly net income by $9.4 million ($.02 per share). Remaining $108.8 million of charges to be recorded as accrual conditions arise; $573.2 million of the charge remained to be utilized at 1998-03-31. No employee-affected counts disclosed. Q1 1998 sub-charges: $4.9 million Personal Care Products, $9.3 million Tissue-Based Products; $8.5 million incurred in North America, remainder outside North America. | |||
| 1998-03-31 | plant_closure | announced | 1998-05-05 | 1999-09 | Mobile, Alabama, United States | Tissue-Based Products — pulp mill (woodlands operations to be sold) | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Post-quarter announcement (subsequent event) to shut the Mobile pulp mill in September 1999 and sell associated woodlands; expected to produce a net gain and avoid roughly $260 million of environmental compliance investment. No headcount figure disclosed. Related: continued operation of the Mobile tissue mill with about $100 million of planned investment. | |||
| 1998-03-31 | restructuring | in_progress | 1997-11-01 | Worldwide | Personal Care Products; Tissue-Based Products | USD 14 (millions) | restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0 | Part of Announced Plan (Nov 1997). Q1 1998 charge of $14.2M includes $4.9M for Personal Care and $9.3M for Tissue-Based. Employee count not disclosed. | |||
| 1998-03-31 | plant_closure | announced | 1998-05-05 | 1999-09-01 | Mobile, Alabama | Pulp Mill | subsequent_events f5-10q / Qwen3.6-27B-Q8_0 | Announced shutdown of pulp mill in Sept 1999. Expected net gain. Employee count not disclosed. | |||
| 1997-12-31 | restructuring | in_progress | 5,000 | 1997-11-21 | Worldwide | Multiple — sale, closure or downsizing of 18 manufacturing facilities | USD 701 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Total program cost approximately $810.0M pretax; $701.2M charged in 1997, remaining $108.8M to be recorded in 1998. 1,900 employees notified by 1997-12-31; remainder to be notified in 1998. Workforce reduction component of charge was $57.3M in 1997. | ||
| 1997-12-31 | acquisition_addition | completed | 1997-12-18 | United States | Professional Health Care / Medical Products | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Acquired via exchange of approximately 8.7 million shares of KMB common stock; no employee headcount disclosed for the acquired business. | ||||
| 1997-12-31 | divestiture_reduction | completed | 1997-03-27 | United States (Alabama) | Newsprint, Paper and Other — Coosa Pines pulp and newsprint operations | Item_1_Business f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sold to Alliance Forest Products Inc. for approximately $600 million in cash; no employee headcount disclosed. | ||||
| 1997-12-31 | divestiture_reduction | completed | 1997-06-06 | Canada | Tissue-Based Products — 50.1% interest in Scott Paper Limited | Item_1_Business f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sold to Kruger, Inc. for approximately $127 million; no employee headcount disclosed. | ||||
| 1997-12-31 | restructuring | in_progress | 5,000 | 1997-11-21 | Worldwide | Manufacturing | USD 701 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Announced Plan includes sale, closure or downsizing of 18 manufacturing facilities and workforce reduction of approx. 5,000 employees. Pretax charge of $701.2 million recorded in 1997. | ||
| 1997-12-31 | restructuring | in_progress | 5,000 | 1997-11-21 | Worldwide | USD 701 (millions) | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Announced Plan includes sale, closure or downsizing of 18 manufacturing facilities and workforce reduction of approx 5,000 employees. Pretax charge of $701.2 million recorded in 1997. Remaining costs of $108.8 million to be recorded in 1998. | |||
| 1997-09-30 | acquisition_addition | announced | 1997-09-04 | 1997-12-31 | United States | Personal Care Products | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Definitive agreement to acquire Tecnol Medical Products, maker of disposable face masks and patient care products; purchase consideration of approximately 8.9 million KCB shares; no employee headcount disclosed. | |||
| 1997-09-30 | divestiture_reduction | announced | 1997-11-03 | 1998-01-31 | Canada | Newsprint, Paper and Other | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Agreement to sell Terrace Bay, Ontario and New Glasgow, Nova Scotia pulp facilities and related woodlands to Harmac Pacific Inc.; subject to financing and regulatory approvals; no employee headcount disclosed. | |||
| 1997-09-30 | restructuring | in_progress | North America | Tissue-Based Products (away-from-home) | USD 204 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Strategic changes combining Kimberly-Clark's and Scott's away-from-home tissue businesses; remaining one-time charge reserve of $203.5M at 1997-09-30 (from $423.1M at 1996-12-31); approximately $125M cash charged to reserves during first nine months of 1997; no employee headcount disclosed. | ||||
| 1997-09-30 | divestiture_reduction | completed | Canada | Tissue-Based Products | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale of 50.1% equity interest in Scott Paper Limited (June 1997) and Coosa Pines, Alabama newsprint/pulp mill (March 1997), reported as extraordinary gains totaling $17.5M; no employee headcount disclosed. | |||||
| 1997-09-30 | restructuring | in_progress | North America | Away-from-home tissue business | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Strategic changes in combination of Kimberly-Clark's and Scott's away-from-home businesses resulted in higher costs and negative impact on operating profit equivalent to approximately 2 cents per share in Q3 1997. | |||||
| 1997-09-30 | restructuring | in_progress | Global | Corporate / General | USD 125 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Approximately $125 million of cash payments were charged to reserves related to the 1995 one-time charge for Scott merger restructuring and other unusual items during the first nine months of 1997. | ||||
| 1997-06-30 | divestiture_reduction | completed | 1997-06-06 | 1997-06-06 | Canada | Tissue-Based Products | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale of 50.1% interest in Scott Paper Limited to Kruger Inc. for approximately $127 million; no employee headcount disclosed. | |||
| 1997-06-30 | plant_closure | completed | 1997-03-01 | 1997-03-31 | United States | Newsprint, Paper and Other | restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale of Coosa Pines, Alabama newsprint and pulp manufacturing mill with related woodlands; no employee headcount disclosed. | |||
| 1997-06-30 | restructuring | in_progress | 1995-12-12 | United States | Consolidated | USD 100 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Ongoing Scott merger restructuring; approximately $100 million in cash payments charged to one-time charge reserves during first six months of 1997; $423.1 million of reserves remained at Dec 31, 1996. No employee counts disclosed. | |||
| 1997-06-30 | restructuring | in_progress | 1995-12-12 | Global | Combined Operations | USD 100 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Approximately $100 million of cash payments charged to reserves related to the 1995 Scott merger one-time charge for restructuring combined operations. | |||
| 1997-06-30 | divestiture_reduction | completed | 1997-06-06 | 1997-06-06 | Canada | Tissue-Based Products | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Sale of 50.1% interest in Scott Paper Limited (SPL), a Canadian tissue subsidiary, to Kruger Inc. | |||
| 1997-06-30 | divestiture_reduction | completed | 1997-03-31 | 1997-03-31 | Alabama, USA | Newsprint, Paper and Other | Notes to Financial Statements f5-10q / Qwen3.6-27B-Q8_0 | Sale of Coosa Pines newsprint and pulp manufacturing mill and related woodlands. | |||
| 1997-03-31 | divestiture_reduction | completed | 1997-03-27 | 1997-03-27 | United States (Coosa Pines, Alabama) | Newsprint, Paper and Other | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale of newsprint and pulp operations plus related woodlands to Alliance Forest Products for approximately $600 million; no employee counts disclosed. | |||
| 1997-03-31 | divestiture_reduction | announced | 1997-02-25 | Canada (Terrace Bay, Ontario; New Glasgow, Nova Scotia) and Spain (Miranda) | Newsprint, Paper and Other (pulp manufacturing) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Intention to sell three pulp facilities announced 1997-02-25; Terrace Bay and New Glasgow expected to be sold at a gain, Miranda written down as impaired; no employee counts disclosed. | ||||
| 1997-03-31 | plant_closure | in_progress | United States (Oconto Falls, Wisconsin; Yucca, Arizona; Everett, Washington) | Newsprint, Paper and Other (recycled fiber, tissue converting, integrated pulp) | USD 112 (millions) | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Impairment losses of $111.5 million before tax benefits on planned disposals under SFAS 121, aggregated with the Coosa sale as an extraordinary gain of $4.8 million net; no employee counts disclosed. | ||||
| 1997-03-31 | divestiture_reduction | announced | 1997-12-31 | Canada | Newsprint, Paper and Other (Scott Paper Limited, 50.1% owned) | other f5-10q / MiMo-V2.6-Flash-fp8-HTML | Corporation intends to sell its 50.1% interest in Scott Paper Limited during 1997; no announcement date or employee counts disclosed. | ||||
| 1996-12-31 | restructuring | in_progress | 4,200 | 1995-12-12 | 1997-12-31 | Global | Multiple segments | USD 1,440 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Cumulative through 1996 (1995 and 1996 combined) from Scott merger integration program; original plan targeted 6,000 reductions; $1,440M one-time charge recorded Q4 1995; $1,016.9M utilized through 1996, $423.1M expected in 1997 | |
| 1996-12-31 | divestiture_reduction | announced | 1,800 | 1997-03-04 | Canada | Tissue-Based Products | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Employees primarily at Scott Paper Limited (SPL) will no longer be employed after sale to Kruger Inc.; announced after fiscal year-end | |||
| 1996-12-31 | divestiture_reduction | completed | 1996-06-28 | 1996-06-28 | United States | Tissue-Based Products (baby wipes) | Item_1_Business f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sale of Scott baby and child wipe businesses and Dover, Delaware facility to Procter & Gamble; required by U.S. Justice Department for Scott merger; no employee count disclosed | |||
| 1996-12-31 | plant_closure | completed | 1996-07-31 | 1996-07-31 | United States | Tissue-Based Products | Item_1_Business f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sale of Fort Edward, New York tissue mill and licensing of Scotties brand to Irving Tissue; required by U.S. Justice Department; no employee count disclosed | |||
| 1996-12-31 | plant_closure | completed | 1996-09-16 | 1996-09-16 | United Kingdom | Tissue-Based Products | Item_1_Business f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sale of Prudhoe, England tissue mill and UK/Ireland consumer tissue businesses to SCA; required by European Commission; no employee count disclosed | |||
| 1996-12-31 | plant_closure | completed | 1996-11-22 | 1996-11-22 | United States | Tissue-Based Products | Item_1_Business f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sale of Lakeview tissue mill in Neenah, Wisconsin to American Tissue Mills; required by U.S. Justice Department; no employee count disclosed | |||
| 1996-12-31 | divestiture_reduction | announced | 1997-02-14 | 1997-03-27 | United States | Newsprint, Paper and Other | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | Agreement to sell Coosa Pines, Alabama pulp and newsprint operations to Alliance Forest Products for ~$600M; announced after fiscal year-end; no employee count disclosed | |||
| 1996-12-31 | divestiture_reduction | announced | 1997-02-25 | 1998-06-30 | Canada; Spain | Tissue-Based Products (pulp) | subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML | Intention to sell pulp operations at Terrace Bay, Ontario; New Glasgow, Nova Scotia; and Miranda, Spain by mid-1998; announced after fiscal year-end; no employee count disclosed | |||
| 1996-12-31 | restructuring | in_progress | 4,200 | 1995-12-31 | 1997-12-31 | Global | All Segments | USD 1,440 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | 1995 one-time charge for merger with Scott Paper Company. 4,200 employees left in 1995 and 1996. Additional 1,800 employees at SPL expected to leave upon sale. | |
| 1996-12-31 | divestiture_reduction | completed | 1996-06-28 | 1996-06-28 | United States | Tissue-Based Products | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Sale of baby and child wipe businesses (Baby Fresh, Wash a-Bye Baby, Kid Fresh) and Dover, DE facility to Procter & Gamble. | |||
| 1996-12-31 | divestiture_reduction | completed | 1996-07-31 | 1996-07-31 | United States | Tissue-Based Products | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Sale of Fort Edward, NY tissue mill and licensing of Scotties brand to Irving Tissue, Inc. | |||
| 1996-12-31 | divestiture_reduction | completed | 1996-09-16 | 1996-09-16 | United Kingdom and Ireland | Tissue-Based Products | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Sale of Prudhoe, England tissue mill and certain consumer tissue businesses to Svenska Cellulosa Aktiebolaget (SCA). | |||
| 1996-12-31 | divestiture_reduction | completed | 1996-11-22 | 1996-11-22 | United States | Tissue-Based Products | Item_1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Sale of Lakeview tissue mill in Neenah, Wisconsin to American Tissue Mills of Neenah, LLC. | |||
| 1996-12-31 | restructuring | in_progress | 4,200 | 1995-12-31 | 1997-12-31 | Worldwide | Various | USD 1,440 (millions) | restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0 | 1995 one-time charge for Scott merger integration. 4,200 employees left in 1995-1996. Additional 1,800 at SPL to be sold. | |
| 1996-12-31 | divestiture_reduction | completed | 1995-11-30 | 1995-11-30 | US, France, Canada | Paper and Forest Products | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Spin-off of Schweitzer-Mauduit International, Inc. (SMI). | |||
| 1996-12-31 | divestiture_reduction | completed | 1996-05-30 | 1996-05-30 | US | Airline Services | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Sale of remaining 20% interest in Midwest Express Holdings, Inc. | |||
| 1996-12-31 | divestiture_reduction | completed | 1996-06-28 | 1996-06-28 | US | Tissue-Based Products | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Sale of baby and child wipe businesses to Procter & Gamble. | |||
| 1996-12-31 | divestiture_reduction | completed | 1996-07-31 | 1996-07-31 | US | Tissue-Based Products | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Sale of Fort Edward, NY tissue mill to Irving Tissue, Inc. | |||
| 1996-12-31 | divestiture_reduction | completed | 1996-09-16 | 1996-09-16 | UK, Ireland | Tissue-Based Products | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Sale of Prudhoe, England mill and consumer tissue businesses to SCA. | |||
| 1996-12-31 | divestiture_reduction | completed | 1996-11-22 | 1996-11-22 | US | Tissue-Based Products | Item_1_Business f5-10k / Qwen3.6-27B-Q8_0 | Sale of Lakeview tissue mill in Neenah, Wisconsin. | |||
| 1996-09-30 | restructuring | in_progress | 1995-12-31 | United States and Europe | Consolidated operations | USD 275 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Over $275M charged against accruals in first nine months of 1996 for severance, professional fees, and lease terminations from the Q4 1995 $1,440M one-time merger/restructuring charge. No employee count disclosed. | |||
| 1996-09-30 | divestiture_reduction | completed | 1996-06-28 | 1996-06-28 | United States | Personal Care Products (baby and child wipes) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale of Scott baby and child wipe brands and Dover, DE facility to Procter & Gamble to satisfy U.S. regulatory requirements for the Scott merger. No employee count disclosed. | |||
| 1996-09-30 | plant_closure | completed | 1996-07-31 | 1996-07-31 | United States | Tissue-Based Products (facial tissue) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale of Fort Edward, NY mill and Scotties facial tissue business to Irving Tissue, Inc. to satisfy U.S. regulatory requirements for the Scott merger. No employee count disclosed. | |||
| 1996-09-30 | divestiture_reduction | completed | 1996-07-01 | 1996-09-30 | United Kingdom and Ireland | Tissue-Based Products | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale of Prudhoe, England tissue mill and consumer tissue businesses in UK and Ireland to SCA of Sweden to satisfy European Commission requirements for the Scott merger. No employee count disclosed. | |||
| 1996-09-30 | plant_closure | announced | 1996-07-01 | United States | Tissue-Based Products | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Agreement reached to sell Lakeview tissue mill in Neenah, Wisconsin to American Tissue Mills of Neenah LLC; would complete U.S. and European regulatory disposals for the Scott merger. No employee count disclosed. | ||||
| 1996-09-30 | acquisition_addition | completed | 1996-07-01 | 1996-09-30 | Brazil | Personal Care Products | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Purchase of 51 percent interest in Kenko do Brasil personal care joint venture in July 1996. No employee count disclosed. | |||
| 1996-09-30 | acquisition_addition | completed | 1996-07-01 | 1996-09-30 | Malaysia | Consolidated operations | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Acquisition of additional 49 percent interest in Kimberly-Clark Malaysia, bringing ownership to 100 percent. No employee count disclosed. | |||
| 1996-09-30 | restructuring | in_progress | 1995-12-31 | Global | Various | USD 275 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | During the first nine months of 1996, more than $275 million of employee severance and other employee-related costs; fees for investment bankers, lawyers and accountants; and lease and contract termination costs were charged to these accruals related to the 1995 merger with Scott Paper Company. | |||
| 1996-06-30 | restructuring | in_progress | 1995-12-12 | United States and Europe | Combined Kimberly-Clark and Scott operations | USD 1,440 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | One-time pretax charge recorded in Q4 1995 for merger with Scott, restructuring of combined operations, and other unusual charges; includes mill/facility write-downs, employee severance and other employee-related costs, lease and contract termination costs, impaired asset charges, and merger fees. More than $200 million of severance, professional fees, and lease/contract termination costs were charged to these accruals during the first six months of 1996. No employee headcount figures disclosed. | |||
| 1996-06-30 | divestiture_reduction | completed | 1996-06-28 | 1996-06-28 | United States | Baby and child wipes business (former Scott) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Sale of former Scott baby and child wipes business (Baby Fresh, Wash a-Bye Baby, Kid Fresh brands and Dover, Delaware facility) to Procter & Gamble; proceeds in excess of $200 million. No headcount disclosed. | |||
| 1996-06-30 | divestiture_reduction | completed | 1996-07-31 | 1996-07-31 | United States | Fort Edward, New York mill and Scotties facial tissue business | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Subsequent event: sale of Scott's Fort Edward, New York mill and Scotties facial tissue business to Irving Tissue, Inc. No headcount disclosed. | |||
| 1996-06-30 | plant_closure | announced | Europe | Baby wipes converting plant, Neunkirchen, Germany | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Corporation decided to divest the baby wipes converting plant in Neunkirchen, Germany. No headcount disclosed. | |||||
| 1996-06-30 | plant_closure | announced | Netherlands | Feminine care products mill, Veenendaal | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Feminine care production consolidated at Forchheim mill in Germany; Veenendaal, Netherlands mill to be sold or closed. No headcount disclosed. | |||||
| 1996-06-30 | restructuring | in_progress | United Kingdom | Tissue mill, Larkfield, England | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Tissue mill in Larkfield, England restructured; negotiations underway to sell the Prudhoe, England tissue mill. No headcount disclosed. | |||||
| 1996-06-30 | restructuring | announced | Germany and Netherlands | Facilities in Flensburg and Koblenz, Germany, and Gennep, Netherlands | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Over the next 18 months, the Corporation expects to downsize facilities in Flensburg and Koblenz, Germany, and Gennep, Netherlands. No headcount disclosed. | |||||
| 1996-06-30 | divestiture_reduction | announced | 1996-04-18 | Canada | Scott Paper Limited (SPL) — 50.1 percent interest | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Corporation announced it would sell its 50.1 percent interest in publicly traded Canadian company Scott Paper Limited; discussions on terms continuing; sale expected to result in a gain when realized. No headcount disclosed. | ||||
| 1996-06-30 | restructuring | in_progress | 1995-12-12 | United States and Europe | Consolidated operations | USD 1,440 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | One-time pretax charge of $1,440.0M for Scott merger integration, restructuring, and other unusual charges. During H1 1996, more than $200M of employee severance, professional fees, and lease/contract termination costs were charged against these accruals. No employee counts disclosed. | |||
| 1996-06-30 | divestiture_reduction | completed | 1996-06-28 | United States | Personal Care Products (baby and child wipes) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale of Scott baby/child wipes business (three brands and Dover, DE facility) to P&G to meet merger regulatory requirements. Proceeds exceeded $200M. No employee count disclosed. | ||||
| 1996-06-30 | plant_closure | announced | 1996-07-31 | United States | Tissue-Based Products (Fort Edward, NY mill and Scotties facial tissue) | subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML | Sale of Fort Edward, NY mill and Scotties facial tissue business to Irving Tissue completed July 31, 1996 (subsequent to quarter end). No employee count disclosed. | ||||
| 1996-06-30 | restructuring | in_progress | Europe (Germany, Netherlands, England) | Personal Care and Tissue-Based Products | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Divest Neunkirchen baby wipes plant; consolidate feminine care at Forchheim while closing Veenendaal mill; restructure Larkfield tissue mill; downsize Flensburg, Koblenz, and Gennep facilities over 18 months. Negotiations underway to sell Prudhoe tissue mill. No employee counts disclosed. | |||||
| 1996-06-30 | acquisition_addition | completed | 1996-06-30 | Argentina, Israel, Venezuela | Personal Care Products and Tissue-Based Products | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Increased Kimberly-Clark Argentina to 100% from 51%; purchased 49.9% of Hogla Ltd. in Israel; purchased 51% of Papelera Guaicaipuro in Venezuela. No employee counts disclosed. | ||||
| 1996-06-30 | restructuring | in_progress | 1995-12-31 | Global | Various | USD 200 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | More than $200 million of employee severance and other employee-related costs charged to 1995 merger accruals during the first six months of 1996. | |||
| 1996-06-30 | plant_closure | completed | 1996-06-28 | United States | Personal Care Products | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Sale of baby and child wipes business and Dover, Delaware production facility to Procter & Gamble. | ||||
| 1996-06-30 | plant_closure | completed | 1996-07-31 | United States | Tissue-Based Products | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Sale of Fort Edward, New York mill and Scotties facial tissue business to Irving Tissue, Inc. | ||||
| 1996-06-30 | plant_closure | in_progress | Germany | Personal Care Products | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Divestiture of baby wipes converting plant in Neunkirchen; consolidation of feminine care production at Forchheim mill. | |||||
| 1996-06-30 | plant_closure | in_progress | Netherlands | Personal Care Products | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Selling or closing feminine care products mill in Veenendaal. | |||||
| 1996-06-30 | restructuring | in_progress | England | Tissue-Based Products | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Restructured tissue mill in Larkfield. | |||||
| 1996-06-30 | restructuring | in_progress | 1997-12-31 | Germany | Tissue-Based Products | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Expected to downsize facilities in Flensburg and Koblenz over next 18 months. | ||||
| 1996-06-30 | restructuring | in_progress | 1997-12-31 | Netherlands | Tissue-Based Products | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Expected to downsize facility in Gennep over next 18 months. | ||||
| 1996-06-30 | plant_closure | in_progress | England | Tissue-Based Products | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Negotiations underway to sell Prudhoe tissue mill. | |||||
| 1996-03-31 | restructuring | in_progress | 1995-12-12 | 1996-12-31 | United States and Europe | Combined operations | USD 1,440 (millions) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | One-time pretax charge recorded in Q4 1995 for Scott merger costs, restructuring of combined operations, and other unusual charges; includes mill/facility write-downs, employee severance and other employee-related costs, lease and contract terminations, and impaired asset charges. During Q1 1996, $88.3 million of severance, professional fees, and lease/contract termination costs were charged to the accruals. No employee counts disclosed. | ||
| 1996-03-31 | divestiture_reduction | announced | 1996-04-18 | Canada | Scott Paper Limited (50.1% interest) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Corporation announced sale of its 50.1 percent interest in Scott Paper Limited, a publicly traded Canadian company acquired in the Scott merger; expected to result in a gain when realized. No headcount figures disclosed. | ||||
| 1996-03-31 | divestiture_reduction | announced | 1996-04-18 | United States | Midwest Express Holdings, Inc. (parent of MEA) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Board approved sale of remaining interest in Midwest Express Holdings, Inc. — approximately 1.3 million common shares — through a secondary public offering; expected to result in a gain when realized. No headcount figures disclosed. | ||||
| 1996-03-31 | restructuring | in_progress | 1996-12-31 | United States and Europe | Combined operations following Scott Paper merger | USD 88 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Q1 1996 charge to restructuring accruals covered employee severance, professional fees, and lease/contract terminations; no employee count disclosed. Program stems from the $1,440.0 million pretax one-time charge recorded in Q4 1995 for the Scott merger, restructuring, and other unusual items; targeted mills and facilities expected to be divested by end of 1996. | |||
| 1996-03-31 | restructuring | in_progress | 1995-12-12 | 1996-12-31 | United States and Europe | Manufacturing and Corporate | USD 88 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Charges for employee severance, investment banker fees, lease/contract terminations related to Scott merger. Mills targeted for disposal expected divested by end of 1996. | ||
| 1995-12-31 | acquisition_addition | completed | 1995-07-16 | 1995-12-12 | Global | Tissue-Based Products | business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Merger of Scott Paper Company consummated 1995-12-12; 119.7 million K-C shares issued at 0.78 ratio, $9.4 billion transaction, accounted for as pooling of interests. Scott headcount added is not separately disclosed; combined workforce referenced only indirectly via the integration plan. | |||
| 1995-12-31 | restructuring | in_progress | 2,700 | 1995-12-12 | 1996-12-31 | Global | Corporate and sales staff (duplicate positions) | USD 220 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Elimination of about 2,700 duplicate staff and sales positions under the worldwide integration plan. Communication of planned reductions occurred no later than 1995-12-31; severance payments expected substantially complete by end of 1996. Announcement date is the merger consummation date; the filer does not state a separate plan announcement date. | |
| 1995-12-31 | plant_closure | announced | 3,300 | 1995-12-12 | Europe, Canada and United States | Tissue-Based Products (mills) and U.S. research facility | USD 212 (millions) | restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Plan contemplates sale of up to 12 mills employing about 3,300 people, plus write-down to net realizable value of nine mills in Europe/Canada and a U.S. research facility. Sale or closure required to eliminate excess capacity. Combined with the staff reduction, the plan targets about 6,000 jobs, roughly 10 percent of the merged workforce. No completion date stated. | ||
| 1995-12-31 | divestiture_reduction | completed | 1995-11-30 | 1995-11-30 | United States, Canada, France | Newsprint, Paper and Other (tobacco-related and specialty papers) | USD 8 (millions) | discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Tax-free spin-off of Schweitzer-Mauduit International, Inc. distributed to stockholders of record 1995-11-13, paid 1995-11-30; one SMI share per ten K-C shares. Spin-off expenses of $7.6 million recognized. Headcount transferred not disclosed. | ||
| 1995-12-31 | divestiture_reduction | completed | 1995-09-27 | 1995-09-27 | United States | Other products and services (Midwest Express Airlines / Astral Aviation) | discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sale of 80 percent of Midwest Express Holdings, Inc. in an initial public offering; pretax gain of $61.4 million ($40.0 million after-tax). Retained 20 percent stake reclassified to equity company investments. Headcount not disclosed. | |||
| 1995-12-31 | divestiture_reduction | completed | 1994-12-20 | 1994-12-20 | United States | Newsprint, Paper and Other (printing and publishing papers) | discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML | Sale of S.D. Warren completed 1994-12-20 for approximately $1.6 billion; reported as a discontinued operation in all periods presented. Included here only because the 1995 filing restates prior periods under pooling-of-interests accounting — the disposition itself occurred in fiscal 1994, not fiscal 1995. Headcount not disclosed. | |||
| 1995-12-31 | restructuring | completed | 6,000 | 10.8% | 1995-07-16 | 1995-12-31 | Worldwide | All Segments | USD 1,440 (millions) | Item 1_Business f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML | Worldwide integration plan following Scott Paper merger. Includes sale/closure of 12 mills (3,300 employees) and elimination of 2,700 duplicate staff/sales positions. Represents ~10% of combined workforce. Charge includes severance, lease terminations, and asset write-downs. |
| 1995-12-31 | restructuring | in_progress | 6,000 | 10% | 1995-12-12 | Worldwide | Combined Operations (Personal Care, Tissue, Newsprint) | USD 1,440 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | Worldwide integration plan following Scott Paper merger. Includes sale of up to 12 mills (3,300 employees) and elimination of 2,700 duplicate staff/sales positions. Represents 10% of combined workforce. | |
| 1995-12-31 | restructuring | completed | 1993-01-01 | 1994-12-31 | Worldwide | Scott Paper Operations | USD 467 (millions) | MD&A f5-10k / Qwen3.6-27B-Q8_0 | 1993 restructuring plan modified in Aug 1994 to accelerate timing and increase workforce reductions. Completed by year-end 1994. No additional charges needed in 1995. | ||
| 1995-09-30 | acquisition_addition | announced | 1995-07 | 1995-12-31 | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Definitive merger agreement with Scott Paper announced July 1995; Scott shareholders to receive 0.78 Kimberly-Clark shares per Scott share, involving issuance of approximately 119.6 million new shares. Merger expected to close in late 1995, subject to regulatory clearances and shareholder approvals. No headcount figures disclosed; a one-time pretax restructuring/merger charge of $1.0-$1.5 billion (after-tax $750 million-$1.15 billion) estimated, including employee termination costs to eliminate duplicate facilities and excess capacity. | |||||
| 1995-09-30 | divestiture_reduction | announced | 1995-05 | 1995-11-30 | United States and France | Tobacco-related businesses (Class II) | MD&A f5-10q / GLM-5.3-flash-fp4-HTML | Spin-off of tobacco-related businesses in the U.S. and France into Schweitzer-Mauduit International, Inc.; distribution of one SMI share per 10 Kimberly-Clark shares payable November 30, 1995 to holders of record November 13, 1995. These operations had 1994 net sales of $404 million. No headcount figures disclosed. | |||
| 1995-09-30 | restructuring | announced | 1995-07-01 | 1995-12-31 | United States and international | Combined Kimberly-Clark and Scott Paper operations | USD 1,000 (millions) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Pretax charge estimated at $1.0–1.5B covering plant rationalizations, employee terminations, integration costs, and merger fees. After-tax estimate $750M–$1.15B. No specific employee count disclosed. Merger expected to close late 1995, subject to regulatory and shareholder approvals. | ||
| 1995-09-30 | divestiture_reduction | announced | 1995-05-01 | 1995-11-30 | United States and France | Tobacco-related businesses (Schweitzer-Mauduit International) | MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML | Spin-off of Schweitzer-Mauduit International, Inc. to Kimberly-Clark stockholders; distribution payable 1995-11-30 to holders of record 1995-11-13. Operations had net sales of $404M in 1994. No employee count disclosed. | |||
| 1995-09-30 | restructuring | announced | 1995-07-01 | Global | Combined Kimberly-Clark and Scott operations | USD 1,000 (millions) | MD&A f5-10q / Qwen3.6-27B-Q8_0 | Merger agreement signed July 1995. Estimated one-time pretax charge of $1.0 billion to $1.5 billion for plant rationalizations, employee terminations, and integration costs. Specific headcount not disclosed. |